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PREFACE 
 Bacterial conjugation, as far as we know, is a uniquely prokaryotic 
phenomenon, reflecting a fundamental structural distinction between prokaryotic and 
eukaryotic cells. Eukaryotic cells, with their genome sequestered from the plasma 
membrane by inclusion in intracellular organelles, have not evolved or retained 
mechanisms of genetic exchange that require the movement of DNA directly from 
one cell to another. Prokaryotic cells, lacking the constraints imposed by such 
organelles, have widely exploited such mechanisms of horizontal transfer. In spite of 
its near-ubiquity in the bacterial world, and its clear relevance to the dissemination of 
antibiotic resistance, conjugal DNA transfer remains a “black box”. The organism 
responsible for the horizontal transfer of genetic material among prokaryotes was 
identified more than half a century ago. 
 In 1940, Max Delbrück and Salvador Luria initiated a series of studies with a 
new organism, destined to become as important to genetic research as the garden 
pea and the fruit fly. This new organism was a group of viruses that attack bacterial 
cells and are therefore known as bacteriophage (“bacteria eater”) or simply, phage. 
Every known type of bacterial cells is preyed upon by its own type of bacterial virus, 
and many bacteria are host to many different kinds of viruses. It was later found that 
phage are the key players of dissemination of genetic material in the bacterial world. 
 In 1985, G.P. Smith proved the concept of “phage display”: fragments of the 
EcoRI endonuclease could be fused to the amino-terminal portion of a phage coat 
protein, to produce a chimeric protein that was packaged into phage particles. These 
phages could be propagated in bacteria, even though they were somewhat defective 
with regard to infectivity. They could be affinity-purified from a mixture of phages in 
which the majority did not contain the EcoRI insert.      
 The present manuscript explores the world of bacteriophages. More 
specifically, it aims at a better understanding of the processes governing bacterial 
infection by filamentous bacteriophages. A better understanding of infection 
mechanisms has implications for biotechnology, concerning phage display 
technology, as well as for medicine, concerning the association of bacterial virulence 
genes with mobile genetic elements like the filamentous phages ctxφ, in the case of 
cholera. 
                                   
 
Felix d’Hérelle was a French-Canadian bacteriologist. In 1910, he was studying a plague of 
locusts in Mexico when he noticed that they were being killed by some natural agent, which 
he called bacteriophage – devourer of bacteria 
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Summary 
 The present work is dedicated, in its first part, to the detailed study of the 
structural processes governing bacterial infection by filamentous phage. In a second 
part, I illustrate the use of filamentous phage as a tool to improve the binding 
property of an antibody fragment.   
 The first section, entitled “Biology and structure of filamentous 
bacteriophages”, is intended to give the reader a general overview of the biology of 
filamentous phages and bacteria, focussing on those concepts that are useful for the 
understanding of the experiments in the subsequent chapters of this dissertation.  
 In the second section, two proteins which are intricately implicated in the 
infection process of Escherichia coli by filamentous bacteriophages have been 
investigated and, to some extent, biochemically characterized. The minor coat 
protein pIII has been extensively studied; its biochemical characterization led us to 
the conclusion that pIII is intrinsically unstable in solution. Once isolated from 
inclusion bodies in E. coli, it is proteolytically processed at its C-terminus. The 
contaminating protease responsible for this spontaneous effect has remained 
elusive. Different protein constructs were generated, and they all showed the same 
pattern of unspecific cleavage. The next chapter of this section is devoted to the 
TolQRA complex, and in particular to the inner membrane-anchored TolR, known to 
be critical for phage entry. This protein has proved to possess a high degree of 
conformational flexibility. Different C-terminal constructs of various lengths were 
assessed by two-dimensional NMR spectra; they all showed a non-optimal 
dispersion pattern, thus preventing any further detailed structural characterization. 
Finally, the topologically related ExbB-ExbD-TonB complex was investigated. This 
complex provides energy for siderophore and colicins transport across the outer 
membrane, but it has also been parasitized by certain phages. Using a prediction-
based method to define the folded domain of TonB, a crystal structure could be 
obtained. Our published crystal structure of the C-terminal domain of TonB forms the 
basis of a critical discussion about the transport mechanism of colicins into E. coli 
(Chang et al., 2001). Our findings have been challenged by other research groups, 
who concluded that our dimeric structure resulted from a crystallization artefact. New 
results on TonB itself, as well as on outer membrane transporters contacted by the 
C-terminus of TonB are reviewed and critically discussed. 
 The third section demonstrates the usefulness of bacteriophages in a  
modern biotechnological application. It is illustrated by the affinity maturation of an 
antibody fragment directed against a mammalian membrane protein complex of 
immunological relevance. By combining phage display and structure-based antibody 
engineering methods, we tried to improve the dissociation constant of a Fab antibody 
fragment specific for the MHC-gp33 peptide complex. By subjecting the variable 
domains of the starting clone to error-prone PCR, several libraries with different 
mutational loads were constructed. The libraries were displayed monovalently at the 
tip of the phage, and off-rate selection was applied in order to select for higher 
affinities. Unexpectedly, the heavy chain of the original wild-type Fab has been 
reselected after two rounds of phage display. By constructing a single domain 
antibody consisting solely on the wild-type heavy chain of the variable domain, full 
binding activity towards the MHC-gp33 was retained, but the affinity did not improve 
as expected. An interpretation of our results is given in view of recent protein 
evolution studies dealing with protein plasticity and their tolerance to amino acids 
mutations.      
Literature 
Chang, C., Mooser, A., Plückthun, A., and Wlodawer, A. (2001). Crystal structure of 
the dimeric C-terminal domain of TonB reveals a novel fold. J Biol Chem 276, 27535-
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Zusammenfassung 
 Die vorliegende Arbeit ist in ihrem ersten Teil der ausführlichen Untersuchung 
der strukturellen Prozesse gewidmet, die die bakterielle Infektion durch filamentöse 
Bakteriophagen regeln. In einem zweiten Teil wird der Gebrauch der filamentösen 
Bakteriophagen als Werkzeug beschrieben, um die Bindungs-eigenschaft eines 
Antikörperfragments zu verbessern.  
Der erste Abschnitt, betitelt „Biology and structure of filamentous 
bacteriophages”, soll dem Leser einen allgemeinen Überblick über die Biologie der 
filamentösen Bakteriophagen und des Bakteriums geben. Er fokussiert auf einige 
Konzepte, die für das Verständnis des Fachstoffes in den folgenden Kapiteln nützlich 
sind. 
Im zweiten Abschnitt wird die Untersuchung und biochemische 
Charakterisierung zweier Proteine beschrieben, von denen man annimmt, dass sie 
im Infektionsprozeß von Escherichia coli durch filamentöse Bakteriophagen involviert 
sind. Das Hüllprotein pIII ist im Detail untersucht worden; seine biochemische 
Charakterisierung führte uns zum Ergebnis, dass pIII in gelöster Form an sich instabil 
ist. Kurz nach Isolierung aus den „inclusion bodies“ in E. coli wird das pIII an seinem 
C-terminalen Ende proteolytisch prozessiert. Die kontaminierende Protease, die für 
diesen spontanen Effekt verantwortlich ist, ist schwer bestimmbar geblieben. 
Unterschiedliche Proteinkonstrukte wurden erzeugt, und sie zeigten alle das gleiche 
Muster von unspezifischer Spaltung. Das folgende Kapitel dieses Abschnitts wird 
dem TolQRA Komplex und insbesondere einem seiner Mitglieder gewidmet. Das in 
der inneren Membran verankerte TolR, bekannt für seine ausschlaggebende Rolle in 
Bakteriophageninfektion, besitzt einen hohen Grad konformationeller Flexibilität. 
Unterschiedliche C-terminale Konstrukte von verschiedenen Längen wurden durch 
zweidimensionale NMR Spektren untersucht; alle zeigten eine nicht-optimale 
Dispersion und verhinderten jede weitere ausführliche strukturelle Charakterisierung. 
Schließlich wird ein Kapitel dem topologisch verwandten ExbB-ExbD-TonB Komplex 
gewidmet. Dieser Komplex stellt Energie für den Transport von Siderophoren und 
Colicinen durch die äußere Bakterienmembrane zur Verfügung, aber er wird auch 
durch bestimmte Phagen ausgenützt. Durch die Definition und erfolgreiche 
Expression und Kristallisation der gefalteten Domäne des TonB konnte dessen 
Kristallstruktur bestimmt werden. Unsere veröffentliche Kristallstruktur der C-
terminalen Domäne von TonB bildet die Grundlage einer kritischen Diskussion über 
die Transportmechanismen von Colicinen in E. coli (Chang et al., 2001). Unsere 
Entdeckungen wurden von anderen Forschungsgruppen in Frage gestellt, die 
feststellten, dass unsere dimere Struktur aus einem Kristallisationsartefakt resultieren 
könnte. Neue Ergebnisse mit TonB selbst, sowie mit den Transportern der äusseren 
Membran, die mit dem C-Terminus von TonB in Verbindung treten, werden 
zusammengefasst und kritisch besprochen. 
 Der dritte Abschnitt zeigt den Nutzen von Bakteriophagen in einem 
modernen biotechnologischen Prozess. Die Anwendung der „Phage Display“ wird 
durch die Affinitätsmaturierung eines Antikörperfragments veranschaulicht, das 
gegen einen Membranproteinkomplex von immunologischen Bedeutung gerichtet ist. 
Indem wir „Phage Display“ und neue Antikörpermethoden kombinierten, versuchten 
wir, die Dissoziationskonstante eines Fab Antikörperfragments spezifisch für den 
MHC-gp33 Peptidkomplex zu verbessern. Die variable Domäne des Startklons 
wurden einer „error-prone“ PCR unterzogen, und mehrere Bibliotheken mit 
unterschiedlichen Mutationsraten wurden gebaut. Die Bibliotheken wurden 
monovalent an der Phagenspitze exprimiert, und „off-rate“ Selektion wurde 
angewandt, um für höhere Affinitäten zu selektionieren. Unerwartet ist die schwere 
Kette des ursprünglichen Wildtyp Fab nach zwei Runden „Phage Display“ wieder 
ausgewählt worden. Ein Antikörperfragment, das nur auf der variablen schwere Kette 
besteht, wurde konstruiert. Bindung an den MHC-gp33 Peptidkomplex wurde 
beibehalten, aber die Affinität verbesserte sich nicht wie erhofft. Unsere Ergebnisse 
werden im Hinblick auf neue Protein-Evolutionsstudien interpretiert, die sich mit 
Proteinplastizität und ihrer Toleranz gegen Aminosäureveränderungen befassen. 
 
Literatur 
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SECTION 1 
INTRODUCTION 
1.1 Biology and structure of filamentous bacteriophages 
 The filamentous bacteriophages (Genus Inovirus) constitute a group of prokaryotic 
viruses that contain a circular single-stranded DNA genome encased in a long protein capsid 
cylinder. The relative simplicity of theses viruses and the ease with which they can be 
manipulated have made them fruitful models to study macromolecular structure and 
interactions. Many different biological strains have been characterized, with DNA sequence 
homology ranging from very little to almost complete, but all strains have a similar virion 
structure and life cycle. The Ff class of the filamentous bacteriophages (f1, fd and M13) have 
been the most extensively studied. The present work concentrates mostly on this class of 
bacteriophages, which use the F conjugative pilus as a receptor and thus are specific for 
Escherichia coli containing the F plasmid. The DNA sequence of these three phages shows 
them to be 98% homologous. Phage particles do not form in the cytoplasm; rather they are 
continually extruded or secreted across the bacterial membranes as they are assembled, 
without causing cell lysis. A mixture of bacterial and phage-encoded components allow the 
single-stranded viral DNA to be replicated via a double-stranded intermediate. The result of 
this replicative process is a newly synthesized viral single-stranded DNA in a complex with 
many copies of a phage-encoded single-stranded DNA-binding protein. 
 All five structural proteins of the virion are synthesized as integral membrane 
proteins and are anchored in the inner membrane of E. coli prior to their incorporation into 
phage particles. Assembly occurs at specific sites in the bacterial envelope where the inner 
and the outer membrane are in close contact (Lopez and Webster, 1985). These contact 
sites, still a matter of controversy, can be visualized by electron microscopy and may reflect 
the existence of special assembly sites or exit complexes necessary for phage assembly and 
extrusion. Phage assembly and extrusion is a membrane-asssociated event, fueled by ATP 
hydrolysis, the membrane potential (Feng et al., 1997) and at least one bacterial protein, 
thioredoxin. During the assembly process, the viral DNA is extruded through the membrane-
associated assembly site, where the phage DNA-binding protein is replaced by capsid 
proteins which wrap around the DNA. This process continues until the end of the DNA is 
reached, so there is little if any constraint on the size of the DNA packaged. The Ff 
bacteriophages have a single-stranded DNA molecule of about 6400 nucleotides, but foreign 
DNA up to 12’000 nucleotides long can be inserted into a non-essential region of the viral 
genome, and this feature has made the phages a powerful tool in biotechnology. By inserting 
foreign DNA as a separate gene, one can create a virus-derived plasmid (or phagemid) 
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which can become a cloning vector. When the foreign DNA is fused in-frame to the gene 
coding for a viral coat protein, the virion can display foreign peptides or proteins on its 
surface. This technology and its applications are discussed in greater detail in the third 
section of this work (“Application Of Phage Display”).  
 The Ff phage particle is a rod about 6.5 nm in diameter and 930 nm in length. 
It has a mass of about 16.3 MegaDalton, of which 87% is made of protein. It comprises a 
sheath of 2’700 identical major coat proteins, also called gene VIII protein (pVIII), in an 
helical array around a single-stranded circular DNA molecule of about 6400 nucleotides 
(Figure 1-1). Minor coat proteins cap each end. The packaging signal end, which is always 
the first to emerge from the cell, contains about 5 copies each of the 33-residue gene VII 
protein (pVII) and the 32-residue gene IX (pIX), necessary for efficient particle assembly. 
Genetic and immunological experiments trying to model the ends of the particle support the 
hypothesis that pVII is shielded from the environment, whereas pIX is exposed (Endemann 
and Model, 1995). pIX has been found to be mainly α-helical (Houbiers et al., 1999). The 
other end contains 3-5 copies each of the 406-residue gene III and 112-residue gene VI 
proteins (pIII and pVI), which are both required for particle stability and phage infectivity. 
Biochemical evidence suggests that pIII and pVI interact with each other in the phage 
particle, as they remain associated after disruption of the phage particle with detergents like 
sodium deoxycholate. The formation of the pIII-pVI complex is essential for correct 
termination of the phage assembly (Gailus et al., 1994); pIII is thought to protect pVI from 
rapid degradation (Rakonjac and Model, 1998). No structure of pVI has ever been reported, 
but its hydrophobic amino terminus is believed to be buried in the phage coat (Makowski, 
1992), whereas the C-terminus might be solvent-exposed allowing the attachment of foreign 
proteins at this site (Jespers et al., 1995) 
  
                
Figure 1-1. Schematic representation of a phage particle. pIII is believed to be present in three to five 
copies at the tip of the phage.  
INTRODUCTION 3 
 
 
  
The pVIII portion of the virion has been extensively characterized and its uninterrupted α-
helical structure solved by NMR (Marassi and Opella, 2003). Before being assembled into 
phage particles, the hydrophobic segment of pVIII spans the inner membrane of E. coli, with 
the negatively charged N-terminal segment outside in the periplasm and the positively 
charged hydrophilic C-terminal segment inside in the cytoplasm (Figure 1-2). In the native 
virion, the carboxy-terminal 10-13 residues of pVIII line the inner surface of the sheath, 
where they neutralize the negative charge of the DNA core (Symmons et al., 1995). The 
amino-terminal portion of pVIII is present on the outside of the particle. 
pIII is made up of three domains, separated by glycine-rich peptide linkers 
(Stengele et al., 1990). It is synthesized as a precursor (424 amino acids), in which the 
mature protein is preceded by an 18-residue signal sequence. Deletion analysis led to the 
conclusion that the N-terminal domain (N1) is mainly responsible for membrane penetration, 
the middle domain (N2) for adsorption to the F-pilus (Deng et al., 1999) and the sole function 
assigned to the C-terminal domain (CT domain) is the anchoring of pIII in the phage coat. No 
proper function has been assigned to the glycine-rich linkers, which are believed to mainly 
convey flexibility to the other domains of pIII.   
 
 
Figure 1-2. Cartoon of the termination of assembly. (a) Before termination, pIII, pVI and pVIII are 
integral membrane proteins. Both pVI and pIII interact with pVIII. The N terminal portions of pIII and 
pVIII are located in the periplasm. pIII is composed of N1, N2 and C domains. N and C depict 
respectively, the N and C-termini of pIII and pVIII. The C to N direction, which is the same for both 
proteins, is indicated by the arrows. The orientation of pVI is not known. (b) After termination, the N 
terminal domain of pIII points in the opposite direction from the N-terminus of pVIII. The white rod 
along the axis of the virion symbolizes ssDNA. The two parallel horizontal lines represent the inner 
membrane of E. coli, with the periplasm at the top and the cytoplasm at the bottom. Picture taken from 
Rakonjac et al. (1999). 
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  The N1-N2 fragment of pIII forms a bilobal, horseshoe-like structure, in which the 
larger N2 domain partially wraps around the smaller N1 domain. The large number of 
exposed aliphatic residues (from N1) and threonine residues (from N2) pointing into the 
central channel have made this central cavity an attrative potential interaction site for the 
pilus (Holliger and Riechmann, 1996; Holliger et al., 1999; Lubkowski et al., 1998). 
Nevertheless, mutagenesis showed that the binding site is on the outer surface of N2 (Deng 
and Perham, 2002). N2 is in fact composed of two subdomains: a globular part, which 
resembles N1 in size and tertiary structure, and a hinge subdomain, which provides an 
extended surface for interactions between N1 and N2 (Figure 1-3). Kinetic studies have 
established the importance of this hinge region. Folding of domain N1 takes a few 
milliseconds, and provides a framework for the subsequent folding of the N2 domain, which 
is achieved in about five minutes. The final reaction in the folding of pIII involves the docking 
between N1 and N2, and its rate is controlled by the trans to cis isomerization of the Gln212-
Pro213 prolyl peptide bond in the hinge subdomain of N2, which was identified as the rate-
determining event of the docking reaction. The very slow domain docking reaction (about 100 
minutes) constitutes a protection against unfolding for the two domains, and has major 
implications with regard to the function of pIII in the infection pathway (see below). From 
these studies, it was concluded that the proline-controlled domain docking is a late step 
occurring after the two domains have reached their final three-dimensional conformation 
(Martin and Schmid, 2003a; Martin and Schmid, 2003b; Martin and Schmid, 2003c). Under 
certain conditions, this portion of pIII can be visualized by electron microscopy as a knob-like 
structure at one end of the particle (Gray et al., 1981). 
 
Figure 1-3. Ribbon representation of the tertiary structure of pIII: the N1 domain is in blue, N2 domain 
in red, and the hinge subdomain of N2 in green. The glycine-rich linker, due to its conformational 
lability, is not resolved. Picture taken from Martin and Schmid (2003c). 
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The carboxy-terminal 150 residues of pIII is required for the release of newly 
assembled virions from the membrane and for structural stability of the phage particle 
(Armstrong et al., 1981; Crissman and Smith, 1984; Stengele et al., 1990). Detailed analysis 
of deletion mutants revealed that the C-terminal domain of pIII contains two functionally 
distinct subdomains: one is involved in capping and stabilizing the assembled phage particle, 
and the second one is required for incorporation into the phage coat and subsequent release 
of the assembled virion from the host membrane (Rakonjac et al., 1999). Although 
filamentous phage infection does not usually kill the host cells, the infection can be lethal if 
assembly is impaired.       
For more information about bacteriophage structure, see Marvin (1998), Marvin et al. (1994), 
Russel et al. (1997). 
1.2 The infection process and the TolQRA pathway 
 The tol-pal gene cluster coding for seven genes is located at 17 minutes on the + 
strand of the E. coli chromosome (Webster, 1991). Currently the precise function encoded by 
the gene cluster is unclear, however they appear to be involved in maintaining the integrity of 
the cell envelope, since mutations in any of the tol-pal genes result in hypersensitivity to 
deleterious agents, release of periplasmic proteins (Lazdunski et al., 1998), formation of 
outer-membrane vesicles at the cell surface and induction of capsule synthesis, which results 
in a mucoid phenotype (Bernadac et al., 1998). The Tol-Pal gene products are organized into 
two complexes: one is composed of TolA, TolQ and TolR and sits in the inner membrane. 
The other is located in the outer membrane and comprises of TolB, Pal, Orf2 and two 
proteins of the outer membrane, Lpp and OmpA (Figure 1-4 and 1-5). There is no direct 
evidence of interactions between the inner membrane and outer membrane complexes; 
however, the localization of Tol proteins in contact sites between the inner and outer 
membranes support this hypothesis (Guihard et al., 1994). The proteins TolQ, TolR and TolA 
are all associated with the inner membrane and appear to interact with each other via their 
transmembrane (TM) domains (Lazzaroni et al., 1995). The TolA TM domain interacts with 
the first TM domain of TolQ and with TolR (Derouiche et al., 1995; Germon et al., 1998), 
while the third TM domain of TolQ interacts with the TM domain of TolR. TolR and TolA have 
a three-domain structure. In addition to the N-terminal anchoring region, TolA contains a 
large central domain with a high degree of α–helical structure and a C-terminal domain 
whose crystal structure has been solved (Lubkowski et al., 1999; Witty et al., 2002). The 
second domain contains an alanine-enriched coiled-coil region, which seems likely to play a 
role in communicating signals from the inner to the outer membrane of E. coli. TolR also has 
an N-terminal anchoring domain, a central domain and a periplasmic C-terminal domain 
which has been proposed to contain an amphipatic helix interacting transiently with the third 
TM segment of TolQ (Journet et al., 1999; Lazzaroni et al., 1995).  
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Figure 1-4. Model for the early events in the phage infection of E. coli. (A) The N2 domain of pIII 
interacts with the F-pilus on the outside of the bacteria. The outer membrane protein OmpF (blue 
cylinders) and Pal lipoprotein (greenish) are also depicted, as they are believed to interact with TolA 
prior to infection (Cascales et al., 2000; Derouiche et al., 1996; Lazdunski et al., 1998). (B) After pilus 
retraction, the N1 domain of pIII can bind to the C-terminal domain of TolA (TolAIII). (C) The retracting 
pilus brings pIII domains in closer contacts with TolA domains. The TolA assumes a more compact 
state of assembly, which might help bringing the outer and inner membranes of the bacteria close 
together (Baron et al., 2002). (D) The CT domain of pIII is inserted into the inner membrane, thus 
creating a pore for phage DNA injection into the bacteria. For further details, see text. Picture taken 
from Karlsson et al. (2003). 
 The stoichiometry of each of the Tol-Pal proteins is not well defined. Based on 
current evidence, a model for the membrane-embedded portion of the complex containing 
TolQ4TolR2TolA1 has been proposed (Cascales et al., 2001). Recently, energy-dependant 
conformational changes in TolA have been characterized. They depend on the 
transmembrane domain of TolA and of TolQ and TolR proteins (Germon et al., 2001).  
The transmembrane fragment of TolR and the third transmembrane fragment of TolQ are 
involved in the proton motive force-dependent activation of TolA (Cascales et al., 2000). 
Genetic suppression studies are consistent with the fact that the Tol system appears to use 
an ion potential from the inner membrane to induce a conformational change of the C-
terminus of TolA in the periplasm, leading to an interaction between inner and outer 
membrane proteins. This kind of signaling may contribute to the role of the Tol system in 
maintaining the outer membrane stability. TolQ and TolR present structural and functional 
homologies not only with ExbB and ExbD of the Ton system but also with MotA and MotB 
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(see Chapter 1.3), components of the flagellar motor, raising the attractive hypothesis that 
the transmembrane domains of TolQ, TolR and TolA constitute an ion potential-driven 
molecular motor (Cascales et al., 2001). 
Infection of E. coli by a filamentous phage is a multistep process requiring 
interactions of the phage pIII protein with the F conjugative pilus and the TolQRA system. 
The F-pilus elaborated by F+ strains of E. coli is an extra-cellular filamentous structure with 
an outside diameter of 8 nm and a 2 nm central, hydrophilic lumen. It belongs to the so-
called “type IV secretion system” (T4SS), which mediates several processes such as 
bacterial motility, host cell adhesion and natural transformation (Koebnik, 2001). The F-pilus 
can be very variable in length, ranging from 1 to 20 µm, and is assembled from multiple 
copies of its structural protein called pilin. Proteins required for its structure, assembly and 
disassembly are encoded by genes in the “tra” operon on the F conjugative plasmid (Lawley 
et al., 2003; Manchak et al., 2002). Propilin, encoded by the traA gene, is processed to a 
mature pilin (70 residues) by the traQ protein, proposed to act as a specific chaperone 
(Harris et al., 1999). Originally, the F pilus was shown to be required for the conjugal transfer 
of the F plasmid DNA from a donor cell into a recipient bacterium lacking the plasmid 
(Silverman, 1997). This horizontal DNA transfer, called conjugation, is initiated by interaction 
of the tip of the F pilus with the envelope of the recipient bacterium. By pilus retraction, the 
donor and recipient cells get closer, thus facilitating the exchange of a single strand of the F 
plasmid DNA. This process results in the presence of the F plasmid in both the donor and 
recipient bacteria. It has been pointed out that conjugative F pili morphologically resemble 
phages made in the absence of pIII, reinforcing the intuitive idea that the two are likely to be 
evolutionarily related (Rakonjac and Model, 1998).  
For reviews about bacterial conjugation see Llosa et al. (2002), about Tra proteins and pilus 
biogenesis see Kalkum et al. (2002). 
Phage infection is initiated by the binding of the N2 domain of pIII to the tip of the F- 
pilus, which is believed to be present in two to three copies per cell. The exact binding 
epitope on N2 has been mapped by competitive ELISA (Deng and Perham, 2002). 
Interaction with the pilus is crucially important, as bacteria lacking F-pili can be infected but 
only at very low frequency (Krebber et al., 1997). Docking of the phage is thought to be 
followed by retraction of the pilus, bringing the pIII end of the phage near the surface of the 
bacteria. It is still a matter of debate whether retraction is a result of normal polymerization-
depolymerization cycles of the pilus or whether phage attachment triggers this process. The 
current model suggests that pilus retraction is triggered by the absence of outgrowth, which 
is dependant upon ATP synthesis and the proton motive force. Thus, retraction could be the 
consequence of an interruption in the flow of signalling down the pilus, caused by the 
attachment of either Ff phage or a recipient cell to the pilus tip (Manchak et al., 2002). The 
force produced by a single pilus is unexpectedly high, and it constitutes one of the strongest 
molecular motors reported so far. Biophysical measurements estimated that a single pilus 
can generate forces exceeding 100 pico-Newton (Maier et al., 2002). The binding of N2 to 
the tip of the F pilus releases the N1 domain, which becomes free to interact with the C-
terminal domain of TolA (TolAIII), also referred as the coreceptor (Riechmann and Holliger, 
1997). Surface plasmon resonance (BIACORE) measurements have detected a micromolar 
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affinity between N1 and TolAIII (Karlsson et al., 2003), but still within pIII, binding of N1 to N2 
is entropically favored because the two domains are covalently linked. As mentioned above, 
domain assembly and dissassembly within pIII is a very slow reaction. The very slow domain 
re-assembly might ensure that, once N1 and N2 became separated, domain closure is 
blocked long enough that the pilus can retract to bring N1 into close proximity of TolA and 
allow the two to productively interact (Martin and Schmid, 2003b). From the structure of the 
TolAIII-N1 complex (Lubkowski et al., 1999), it has become clear that TolAIII binds N1 at a 
site overlapping that of N2. Thus, during phage binding to the F pilus, the N1 domain must be 
displaced from the N2 domain and is thus available for binding of the coreceptor. 
Nevertheless, although the binding sites for N2 and TolA are overlapping, neither structural 
homology nor even a similarity of secondary structure between the N1-binding interfaces of 
N2 and TolA is seen. Recently, the CT domain of pIII was found to interact specifically with 
the N1-N2 domains, leading to a stable compact conformation of pIII at the tip of the phage, 
which is expected to unravel during infection (Chatellier et al., 1999). The further steps of the 
phage infection process are unclear. After the formation of the complex between TolAIII and 
the N1 domain of pIII, infection may proceed by subsequent interaction of this complex first 
with the periplasmic C-terminal domain of TolR (Kampfenkel and Braun, 1993; Muller et al., 
1993), and then with the entire TolQRA system. Through the action of TolA, the major capsid 
protein, pVIII, and probably the pVII and pIX minor coat proteins, then depolymerize and 
become integrated into the host inner membrane as the single-stranded DNA enters the 
cytoplasm (Click and Webster, 1998). The relief of the capsid internal pressure, which results 
from the electrostatic repulsion between the polyelectrolyte molecules, is probably the major 
force driving the DNA out of the capsid and allowing it to emerge from the filamentous 
particle and pass through the putative pIII pore (Letellier et al., 1999). Some authors inferred 
that decapsidation and full penetration of the phage DNA are dependant upon and closely 
linked to its replication (Marco et al., 1974). It has been further hypothesized that pIII may link 
the phage DNA to a cellular replicative system in or near the inner membrane, and thus 
participates in initial replication of the DNA (Jazwinski et al., 1973).  In vitro studies support 
the idea that a trimeric form of pIII displays pore-forming properties, thus creating a channel 
allowing DNA penetration through the inner membrane, and indeed pIII has been shown to 
interact with DNA (Marco et al., 1974). The estimated radius of the pIII-pore (0.81 nm) is in 
agreement with such a function, the radius of the phage DNA helix being 0.85 nm (Glaser-
Wuttke et al., 1989). The rate of DNA transport, although varying from one phage to another, 
can reach value as high as 3’000 base pairs/second, a value significantly higher than that 
attained during the transport of DNA in conjugation and natural transformation (100 
bases/second). Once in the E. coli membrane, the pVIII protein of the infecting phage joins 
the pool of newly synthesized pVIII, and both are assembled to newly formed particles. 
Electron microscope studies suggest that a chloroform/water interface is able to induce 
morphological changes, contracting the filaments sequentially into shortened forms (I-forms), 
and then into spheroidal particles (S-forms). Chloroform might lead to phage contraction, due 
to its interactions with pVIII. The conversion to the I-form could correspond to the activation 
step that enables depolymerization of pVIII into the bilayer, while the I-form to S-form step 
might mimic the depolymerization step of the infection process (Oh et al., 1999).  
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1.3 TonB-ExbB-ExbD system and its analogy to TolQRA 
Colicins are bacterial protein toxins, encoded by plasmids, which are active against 
E. coli and other related species. They are produced in large amounts and are generally 
released into the extracellular medium. A few colicins have been structurally characterized 
(Cheng et al., 2002; Elkins et al., 1997; Hilsenbeck et al., 2004; Soelaiman et al., 2001; Sui 
et al., 2002; Vetter et al., 1998; Wiener et al., 1997).  They use different ways to kill 
susceptible cells, ranging from the ability to depolarize the inner membrane or to cytotoxic 
activity against cytoplasmic nucleic acids (Lazdunski et al., 2000; Lazdunski et al., 1998). 
The mechanism by which these folded proteins are able to cross the membrane of the target 
cells has been extensively studied. To enter bacterial cells, colicins parasitize outer 
membrane receptors used by sensitive cells for important biological functions, such as porins 
(e.g. OmpF), vitamin B12 receptor (BtuB) or high-affinity receptors for iron (FepA, FhuA, 
FecA), then they interact with proteins in the periplasmic space to reach their target. Each 
colicin shows the same type of organization, coherent with their mechanism of action. Their 
structure comprises three distinct domains; (i) a central domain involved in the recognition of 
a specific receptor at the surface of the target cell, (ii) an N-terminal domain involved in 
translocation, and (iii) a C-terminal domain responsible for lethal activity. Both TonB and Tol-
Pal systems have been parasitized and are required for the import through the cell envelope 
of both colicins and phage DNA.  
Interestingly, in a way similar to colicins, a specific interaction or action can be 
assigned to each of the domains of pIII. The central domain (N2) interacts with the F pilus 
playing the role of receptor. Together with a retraction of the pilus, this unmasks the N1 
domain that can then interact in the periplasm with the C-terminal domain of TolA (TolAIII), 
which plays the role of a co-receptor. The N-terminal domain of pIII is comparable to the 
translocation domain of colicins, and indeed, it can play the role of a colicin translocation 
domain since it was shown that a fusion of the N-terminal domains of pIII (N1 + N2) to the 
catalytic domain of colicin E3 was active against bacteria (Jakes et al., 1988). Colicins are 
classified into two groups depending on the translocation system they use. Group A colicins 
need the Tol proteins, group B colicins use the TonB-ExbB-ExbD system.   
For reviews about colicins, see Cao and Klebba (2002), Lazdunski et al. (1998), 
Zakharov and Cramer (2002). 
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Figure 1-5. Schematic illustration of the different components of the three ion-potential coupled 
systems discussed in the text: the Tol-Pal system (left), the TonB/ExbB/ExbD system (centre) and the 
flagellar motor MotAB (right). Picture taken from Cascales et al. (2001). 
 Some components of the Tol system and the TonB system are homologous (Figure 
1-5). Homologues of TonB have been found widely distributed among Gram-negative 
bacteria. They energize the active uptake of iron obtained from mammalian iron-binding 
proteins (Braun and Braun, 2002), iron siderophores (Braun and Killmann, 1999) and of 
vitamin B12 (Buchanan et al., 1999; Cadieux and Kadner, 1999) across the outer membrane. 
TonB-ExbB-ExbD are three components of the multimeric TonB-dependent energy-
transducing system (Higgs et al., 1998; Larsen et al., 1999) present in stoichiometries of 
about 1:7:2 (Higgs et al., 2002). According to the available experimental evidence, the 
energized TonB protein physically contacts a ligand-bound outer membrane receptor and 
transduces energy from ExbB-ExbD, inducing a conformational change in the outer 
membrane receptor (Ferguson et al., 1998; Lazzaroni et al., 1999; Letain and Postle, 1997). 
This results in the release of the ligand into the periplasm. The two Exb proteins together 
contribute to the stability of TonB, therefore these three proteins are presumed to interact 
directly through their transmembrane domains. An essential function has been ascribed to 
ExbD, and in particular to aspartate 25 and leucine 132 within the protein. It is conceivable 
that aspartate 25 of ExbD and histidine 20 of TonB are involved in sensing the 
electrochemical potential of the inner membrane, which induces a conformation in the Ton 
complex that triggers the opening of the channels in the outer membrane receptor proteins 
(Braun, 1995).     
  TolQ and TolR are structurally and functionally related to ExbB and ExbD, 
respectively (Braun and Herrmann, 1993). TolA and TonB have a similar elongated 
conformation but are homologous only in their N-terminal transmembrane domains, where 
they both have a well conserved “SHLS” motif (Germon et al., 1998; Karlsson et al., 1993). 
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The TolQ-TolR-TolA-N-terminus complex can partially replace ExbB-ExbD-TonB-N-terminus 
for energy transduction (Karlsson et al., 1993). However, the TolA and TonB proteins span 
the periplasm by quite different mechanisms, since the TolA central domain has an α–helical 
structure whereas that of TonB has a stretch of X-Pro repeats. Thus the presence of a similar 
trans-periplasmic system encoded by the Tol genes (TolQ and TolR) that can compensate 
for mutations in two of the inner membrane proteins of the TonB system (ExbB and ExbD) 
suggests that a similar mode of energy transduction from the inner membrane to the outer 
membrane is used by both the Ton and Tol systems. TolQ-TolR seem to transduce the 
proton-motive force to TolA by a mechanism probably homologous to the transduction of the 
proton-motive force to TonB by ExbB-ExbD. The TolA protein might be involved in 
transducing energy from the inner membrane to the Pal lipoprotein or via Pal lipoprotein to 
some other periplasmic or outer membrane component. TolA could drive newly synthesized 
outer membrane components across the periplasm through its C-terminal interaction with Pal 
(Levengood et al., 1991). It has been suggested that the Tol proteins are involved in the 
dynamic assembly of outer membrane trimeric porins (Derouiche et al., 1996). Thus, the 
TonB and Tol-Pal systems are both able to couple the cytoplasmic membrane proton 
gradient to energy-requiring processes (Cascales et al., 2000) and thus energize active 
transport across the outer membrane and maintain cell envelope integrity, respectively. The 
proton motive force corresponds to an electrochemical potential of protons, resulting from the 
active transport of protons across the inner membrane into the cytoplasm of E. coli. It is 
assumed that the two systems probably originated from a common ancestor, and their 
physiological functions appear to be essential because they are conserved in many Gram-
negative bacteria.  
 The importance of the proton motive force in the phage infection mechanism still 
remains largely elusive: depolarization of the inner membrane seems to be essential for 
successful infection of a bacterial cell with phage DNA. In several investigations it has been 
demonstrated that phage infection results in a reduction of the proton-motive force and in an 
exchange of cations across the cell membrane (Feucht et al., 1990).    
 At first sight, these Ton and Tol systems have little in common with the flagellar 
motor other than the use of a transmembrane electrochemical gradient as an energy source. 
The bacterial flagellum is a complex macromolecular assemblage forming a multipartite 
structure composed of a long helical propeller, a flexible hook region and a rotary motor in 
the bacterial inner membrane. The source of energy for motor rotation is the membrane 
gradient of protons or, in some species, sodium ions (Okabe et al., 2002). The flagellar motor 
thus converts chemical energy into mechanical work. MotA and MotB are integral membrane 
proteins essential for flagellar rotation, which are believed to form the stator of the motor 
(Figure 1-5). They bind to each other and function together to conduct protons across the 
inner membrane. Two conserved proline residues (Pro 173 and Pro 222) of MotA are 
important for torque generation. Asp 32 of MotB is also critical for function, because it forms 
part of the proton path through the motor. All three residues are predicted to be near the 
cytoplasmic ends of membrane segments, so they could very likely function directly in 
coupling proton transfer to motor rotation (Braun et al., 1999). There are presently no high-
resolution structural data on the MotA/MotB complexes, but a new model of the flagellar 
motor rotation has been proposed, based on KcsA potassium ion channel dynamics 
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(Schmitt, 2003). Biochemical data determined a stoichiometry of four copies of MotA for two 
copies of MotB (Blair, 2003). Based on sequence alignment and notably the conservation of 
a critical aspartate residue in the TM helix of ExbB, TolR and MotB, it has been postulated 
that the TolQRA complex could exist in the inner membrane with the same stoichiometry. 
Therefore, a model was proposed for the membrane-embedded portion of the complex, 
composed of TolQ4TolR2TolA1. This has raised the attractive idea that the last two 
transmembrane (TM) helices of TolQ, the single TM helix of TolR and possibly its C-terminus 
might form an ion pore (Cascales et al., 2001). Molecular dynamics simulations were then 
used to propose a simple structure of MotA-MotB. This theoretical structure served as a 
template to design a structural model for the evolutionary-related ExbB-ExbD-TonB system. 
It allows to identify conserved residues in the complex (Figure 1-6); it is remarkable that all of 
them but one (F34) face inward and may be important for function. From this model, a 
pathway for proton transport in ExbB-ExbD-TonB implicating water molecules is suggested. 
A possible role of TonB in this pathway is suggested and discussed (Zhai et al., 2003).   
For reviews about the bacterial flagellar motor, see DeRosier (1998) and Blair (2003). 
 
 
Figure 1-6. This figure shows the conserved transmembrane segments of the ExbB-ExbD-TonB 
complex. These residues are P141, G144 and G151 on the 2nd helix of ExbB; A177, T181 and G184 
on the 3rd helix of ExbB, D25 and F34 on the helix of ExbD, and H20 and S16 associated with the helix 
of TonB. T181 and D25 might be involved in proton translocation. Picture taken from Zhai et al. 
(2003). 
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1.4  Display of proteins on filamentous bacteriophages  
The major interactions that occur among the coat proteins (pIII and pVIII) during the 
assembly process involve the hydrophobic regions of these proteins, which initially span the 
inner membrane. These membrane-associated assembly properties of the coat proteins 
allow packaging of chimeric proteins into the phage particle. Any protein fused to the 
periplasmic portion of these coat proteins should theoretically have a good chance of being 
packaged into a phage particle, provided it can be translocated efficiently across the inner 
membrane and not interfere with the process that occurs at the assembly site. In 1985, 
George Smith demonstrated that a foreign peptide could be displayed on the surface of 
filamentous bacteriophage as a genetic fusion with the minor coat protein, pIII (Scott and 
Smith, 1990; Smith, 1985). Because the displayed peptide forms a structural association with 
its encoding DNA, phage display was immediately recognized as a powerful tool for selecting 
and evolving ligands from large combinatorial librairies. In this way, a physical linkage 
between phenotype (displayed peptide) and genotype (DNA) is established, and extremely 
diverse libraries (>1011 members) of DNA-encoded peptides or proteins can be generated 
with simple molecular biology methods. Furthermore, phage-displayed libraries can be 
amplified by passage through a bacterial host, and even the largest repertoires can be 
contained in less than one millilitre of solution. The bacteria tolerate this process quite well 
and continue to grow and divide with a generation time only about 50% longer than that of 
uninfected bacteria. There is a burst of about 1000 phage particles produced in the first 
generation after infection, and then the bacteria produce about 100-200 phage particles per 
generation. This continues for many generations, resulting in titers of 1011 to 1012 particles 
per ml. The plaques are turbid and of varying size and contain about 108 infective phage 
particles.   
By using selection with immobilized ligands (on plates or magnetic beads), library 
pools can be enriched for polypeptides with particular binding characteristics (Figure 1-7). 
Following binding selection, individual clones from enriched pools can be analyzed by using 
enzyme-linked immunosorbant assays (ELISA) to quantify binding in a high-throughput 
fashion. Finally, and most importantly, the amino acid sequence of any clone can be readily 
deciphered by sequencing the DNA inside the phage particle. Historically, phage display has 
relied on creating amino-terminal fusion peptides with either pIII or pVIII. Small peptides can 
be displayed on all copies of pVIII in the coat, in contrast to larger proteins, which require a 
mosaic display with the inclusion of some wildtype pVIII so as not to disrupt assembly. The 
great majority of phage display libraries fuse foreign peptides and proteins to the N-terminus 
of either pIII or pVIII; however, recent studies indicate that pVI (Jespers et al., 1995), as well 
as pVII and pIX may be used for this purpose (Gao et al., 2002; Gao et al., 1999) suggesting 
greater flexibility in phage particles than previously thought. Using a special two-gene pVIII 
display system, Sidhu and colleagues showed that the pVIII can actually accommodate a 
surprisingly large number of mutations. Furthermore, many of these mutations improve 
packaging, and hence protein display, in a predominantly wild-type coat (Sidhu et al., 2000). 
As an extreme example of sequence divergence, Weiss and colleagues were able to 
construct a functional pVIII variant with only 50% identity with the wild-type  
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Figure 1-7. In vitro selection with phage display. Proteins are displayed on phage particles that also 
contain the encoding DNA. Display is usually achieved by fusion to pIII located at one end of the 
particle, as depicted here. The library is incubated with an immobilized target to select for binders, and 
non-binding phages are removed by washing. Bound phages are then eluted and amplified in E. coli. 
Amplified phage pools can then be subjected to additional rounds of selection, or alternatively, the 
sequences of individual clones can be determined by sequencing the encapsulated DNA. Picture 
taken from Sidhu et al. (2003).  
(Weiss et al., 2000). The same group could even evolve pVIII to render it compatible with C-
terminal display. Improved variants of pVIII could be identified, which supported the 
simultaneous display of N and C-terminal fusions (Held and Sidhu, 2004).  
 Not all proteins are efficiently displayed on phage, yet a wide range of peptides and 
proteins can be used. In addition, various forms of antibodies, including Fabs and single-
chain antibodies (scFvs) have been displayed. Originally, the display of large polypeptides 
and proteins was severely limited. This problem was circumvented by the use of two-gene 
phagemid systems which enabled the packaging of fusion gene products in a phage coat 
predominantly composed of wild-type proteins supplied in trans from a helper phage. In such 
systems, the recombinant pIII fusion-protein is encoded on a phagemid. This phagemid 
produces large amounts of the recombinant display protein, but is unable to make complete 
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large phage, unless the bacteria carrying the phagemid become infected by a helper phage 
which supplies all the other proteins required to assemble functional phage. Thus, the pIII 
fusion (supplied from the phagemid) is a non-functional coat protein that incorporates into the 
phage particle as a non-essential addition to the wild-type pIII (supplied from the helper 
phage). However, as the incorporation of the pIII fusion is slightly disfavoured in comparison 
to the wild-type pIII, it is assumed that recombinant phage generated with a phagemid 
system carry only one copy of the pIII fusion along with two to four copies of the wild-type 
pIII. We speak of a monovalent display of the pIII fusion-protein at the tip of the phage.  
 pIII is the minor coat protein most widely used for display of proteins (and especially 
antibodies). Its main disadvantage of displaying only about 5 molecules per phage particle is 
compensated by the fact that large proteins appear to package reasonably well. In our set-up 
discussed in the third section, the protein (Fab antibody fragment) is fused to the C-terminal 
domain of pIII. Once in the membrane of the host bacteria, the foreign protein presumably 
does not interfere with assembly, a process mediated by the C-terminus of pIII. The ability to 
display an active protein depends on whether the fusion protein can be translocated properly 
into the membrane, fold properly, escape degradation in the periplasm, and be acceptable 
for packaging into phage.   
It is rather amazing how versatile and flexible the phage-display system is, 
considering the possible constraints that the processes of protein translocation, folding, and 
phage assembly might place on it. Recent developments of this powerful technology have 
made it an attractive tool for selecting the protein of choice. This great success has led to a 
variety of clever methods designed in order to extend the range of future applications. The 
potential of phages as an in vivo or in vitro targeted gene delivery vehicle was illustrated by 
the re-engineering of phage F5, in order to infect eukaryotic cells (Poul and Marks, 1999). It 
was recently demonstrated that a modified phage-display vector can be used to specifically 
target mammalian cells, thus being able to deliver genes into eukaryotic cells. The principles 
of directed evolution used in phage display could be applied to phage vectors to tailor them 
for gene delivery to specific target cells in vivo (Larocca and Baird, 2001; Larocca et al., 
2001). 
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1.5 Work outline  
There are only few ways, either natural or engineered, that new binding entities can 
be discovered in a short period of time. The immune system is probably the best known 
natural example. When challenged with a foreign antigen, high affinity antibodies are 
generated in a matter of weeks. This process occurs in stages, with the first step being the 
generation of low-affinity antibodies, displayed on the surface of B-cells, with each cell 
presenting a single antibody species. Initially, there is a resident library of naïve antibodies 
(believed to be in the range of 107 different molecules) that cover a wide range of diversity. At 
this point, the affinities are only in the micromolar range; but the binding properties of these 
antibodies of the primary response are boosted significantly by multiple attachment to the 
antigen (often in multimeric form). This avidity effect, coupled to the large number of naïve 
antibodies in the starting pool, allow a small group of antibodies to be clonally selected. The 
second stage in antibody selection involves an affinity maturation process. Mutations are 
introduced into the variable domains of selected antibodies by a process known as “somatic 
hypermutation”. It results in the production of antibodies with more diversity, and permits 
improvements in the complementarity between the antibody and antigen. The affinities of 
these natural antibodies are increased; they are also called “antibodies of the secondary 
response”. 
Phage display, as it is practised today for selection of binders from naïve libraries, 
mirrors the natural immune system (Marks et al., 1992). One begins with a large and diverse 
set of proteins (in our case, antibody fragments) that are presented in a polyvalent format at 
the tip of the phage particle. Antibody fragments, selected from this polyvalent format bind 
their target in the high micromolar range. In a subsequent step, antibody fragments with 
higher affinities are generated from these leads by introducing additional random mutations 
and transferring them onto a lower valency format to allow for selection of antibodies with 
affinities in the nanomolar range. 
The present work aims at understanding the structural processes governing 
bacterial infection by a filamentous bacteriophage, which is one of the foundations of phage 
display. The next section of this work (section 2) is devoted to the study of three proteins that 
are intricately implicated in the infection process. First, an extensive study of the C-terminus 
of pIII provided some data, hinting at its intrinsic unstability in solution; we were unable to get 
this fragment of pIII in its full form. We provide evidence that once isolated from inclusion 
bodies in E. coli, it gets proteolytically processed, in a spontaneous way and by some still 
unknown proteases. The primary goal of obtaining a crystal structure of this domain thus 
failed. TolQRA and one member of this complex is the topic of the next chapter. The inner 
membrane-anchored TolR has been shown to be critical for phage entry into E. coli. The 
biochemical and spectroscopic characterization of its periplasmic C-terminal domain showed 
it to possess a high degree of conformational flexibility. This observation was corroborated by 
the study of several constructs of various lengths, which all show a non-optimal dispersion in 
two-dimensional NMR spectra, thus preventing any further structural characterization. 
Finally, we will draw our attention to the related ExbB-ExbD-TonB system. TonB is indirectly 
used by colicins and siderophores to get entry into bacterial cells, but this pathway has been 
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shown to be parasitized by certain phages as well. The transport mechanism of siderophores 
into E. coli is discussed in the light of our published crystal structure of the C-terminal domain 
of TonB. Our findings are confronted with new recent results on TonB itself, as well as on 
crystal structures of outer membrane transporters which are contacted by the C-terminus of 
TonB.  
The third and last section illustrates the use of phage display to select an antibody 
fragment with better binding properties toward an antigen of immunological relevance. Based 
on earlier work in our laboratory (Frédéric Pecorari, Maurice Brozzo, Stefan Ewert, all 
unpublished results), we tried to improve the dissociation constant of a Fab antibody 
fragment directed against the MHC-gp33 peptide complex. We have applied phage display to 
affinity mature this Fab fragment and isolated novel Fab clones against the MHC-gp33 from 
a self-constructed antibody library. Interestingly, the paratope of the improved clones could 
be mapped exclusively to the heavy-chain of the original Fab. A single domain antibody was 
constructed consisting solely of the variable domain of this heavy chain. We provide 
evidence that it retains full binding activity towards the MHC-gp33, despite the fact that the 
binding affinity did not show substantial improvement. This finding has fundamental 
implications with regard to the affinity maturation process and the structural basis of the 
peptide-MHC recognition mechanism. 
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SECTION 2 
THE STRUCTURAL BASIS OF PHAGE DISPLAY 
2.1 pIII and the phage infection mechanism 
2.1.1 Introduction 
 Originally called adsorption protein (or protein A), pIII has been the main subject of 
attention of the first scientists working with filamentous bacteriophages. After the three 
different functional domains had been identified, different research groups tried to elucidate 
their different properties and were able to assign a particular function to each of the N1, N2 
and C-terminal domains. A significant step was achieved with the publication of the NMR 
structure of the N1 domain alone (Holliger and Riechmann, 1996); the crystal structure of N1 
in complex with N2 revealed a striking homology between the two domains, which may 
indicate they are evolutionarily related (Holliger et al., 1999; Lubkowski et al., 1998). Yet, the 
C-terminus still remains structurally uncharacterized, and its expression proved to be 
problematic (Beckmann et al., 1998; Martin and Schmid, 2003a; Rakonjac et al., 1999). 
Recently, Weiss et al. proposed a computational model of the three-dimensional structure of 
the C-terminus (Weiss et al., 2003). 
 It is always stated that between three and five copies of pIII are located at the end 
of the phage particle, and it has been proposed that they function as a multimer (Gailus et 
al., 1994), but pIII’s have never been seen directly in electron microscopy. The presumed 
stoichiometry is based on the observation that a threshold pIII concentration of about 160 
molecules per cell is needed for termination of phage assembly and formation of infectious 
particles. A Poisson calculation revealed that, with a low concentration of pIII in the cell, 200 
assembly sites would be formed, which suggested that four or five molecules of pIII per 
assembly site are required for the formation of the infectious particle (Rakonjac and Model, 
1998). As no indication of oligomerization of the N1-N2 complex are presented in the crystal 
structures, one can reasonably deduce that the multimeric arrangement of pIII is most likely 
caused by its C-terminal domain, or possibly its C-terminal hydrophobic anchor.   
 
 With this project, we wanted to investigate the biochemical and structural 
characteristics of the C-terminus of pIII by expressing it in large amounts in E. coli. The 
original idea of solving the crystal structure had to be abandoned due to the proteolytic 
processing of this fragment and its resulting instability in solution. Nevertheless, evidence is 
presented supporting the hypothesis that under certain circumstances pIII might have a 
trimeric arrangement in vitro.     
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2.1.2 Materials and Methods 
 Protein expression and purification - All constructs involving a fusion to protein D 
were designed as described in Figure 2-1. The sequences encoding nucleotide positions 
1632-2852 (Long construct, i.e. with the C-terminal helix) or 1632-2768 (short construct, i.e. 
without the C-terminal helix) of pIII from phage cloning vector m13mp19 (Genbank accession 
# L08821) were polymerase chain reaction-amplified and cloned into the plasmid pAT37 
(based on pQE30 from Qiagen), with an engineered enterokinase cleavage site, recognized 
by bovine enterokinase (purchased from Invitrogen). The different recombinant proteins were 
expressed and purified as specified in the text. Where explicitely mentioned in the text, 
denaturing conditions were used for protein purification. The protein was denatured overnight 
in a buffer containing 8 M urea and 50 mM DTT. After dialyzing out DTT overnight, the 
denatured protein was refolded by dialysis against 0.2 M Tris pH 9.0 (4°C), 2 mM EDTA, 0.5 
mM benzamidine-HCl, 0.8 M arginine, 0.5 mM amino-n-caproic acid. After 24 hours refolding 
at 4°C under magnetic stirring, insoluble material was removed by centrifugation and the 
various constructs were processed differently. The constructs without pD fusion were 
dialyzed against MHA buffer (33 mM MES, 33 mM HEPES, 33 mM acetate, pH 8.0), and 
directly loaded on an anion exchange chromatography column (equilibrated at pH 8.0) on a 
BIOCAD 700 workstation (Applied Biosystems). The eluted fractions were collected and 
dialyzed against an appropriate buffer for further processing. The pD fusion constructs were 
digested with enterokinase at room temperature for 4 h in a buffer containing 50 mM Tris pH 
8.0, 1 mM CaCl2, 0.1% Tween-20, using 1 Unit per mg of fusion of the recombinant bovine 
enterokinase. The solution was then dialyzed against 100 mM MHA buffer pH 8.0. Removal 
of pD and enterokinase was achieved with the coupled IMAC/AIEX (anion exchange) 
protocol on the BIOCAD workstation, based on the different isoelectric points of pIII, pD and 
enterokinase.        
 
5’  --ATG------HHHHHH                              DDDDK                   TAGTAA--------- 3´    pIII proteinD 
      
                                                                    
                                                    enterokinase cleavage site  
Figure 2-1. Design of the protein D fusions constructs, cloned into the vector pAT37, under the control 
of a T5 promoter (Forrer and Jaussi, 1998). Protein D is the major capsid protein of phage lambda; it 
contains an hexahistidine-tag at its N-terminus, and a smaller linker (GSGS) at the C-terminus. The 
recognition sequence for enterokinase (DDDK) is not originally present in the vector, and is 
engineered by PCR.  
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Molecular biology - DpnI site-directed mutagenesis was done as described in the 
specifications of the manufacturer (QuikChange Site-Directed Mutagenesis kit, Stratagene), 
in order to introduce the lysine (AAG) to alanine (GCG) mutation. The following primers were 
used: 5’-TCCGGTGATTTTGATTATGAAGCGATGGCAAACGCTAATA AGGGG-3’ 
for the forward reaction, and 5’-CCCCTTATTAGCGTTTGCCA 
TCGCTTCATAATCAAAATCACCGGA-3’ for the reverse reaction.  
PCR conditions were as follows: 95°C (30 sec), and then 16 cycles of 95°C (30 sec), 55°C (1 
min), 68°C (10 min) with 20-50ng of DNA template, 100 µM of each primer, 10x Pfu-
polymerase buffer, 5 mM of each dNTPs, and 2.5 Units of Pfu polymerase. Mutation insertion 
was checked by DNA sequencing. 
Western blotting – SDS-gel was blotted onto a PVDF membrane (Millipore, cat.# 
IPVH00010) previously soaked into methanol, and rinsed with water. After 1 h transfer, the 
membrane was blocked for 1 h with 5% milk/TBST, washed 3x with TBST, and incubated for 
1 h with monoclonal antibody 10C3 (500x diluted in 2% milk/TBST). After 3 washing steps, 
the anti-mouse IgG-horseradish peroxydase secondary antibody (Pierce, cat.# 31438, 
10’000x dilution) was added and further incubated for 1 h. After 5 sequential washing steps, 
development was done with 5 ml ECLA/ECLB 1 :1 mix (Amersham) during 1 minute. The 
detection was done on an X-ray film (Amersham)  
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2.1.3 Results 
 As we were interested in the C-terminal domain alone, we first tested the 
expression of the CT domain with and without the hydrophobic region (underlined in Figure 
2-2b), thus giving rise to so-called pIII-Long and pIII-short, respectively (in both cases, 
without the signal sequence named “ss” in Figure 2-2a). The boundaries of the C-terminal 
anchor were determined on the basis of published data (Davis et al., 1985). Both constructs 
were cloned into the vector pTFT74 and expressed in E. coli as inclusion bodies in the strain 
BL21(DE3)pLysS (Studier, 1991). Both constructs gave no significant band on an SDS-
PAGE gel; however, the pIII-Long construct could be detected on a Western blot (Figure 2-
3). Other attempts in the strain C41(DE3) (Miroux and Walker, 1996), or BL21(DE3)pLysE 
gave no conclusive results. It might be that the membrane-active C-terminal fragment is lytic 
when cloned in such E. coli strains, enhancing the effect of the T7 lysozyme. Alteration of 
inner membrane permeability allows the passage of the lysozyme to the periplasmic space 
where it could exert its lytic activity on the bacterial outer membrane (Ciccaglione et al., 
1998).  
(a)  
Membrane 
anchorperiplasm 
 
 
(b)  
 
Figure 2-2. (a) General overview of pIII, with the three segmented domains (N1, N2 and C), delimited 
by the glycine-rich linkers. The 18 first amino acids contain the signal sequence (ss). The letters in 
parentheses (D/S) indicate the boundaries of the C terminus, whose sequence is detailed in (b). 
“Periplasm” and “cyto” mean the part of the protein which is located in the periplasm, or in the 
cytoplasm respectively, of E. coli before assembly. Taken from Rakonjac et al. (1999). (b) Amino acid 
sequence of the C-terminus ; the hydrophobic α-helical membrane anchor region is underlined. The 
end of the second glycine-rich linker is boxed. The desired cleavage site is indicated by a black arrow. 
The colored arrows show the unspecific cleavage sites, resulting from digestion with enterokinase or 
contaminating proteases from E. coli (see text for details). The residue in bold (4th position, 4th row) 
differs from the sequence in Swiss-Prot (entry PO3662), which has a serine at this position.  
N2 domain G G S G G G S G S G D F D Y E K M A N A N K G A M T E N A D
E N A L Q S D A K G K L D S V A T D Y G A A I D G F I G D V S G L A N G N G A T
G D F A G S N S Q M A Q V G D G D N S P L M N N F R Q Y L P S L P Q S V E C R P
F V F G A G K P Y E F S I D C D K I N L F R G V F A F L L Y V A T F M Y V F S T
F A N I L R N K E S
cytoplasm 
ss Gly Gly 
N1 N2 C 
   1 18 86 104 236 275 (D) 397 424 (S) 
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                                t=0       t=2     t=4      t=6 
                                              L     S        L     S      L     S     L     S 
  
Figure 2-3. The long construct (L, red arrow) of the C-terminal domain of pIII is recognized by the 
monoclonal antibody 10C3 (Beckmann et al., 1998), it migrates on this blot at the proper molecular 
weight (14 kDa). The short construct (S, blue arrow) has a reduced expression yield, and is smaller 
(12 kDa). On top of each lane is indicated the time (in hours) after induction of protein expression. 
Whole cell extracts were boiled at 95°C for 10 minutes, loaded and run on a 15% SDS-gel, and blotted 
onto a PVDF membrane. 
 We fused the CT domain (again as long and short construct) with the protein D from 
bacteriophage Lambda, as this strategy meanwhile proved to be successful with TonB (see 
chapter 2.3). The cells reached an optical density of 1.4 (at 600 nm) after 2 hours expression 
at 30°C, then stopped growing before eventually dying, probably due to the toxicity of the 
protein. The fusion protein was expressed in soluble form in the E. coli strain XLI-Blue, and it 
showed an extensive degradation pattern when visualized on an SDS gel (Figure 2-4a). With 
the aid of a hexahistidine-tag at the N-terminus of protein D, both fusions were purified over 
nickel-NTA beads. Rapid processing of the protein thought to minimize the degradation 
propensity, did not prevent proteolysis (which, maybe, occurred already in the cell). The 
subsequent digestion with enterokinase in an effort to recover the pIII alone thus failed 
(Figure 2-4b). Because of the presence of two cysteines, most probably disulfide-bridged 
(Kremser and Rasched, 1994), we devised an alternative strategy to denature and fully 
reduce the protein in 8 M urea containing 50 mM DTT, dialyzing out the DTT and then 
refolding the fusion in a redox buffer at pH 9.0. Strong precipitation was observed upon 
removal of arginine (present in the refolding buffer) which would be necessary for  
subsequent purification over an ion-exchange chromatography column.  
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Figure 2-4. (A) SDS gel electrophoresis showing extensive proteolysis upon expression of pIII-short 
fused to protein D, and expressed in soluble from in E. coli (strain XL1-Blue). Three different clones of 
the same fusion construct are shown. The upper most band matches with the computed molecular 
weight (30 kDa). The numbers on the left side indicate the sizes in kilodalton. (B) batch purification of 
the pIII-Long construct (fused to protein D); the protein has been expressed (as described in Material 
and Methods) and loaded on a column containing nickel-NTA agarose beads. After washing (lane 1), 
the fusion protein is eluted with 0.5 M imidazol (upper arrow), along with degradation products 
(double-arrow with question mark). Both gels contain 15% SDS and are stained with Coomassie. 
 New results indicated that despite the presence of a long, flexible glycine-rich linker 
between all the domains of pIII, there is a specific interaction between N1-N2 and the CT 
domain, meaning that the latter cannot be regarded as an independent domain. This 
interaction was inhibited to varying degrees by the fusion of a peptide at the N-terminus of 
the CT domain (Chatellier et al., 1999).  
 Expression of the full pIII (containing N1, N2 and the CT domain cloned in pTFT74) 
was therefore tested, but no significant enrichment of the protein in inclusion bodies was 
observed when expressed in the strains BL21(DE3) or C41 (data not shown). We then  
devised a new strategy, involving again the fusion of the full pIII (N1, N2 and CT domain, 
without the signal sequence) to protein D. Again, two constructs were created with and 
without the hydrophobic anchor, thus giving rise to the so called “pD-pIII-Long” and “pD-pIII-
short”, respectively. The absence of the C-terminal helix had a beneficial effect on the 
expression, and a thick band was clearly visible on the gel; pD-pIII-short was observed to be 
expressed in soluble form in XL1-Blue up to an OD(600nm) of 1.8 after 3 – 4 hours 
expression at 30°C, and no visible degradation occurred on the gel. The theoretical mass of 
the undigested pD-pIII-short fusion protein is 53’361 Dalton, which is considerably smaller 
than the band in lane 2 on Figure 2-5. However, due to the flexible glycine-rich linkers, pIII is 
known to display aberrant migration properties on SDS-gels (Crissman and Smith, 1984; 
Gray et al., 1981). The undigested fusion protein (lane 2, Figure 2-5) was subjected to mass 
spectrometry 
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Figure 2-5. This 12% Coomassie-stained SDS gel illustrates the various steps of purification of the 
pD-pIII-short construct (53.3 kDa). Two molecular weight standards are indicated in the far right lane. 
After purification on a nickel column (IMAC) under native conditions, the fusion protein was denatured 
and reduced in 8 M urea (with 50 mM DTT). Dialyzing out the DTT allowed the refolding of the protein 
in a refolding buffer containing a redox shuffle (lane 2). The protein was then dialyzed against the 
enterokinase-buffer, in order to maximize the rate and the specificity of enterokinase cleavage, done 
for 4 h at RT (lane 3). The cleaved fusion protein was then loaded on an IMAC column coupled to an 
anion-exchange column (HQ), in order to quantitatively remove the protein D moiety, which is not 
visible on this gel. On lane 4 and 5 are loaded the flow-throughs of the IMAC column and the HQ 
column, respectively. Lane 6 contains the pure pIII, eluted from the HQ column (see text for more 
details).   
analysis: the calculated mass of 52’700 Dalton was a first hint that some degradation might 
have occurred. Amino acid sequencing confirmed that the amino terminus of the protein was 
intact and, therefore, that the proteolysis started at the C-terminus. By mass computation, it 
could be easily deduced that the last four residues before the C-terminal helix (sequence 
“NLFR”, see Figure 2-2) were actually missing.   
 The pure protein without the pD moiety specifically eluted from the HQ column (lane 
6 in Figure 2-5), was subjected to mass spectrometry analysis, which gave a molecular 
weight of 41.2 kDa (data not shown). The theoretical mass of the pIII-short construct after 
digestion with enterokinase is 39.3 kDa. Unexpectedly, N-terminal amino acid sequencing 
revealed that our purified product started with the hexahistidine-tag sequence. Furthermore, 
the SDS-gel shown in Figure 2-5 was transfered onto a nitrocellulose membrane and the 
membrane was probed with an anti-tetra histidine-tag antibody. The two bands present on 
the gel in lane 6 were also visible on the blot, indicating that proteolysis did happen from the 
C-terminus of pIII-short (data not shown). Therefore, it was concluded that the enterokinase 
cleaved the fusion protein in an unspecific manner within pIII, at the first lysine residue in the 
C-terminal domain (see blue arrow in Figure 2-2). This lack of specificity is not a rare event 
and has already been documented (Choi et al., 2001). The first amino acid downstream of 
the recognition sequence of enterokinase was suggested to be important for specificity; in 
that respect, aspartic acid was proposed to be among the residues conferring the best 
cleavage specificity (Hosfield and Lu, 1999). The exact identity of the two bands in lane 6 
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(Figure 2-5) could not be resolved. However, mass spectrometry analysis and N-terminal 
amino acid sequencing of the sample loaded in lane 6 detected one single species, with a 
mass of 41.2 kDa and an intact hexa-histidine tag. It was concluded that pIII adopts two 
different conformers, displaying distinct migration properties on an SDS-gel. Alternatively, it 
is entirely plausible that the upper band in lane 6 corresponds to a molecule still containing a 
portion of the C-terminal domain. The lower band could then be the 41.2 kilodalton species 
where the proteolysis of the C-terminal domain has reached completion. However, it remains 
to be explained why only this lower band was detected by the mass spectrometry and the 
amino acid sequencing. The pD-pIII-Long construct behaved in the same way, except that 
the expression yield was lower (probably due to the lethality effect of the hydrophobic helix 
which tends to insert into the inner membrane).  
 The most evident experiment to perform next was to mutate the lysine residue after 
which the unspecific cleavage was thought to occur. Introduction of an alanine residue at this 
position, however, did not restore cleavage specificity. The protein was expressed and 
purified in the same way, as it was done for the above-mentioned construct. The same kind 
of investigations led us to the conclusion that the enterokinase (or a contaminating protease 
from E. coli) did cleave this time after the next occurring lysine residue in the sequence (see 
green arrow, Figure 2-2). Mass spectrometry analysis detected a species at 41.78 kilodalton, 
exactly matching with a product cleaved at this position. 
 We then came back to our original idea, namely the expression of the unfused, full 
length pIII (without the signal sequence) as inclusion bodies, under the control of the strong 
T7 promoter, now with a hexahistidine-tag at the N-terminus. Both constructs, with and 
without the C-terminal helix were processed in parallel. The long construct (i.e. with the C-
terminal helix) could be expressed at some levels in BL21 (DE3), but was later found to form 
soluble aggregates resistant to detergents such as dodecyl-maltoside (0.5 mM) or CHAPS (8 
mM), as confirmed by the presence of the protein in the void volume of a gel filtration 
chromatography (data not shown). The short construct (i.e. without the C-terminal helix) 
showed the best expression pattern in the strain BL21(DE3), albeit at lower levels than in 
fusion with protein D (Figure 2-6). It is this protein, termed pIIIfull-short, which was studied in 
greater detail. 
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Figure 2-6. Expression and purification of pIII full-short (no fusion, no signal sequence, no C-terminal 
helix), inserted into pTFT74, for expression in inclusion bodies: (1) before induction, (2) crude extract 
after 3 hours induction at 37°C, the cells reached on OD600 of 2, (3) flow-through of IMAC purification 
under denaturing and reducing conditions (6 M GuHCl + 2 mM β-mercaptoethanol), (4) 2nd 
flowthrough, reloading of the first flow-through (lane 3) onto the column, (5) after refolding by dialysis 
in 0.8 M arginine, (6) after dialysis against a buffer suitable for anion-exchange chromatography, (7) 
elution with 700 mM NaCl from an anion-exchange column (BIOCAD) under native conditions, (8) 
same as lane 7, 10x concentrated. (15% SDS-PAGE, Coomassie-stained) 
 Curiously, quite a big proportion of pIIIfull-short did not bind to the IMAC column on 
the BIOCAD, even though this purification step was done under strong denaturing conditions 
and the disulfide bridges had been fully reduced by prolonged incubation with β-
mercaptoethanol (see lane 3 and 4, on Figure 2-6). This phenomenon could not be 
circumvented, whatever the flow rate was when loading the extract onto the column; this may 
possibly reveal the presence of soluble aggregates. Again, the purified protein showed up as 
a double-band (lane 8), similar to what was observed with the protein D fusions (lane 6 in 
Figure 2-5). We were able to obtain 1 milligram of pure protein out of 1 liter culture; the 
protein was subjected to mass spectrometry, which detected a species at 40’362 Dalton, 
much in accordance with the computed mass of 40’363 Dalton (without the start Methionine).  
 A number of experiments were conducted in order to further characterize pIIIfull-
short. The idea was to grow TG-1 F+ cells (i.e. TG-1 cells harbouring the F-pilus) in the 
presence of varying concentrations of pIIIfull-short in the culture medium, and see if the 
bacteria might import it and were sensitive to the presence of the protein. Only a small 
quantity of pIII is known to cause strong membrane disturbances, which includes 
deoxycholate sensitivity, increased leakage of β–lactamase, enhanced tolerance to certain 
colicins, and defective F-pili (Boeke et al., 1982). Furthermore, it is well documented that E. 
coli cells induce the expression of the so-called “phage-shock-proteins” when challenged by 
phage proteins (Model et al., 1997). However, in our set-up, no specific accumulation of 
proteins of any kind could be detected following incubation with pIIIfull-short when compared 
to a control experiment with no protein (data not shown). The concentrated culture medium 
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was subjected to mass spectrometry, with the idea of seeing if any periplasmic E. coli protein 
(e.g. β-lactamase) could have leaked out of the cell following incubation with the protein. The 
molecular weight of the species present on the spectrogram did not fit to any E. coli protein, 
as told by the “TagIdent” software (available under http://au.expasy.org/tools/tagident.html). 
Similarly, the cells did not behave anomalously if detergent (e.g. Tween-20) was also present 
in the medium. 
    It was nevertheless decided to pursue the biochemical characterization of pIIIfull-
short, and we next adressed the oligomeric state of the protein by loading it on a gel filtration 
column. We found it to be monomeric, in marked contrast to the pD-pIII-short construct 
thought to form trimers (Figure 2-7). A large scale purification was undertaken and 9 
milligrams were sent to Alex Wlodawer’s group for a first crystallization screening. An initial 
crystal survey yielded only clustered needle crystals of insufficient quality for further 
structural studies (Changsoo Chang, personal communication).   
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Figure 2-7. Elution profile of two different pIII constructs loaded on gel filtration chromatography 
columns. The left panel shows the behavior of the pD-pIII-short construct (in red) on a Superose 12 
gel filtration column (SMART system, Pharmacia Biotech). The molecular weight standards are 
colored in black (200-150-66 kDa). The protein displays a main elution peak at ca.170-180 kDa, thus 
making it a trimer (the theoretical mass is 53'360 kDa). Even boiling at 95°C for 45 minutes does not 
affect significantly the elution behavior (a small amount of precipitate appeared). Protein D has been 
shown to be always monomeric on a gel filtration column (Patrik Forrer, personal communication).  
On the right panel, pIIIfull-short construct (no fusion to protein D) has been loaded on a Superdex 75 
column. The elution behavior (about 70 kDa) shows a huge discrepancy with the theoretical mass 
(40'363 kDa), probably due to the glycine-rich linkers causing a non-globular shape of the protein.  
From the molecular weight standards in black (66-29-12 kDa), one can deduce that pIIIfull-short is 
monomeric, and not aggregated as proved by running blue dextran (not shown).   
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In later investigations however, we did observe, to our great surprise, that pIIIfull-short 
was undergoing proteolysis after 2-3 days of storage at 4°C (or overnight at room 
temperature), as illustrated in Figure 2-8a. Mass spectrometry analysis (MALDI 
measurement) revealed that the molecular weight of this species was 28.4 kDa, matching 
with a sequence being truncated at the beginning of the C-terminal domain (see red arrow in 
Figure 2-2). The N-terminus was left intact, as confirmed by N-terminal amino acid 
sequencing. Basically, we ended up with the N1-N2 fragment (with the second glycine-rich 
region), whose structure had already been published (Holliger et al., 1999; Lubkowski et al., 
1998). This fragment proved to be resistant to trypsin digestion. In order to test if the 
proteolysis was due to a contaminating protease carried along in the purification process 
(performed under strong denaturing conditions !), pIIIfull-short was incubated in the presence 
of a home-purified fusion protein (protein D-TonB). As pD-TonB was digested only in the 
presence of the truncated pIII, this could potentially mean that the contaminating protease 
should first attack pIII, before digesting the fusion pD-TonB. This observation led us to the 
conclusion that the putative contaminating protease should have a substrate preference for 
pIIIfull-short against proteinD-TonB (Figure 2-8b). The E. coli protease FtsH was immediately 
seen as a candidate responsible for this strange behavior, as its extreme resistance to 
denaturation has been documented (Cooper and Baneyx, 2001). As the activity of FtsH is 
known to be dependent upon ATP hydrolysis, ATP dependency was investigated, but no 
enhancement of the proteolysis through ATP was found (compare lanes 1 and 2 in Figure 2-
8c). 
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Figure 2-8. These Coomassie-stained SDS-gels illustrate the proteolysis by contaminating protease, 
which affects pIIIfull-short: (a) Some degradation already occurred in the freshly purified protein (left 
lane), becoming effective after overnight incubation at room temperature (right lane). (b) in lane 1, the 
truncated form (termed “pIII-28k”, red arrow) was mixed with pD-TonB (blue arrow, all three bands), 
and incubated overnight in Tris buffer, at room temperature: pD-TonB is partially digested into pD 
(green arrow) and TonB (yellow arrow). Lane 2 is a control where the pD-TonB fusion was 
incompletely digested with enterokinase. Curiously, no digestion is seen when the original 
unprocessed pIIIfull-short (black arrow) is mixed with pD-TonB (lane 3). The fourth lane contains the 
molecular weight standards. (c) “pIII-28k” (red arrow) was incubated with pD-TonB (lane 1), and 
supplemented with ATP (lane 2). A slight band corresponding to pD can be seen at the bottom of the 
gel (green arrow, confirmed by a Western blot not shown here). Similarly, pIIIfull-short and pD-TonB 
were incubated with and without ATP (lanes 3 and 4, respectively).   
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2.1.4 Discussion 
 In view of these results, it becomes evident that all attempts to purify the entire pIII 
protein have failed due to the impossibility to keep the full protein in solution in a stable form, 
and free of any fusion partner: the C-terminal domain gets proteolytically processed. The 
reason for the spontaneous proteolysis of the full-length pIII is still unresolved and remains 
an open question. All kinds of explanations can account for this behavior, but it still remains  
mysterious why the cleavage repeatedly occurs almost at the same position, no matter  
enterokinase is involved or not in the purification procedure. A contaminating protease, itself 
slowly refolding, may be one hypothesis. After it has refolded, it will cleave pIII, thus 
explaining why cleavage of pD-TonB is only seen in the presence of pIII-28k. Indeed, when 
looking at Figure 2-2, it becomes clear that the residues at the beginning of the C-terminus 
should have some propensity to form an unstructured and/or exposed region, particularly 
prone to proteolytic activity, despite the fact that structure prediction algorithms model this 
segment as an α-helix (data not shown). The susceptibility to proteolysis, as discussed in a 
recent review (Hubbard, 1998), is primarily determined by the ability of the protein to unfold 
locally, and this feature seems to be accomplished more easily in an α-helix than in a β-
sheet. The rationale for this is that too many inter-strand hydrogen bonds would need to be 
broken and the ends brought closer together to deform an extended chain segment such as 
found in β-sheets. Interestingly, it has long been known that during its transfer from the 
phage coat to the inner membrane of the infected cell, pIII was reduced to a low molecular-
weight form of about 13 kDa, based on its mobility in an SDS-gel (Marco et al., 1974). The 
question as to which part of pIII corresponds to the truncated form has never been adressed.  
 Furthermore, it must be stressed that maturational cleavage of phage proteins is not 
an unusual phenomenon. The attachment proteins of R17 and RNA phage Qβ are known to 
undergo such cleavage reaction upon attachment of the phage to the sides of the pilus 
(Manchak et al., 2002). In bacteriophage T4, a huge complex consisting of gene product 5 
(gp5) and gp27 is required to penetrate the outer cell membrane of Escherichia coli and to 
disrupt the intermembrane peptidoglycan layer, thus allowing formation of a channel for 
injection of DNA into the host. Lysozyme activity, necessary to digest the peptidoglycan 
layer, is attributed to the lysozyme domain of gp5. When incorporated into the phage or 
stored at high concentrations, gp5 undergoes maturational cleavage resulting in two 
fragments which remain in the phage particle (Kanamaru et al., 2002). 
 The question of the stoichiometry of pIII in the phage coat still remains 
controversial. Indeed we obtained very contrasting results: pD-pIIIfull short did migrate as a 
trimer on a size-exclusion chromatography column, whereas the same protein not fused to 
protein D gave a monomeric peak, though at a higher size than expected (70 kDa, instead of 
40 kDa, see Figure 2-7). However, as the latter proved to be prone to proteolysis, the results 
obtained with the undigested pD-pIIIfull-short construct look more reliable. In this respect, 
one can reasonably propose that pIII is displayed at the tip of the phage as a multimer (most 
probably trimer), and at least part of the C-terminus serves as an oligomerization module. 
Our last construct (pIIIfull-short), which actually lost the full C-terminus upon spontaneous 
proteolysis and showed monomeric behavior (Figure 2-7 and 2-8a) comes in support of this 
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hypothesis. It remains to be determined if oligomerization may have some physiological 
significance and to which extent it might affect the infection process. 
 Oligomerization of a protein for its proper membrane insertion is already a well 
documented phenomenon. The study of α-toxin from Staphylococcus aureus is an instructive 
case, giving some interesting insight into the mechanism of protein insertion into 
membranes. This toxin belongs to a family of pore-forming toxins that are essentially built of 
β-sheets and are thought to form porin-like channels. In order to form a transmembrane 
channel, the toxin has to undergo oligomerization and membrane insertion, a process shown 
to be powered by acidic pH. The protein is secreted as a soluble monomeric protein, and its 
N- and C- termini are separated by a protease-sensitive, glycine-rich loop. The N-terminus is 
the less pH-sensitive region of α-toxin, in contrast to the C-terminus, which has been 
proposed to unfold partially in a two-step process upon acidification (Vecsey-Semjen et al., 
1996). At pH 3.5, it seems that the N-terminus is still fully folded, whereas the rest of the 
protein shows typical characteristics of the molten globule-like state necessary for membrane 
insertion to occur. The protein is sensitive to the local pH at the membrane surface, and this 
pH has to be lower than 4 for channel formation. Unfortunately, working with pIIIfull-short 
through a pH range of 5 to 10 did not diminish the extent of proteolysis, as visualized on an 
SDS-gel (data not shown).          
 The proteolysis of all our constructs is a critical issue which has to be adressed. 
Clearly, one has to find alternative ways to obtain a stable protein in solution, necessary for 
structural characterization or biophysical studies. If one assumes that the extensive 
degradation pattern of the domain is due to disordered structure resulting in protease 
sensitivity, it might be that the C-terminal domain may become folded upon interaction with 
its cognate partner. In this respect, pVI might be a good candidate for such an induced-
folding mechanism, and its co-expression (under the same operon) might stabilize the C-
terminus of pIII. It is well known that pVI by itself is highly hydrophobic, thus preventing any 
simple purification procedure, but it is not unreasonable that its association with pIII might 
shield some hydrophobic regions. The N1 and N2 domains provide the best example in 
support of this idea: N2 is known to precipitate heavily when expressed alone, whereas the 
N1-N2 complex can be expressed in soluble form and shows unusual stability properties 
(Martin and Schmid, 2003b). Another potential “folding-inducer” of pIII could be DNA, as both 
are known to interact with each other (Jazwinski et al., 1973).  
 Regarding our project, a contaminating protease is at the moment the single 
hypothesis which can account for the unusual degradation pattern of all our constructs. 
However, in this “contamination hypothesis”, it remains to be explained why this 
contamination first attacks pIII and then the fusion proteinD-TonB (see Figure 2-8b). It might 
be that pIII is more unstructured, thereby being a better substrate for the protease. 
Furthermore, it is quite odd that all our constructs are cleaved always at the same position 
(compare red, blue and green arrows in Figure 2-2). In other words, one can not totally 
exclude that a contamination has been carried all along the purification procedure, and that 
this contaminant is fairly resistant to harsh denaturing and reducing conditions (8 M urea and 
50 mM DTT). FtsH could be a candidate for this action, as its metalloprotease active site 
remains functional in presence of 3-5M urea (Cooper and Baneyx, 2001). Expression of the 
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protein in an FtsH deficient strain could be a way to solve this problem (Qu et al., 1996). 
Therefore, for all the reasons mentioned, and as long as one can not prove the absence of 
any contamination, we still believe that the C-terminal domain of pIII is proteolysis-sensitive 
and cannot be obtained in a stable soluble form if expressed alone. 
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2.2 Biochemical characterization of the C-terminus of TolR 
2.2.1 Introduction 
 In line with the previous chapter, this second chapter deals with the phage infection 
process, but now from the bacterial “perspective”. The TolQRA pathway is studied in greater 
detail; and one if its component, the TolR protein, is the center of our investigation. The role 
provided by TolR during the phage infection mechanism still remains elusive. Its various 
interactions with the transmembrane helices of the neighbouring TolQ and TolA have been 
extensively described, but no precise function has ever been ascribed to TolR. This project 
was initiated in order to get a better understanding of the biochemical and biophysical 
properties of TolR, and possibly come to a crystal structure of its periplasmic C-terminal 
domain. It was in keeping with the general goal of better characterizing components of the 
TolQRA complex, as examplified by the crystal structure of the N1 domain with TolAIII 
(Lubkowski et al., 1999). From the beginning we were challenged by another group, which 
reported having obtained diffracting crystals of (almost) the same portion of TolR  (Abergel 
et al., 2001). However, this structure has not been reported 
 Our data present evidence that the periplasmic portion of TolR (amino acids 41-
142) displays high conformational flexibility, thus almost precluding any structural 
characterization. Elution properties of TolR on size exclusion chromatography reinforce the 
hypothesis that this portion of the protein is elongated in solution, thus confirming 
assumptions made by others. NMR spectra performed with two slightly different segments of 
TolR did not show a convincing dispersion pattern. Additionally, we present evidence that 
the portion of TolR from residues 54 to 142 is monomeric in solution.    
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2.2.2 Materials and Methods 
- Molecular biology- The periplasmic part of TolR (residues 41–142, Swiss-Prot entry: 
P05829) has been fused to protein D and cloned into the vector pAT37 (see Figure 2-1, 
previous chapter) using the restriction sites KpnI/HindIII. The tolR gene was amplified from 
genomic DNA using the following primers (the enterokinase cleavage site is underlined):  
5’-GGCCTTGGTACCGATGACGATGACAAGCAGAGCGTGGAGGTCGATC-3’ (forward) 
5’-CTATCAAGCTTATCAGATAGGCTGCGTCATTAAACC-3’  (backward) 
PCR reactions conditions were as follows: 92°C (2’); then 30 cycles at 92°C (30’’); 58°C 
(45’’); 72°C (45’’); and a final elongation step of 10’ at 72°C. 
For the shorter constructs (residues 54-142), the backward primer was the same as above. 
Two shorter constructs were made: one cloned in pAT37 in fusion with protein D, using the 
following forward primer: 
5’- GGCCTTGGTACCGATGACGATGACAAGCAGGCGGTGAGCAGTAACG-3’ 
and another construct, without protein D fusion, cloned into pQE30 (from Qiagen) using the 
following forward primer (underlined is an alanine spacer): 
5’- GGCCTTGGATCCGCAGCGGCACAGGCGGTGAGCAGTAACG-3’ 
PCR reactions conditions were in both cases as described above. 
After purifying the PCR products with the QiaQuick PCR purification kit (Qiagen), the DNA 
was digested by the restriction enzymes KpnI/HindIII, before being ligated into the similarly 
digested vector pAT37 for the pD constructs. The construct without pD fusion was digested 
with BamHI/KpnI and ligated into pQE30 (which contains a His-tag at the N-terminus, vector 
commercially available at Qiagen). Transformation into chemically competent E. coli XL1-
Blue cells allowed one to identify single clones containing the correctly inserted, in frame 
tolR gene (checked by DNA sequencing)  
-Protein expression and purification - Expression was done in LB medium in XL1-Blue cells 
as follows: from freshly transformed colonies on a plate, a single clone was picked and used 
to inoculate a culture containing 1% glucose and 100 µg/ml ampicillin. After overnight growth 
at 30°C (OD600 = 2.4), the culture was diluted 100x into fresh LB medium (supplemented 
with 100 µg/ml ampicillin, but without glucose) and allowed to grow until an OD600 of 0.8 was 
reached. Protein expression was induced with 1 mM IPTG and done overnight at 30°C. After 
overnight growth, cells usually reached an OD600 of 2.4. Cells were then harvested, 
resuspended in 100 mM Hepes buffer pH 8.0 containing 500 mM NaCl and 10 µg/ml 
DNAse. Cell lysis was performed with a French Press (Emulsiflex, Avestin). After 
centrifugation (30 minutes at 20’000 rpm), the supernatant was kept, filtrated (0.22 µm filter) 
and loaded onto a nickel column (IMAC) on a BIOCAD 700 perfusion chromatography 
Workstation (Applied Biosystems). TolR without fusion to protein D was then loaded onto a 
coupled anion exchange column (HQ), the elutate was collected and used for experiments. 
The pD fusion construct, eluted from the IMAC column, was dialyzed overnight against a 
buffer containing 50 mM Tris pH 8.0 and 2 mM CaCl2; it was digested with enterokinase for 
6 hours at room temperature, using 5 U/mg fusion. The last purification step involved a 
coupled IMAC/HQ (anion exchange) column on the BIOCAD, at pH 7.0. The flowthrough of  
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the HQ column was collected (!) as the TolR fragment did not bind to the matrix.  
All the procedures involving the anti-protein D antibody fused to the chitin-binding domain 
were done as described (Blank et al., 2002). 
Expression of the 15N-labeled protein for NMR studies was done in the same way as 
described above, except that instead of LB, minimal M9 medium with the following 
composition was used: 10.6 g/L K2HPO4, 4.9 g/L KH2PO4, 0.5 g/L NaCl, 0.5 g/L 15NH4Cl, 10 
g/L glucose, 6.7 ml/L vitamin solution (purchased by Sigma, cat.# K-3129), 1 ml/L trace 
metal mix, 2 mM MgSO4, 100 µM CaCl2.  
The overnight preculture was washed 3 times in M9 medium before being inoculated into 
fresh M9 medium for expression.       
Light scattering study was performed on a Mini Dawn Tristar (Wyatt Technology) with the 
protein at 130 µM in a buffer containing 50 mM phosphate pH7.0, 150 mM NaCl, 0.005% 
Tween-20. 
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2.2.3 Results 
 As a first construct, the periplasmic portion of TolR covering residues 41 to 142 
was investigated. As the strategy of expression with protein D proved to be successful with 
TonB (see next chapter), the same concept was applied here (Figure 2-9). Good expression 
yields for the fusion protein were obtained, which was already quite pure after a single 
purification step over an IMAC column (Figure 2-10). The fusion construct was subjected to 
digestion by enterokinase, and the products of the reaction were loaded on coupled IMAC / 
AIEX (anion exchange) chromatography columns to separate protein D, enterokinase and 
the TolR fragment based on their different isoelectric points. Enterokinase cleavage for 
quantitative removal of protein D proved to be rather unspecific, resulting in a protein D 
fragment cleaved from its N-terminal histidine-tag, thus preventing any additional purification 
step by IMAC (data not shown).  
2nd  construct   
QSVEVDLPDATESQAVSSNDNPPVIVEVSGIGQYTVVVEKDRLERLPPEQ  
1st construct 
VVAEVSSRFKANPKTVFLIGGAKDVPYDEI IKALNLLHSAGVKSVGLMTQPI   
Figure 2-9. Amino acid sequence of the two constructs designed for the study of the periplasmic 
domain of TolR. The first one (red) starts with amino acid 41, whereas the second one (blue) starts at 
position 54 (numbering according to Swiss Prot entry P05829). 
This impurity had to be removed by an alternative strategy. An anti-protein D antibody (from 
Morphosys, Martinsried, Germany) was genetically fused to a chitin-binding domain allowing 
specific binding of this fusion protein to a chitin column (Blank et al., 2002). By loading the 
product of the enterokinase digestion onto this affinity column, quantitative removal of the 
cleaved protein D fragment could be achieved. This purified sample of the C-terminal 
domain of TolR (lane 4, Figure 2-10) displayed a dimer/trimer equilibrium on a size 
exclusion chromatography, and circular dichroism attested the presence of some secondary 
structure, thus excluding any random coil conformation (Figure 2-11). Algorithms predicted 
an α–helical content of 13.7%, whereas the rest is composed of 49% β–sheet and 37.3% 
random coil. 
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Figure 2-10. Expression and purification of the fusion proteinD-TolR, as visualized on a 17% SDS 
gel, loaded with the undigested fusion proteinD-TolR after IMAC purification (lane 1), fusion protein 
after cleavage with enterokinase (lane 2), protein D removed via IMAC purification (lane 3) and TolR, 
C-terminus (lane 4). The yield of the undigested fusion (lane 1) was 20 mg/L culture, and the final 
yield of the TolR C-terminus (lane 4) was 4 mg/L culture. The protein D fragment resulting from 
unspecific enterokinase cleavage is not visible here. Molecular weight markers are shown on the left.   
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Figure 2-11. (a) TolR C-terminus (aa 41-142, MW = 10’940 Dalton), at 0.2 mg/ml in TBS150 pH 8.0, 
was loaded on a Superdex 75 gel filtration column (Pharmacia Biotech). TolR is eluted in two peaks 
of 24 and 35 kilodalton, suggesting the presence of a dimer/trimer equilibrium. As standards, BSA (66 
kiloDalton), carbonic anhydrase (29 kDa) and cytochrome c (12 kDa) have been used. (b) the circular 
dichroism spectrum has been recorded with the protein in a 20 mM phosphate buffer pH 8.0, at a 
protein concentration of 0.74 mg/ml, in a 1 mm cuvette. 
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Mass spectrometry detected a main species at 10’939 Dalton (computed mass: 10’940 
Dalton), and a side product of 9’569 Dalton, which is not visible on SDS-gels. Theoretical 
mass calculations predicted that this side product could be a portion of TolR, with its first 
thirteen amino acids deleted. This N-terminal portion of TolR might adopt conformational 
flexibility, rendering it sensitive to any protease contaminant. In view of the deceiving results 
obtained in the crystallization trials (formation of aggregated needle-shaped crystals), it was 
decided to subject the protein to limited proteolysis through incubation with the V8 protease 
from Staphylococcus aureus, as this strategy might sometimes be successful in yielding a 
crystallizable construct (Chen et al., 1998). Unfortunately, this treatment did not affect the 
crystallization properties of our protein either (Changsoo Chang, personal communication) 
 We then reasoned that NMR might possibly be more suitable to the study of TolR, 
showing such a high content of conformational flexibility. Thus, a one-dimensional spectrum 
was recorded at pH 6.0, which shows a rather good dispersity (Figure 2-12a). An 15N-
labeled sample was later expressed and purified for in depth analysis, but this preparation 
proved to be highly conformationally inhomogenous (Figure 2-12b). Based on this result, it 
was decided to remove the putative flexible part and a new construct was engineered, 
starting from amino acid residue 54 (Figure 2-9, blue), but now expressed without any 
protein D fusion. HSQC spectra run with an 15N-labeled protein look very similar to the one 
presented in Figure 2-13a. This result was quite surprising, as this protein (TolR 54-142, 
15N-labeled) gave an almost ideal dispersion behavior in a light scattering measurement 
(Figure 2-13b). Interestingly, this last experiment detected the presence of a clear 
monomeric species in solution, which is worth being compared with other studies (Abergel 
et al., 2001; Journet et al., 1999). As these two publications were dealing with a fragment 
extending from residues 44 to 142, it is tempting to speculate that the 10 residues removed 
at the N-terminus of our construct might form a dimerization module. 
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Figure 2-12. NMR spectra of TolR, C-terminal domain (amino acids 41-142). 
(a) The interesting region (6-9 ppm) in this one-dimensional spectrum shows sharp peaks, indicative 
of good dispersion properties, as well as a flexible region at the N-terminus (arrow). (b) 2D spectrum 
of an 15N-labeled sample showing high conformational inhomogeneity. Only 6 glutamine and 
asparagine residues are visible here (red arrow), whereas there should be nine, thus reinforcing the 
intuition that some proteolytic processing occurs at the flexible N-terminus. Some sharp peaks do 
show up, which are probably coming from contaminating protein D (Prof. Hideo Iwai, personal 
communication). 
Both spectra were taken in 10 mM phosphate buffer pH 6.5, with 1 mM TolR. 
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Figure 2-13. (a) HSQC spectrum (pH 5.0, 27°C) of the TolR fragment (amino acids 54-142). About 
half of the protein looks unfolded. A large overlap in one region is boxed; this did not change upon 
varying pH, temperature or salt conditions. The line width of the spread peaks (indicated by arrows) 
are broad for this molecular size, indicating the chemical exchanges. The other peaks are very sharp,  
which is typical for flexible tails. Different temperature and pH conditions were tested, but all spectra 
look similar (personal communication from Prof. Dr. Hideo Iwai) (b) light scattering pattern of this 
same construct of TolR, attesting the presence of a monomeric and homogenous protein (calculated 
molar mass moment = 11’330 g/mol). 
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2.2.4 Discussion 
 “No longer can binding be viewed as simply a “lock and key” event or as an 
interaction involving rigid macromolecular surfaces”. This citation, taken from a review 
(Dyson and Wright, 2002), summarizes the whole problematic encountered with this project. 
Because protein functions are based on precise arrangements of atoms, there was 
generally a rather naive belief that well-defined and fairly rigid protein structures as revealed 
by X-ray crystallography are the norm. However, it has been recognized only recently that 
numerous proteins lack intrinsic globular structure or contain long disordered segments 
under physiological conditions, and furthermore, that this is their normal, functional state. 
Partial disorder of a molecule means that the conformation of that portion has flexibility as 
well as adaptabiity. In many macromolecular assemblies (e.g. virus or flagellum assembly), 
conformational adaptability is an essential requirement in forming intricate molecular 
interactions. The assembly of icosahedral viruses, such as simian virus 40 or polyoma virus, 
cannot occur with predetermined rigid structures of the coat protein subunits. The C-terminal 
chains must be disordered and flexible until they meet with the partner structures to which 
they adapt their conformation (Namba, 2001).   
In bacteriophage λ, the FII protein (gpFII) is a structural protein responsible for the joining of 
phage heads and tails. Its NMR structure displayed two large unstructured regions at the N-
terminus and a large loop near the middle of the protein. The authors speculated this 
unstructured region becomes structured upon assembly: gpFII is present in multiple copies 
in the phage and is believed to assemble into a stable multimeric structure only when the 
correct target surface provided by phage heads is contacted (Maxwell et al., 2002). 
Therefore, it is not totally excluded that, in the case of TolR, the folding of the C-terminus 
into a compact domain requires a partner structure. In its absence, the folding process is 
incomplete and results in partial disorder of the domain. The search for having the right 
partner to achieve folding of TolR is a rather risky guess, and some potential candidates 
include the C-terminus of TolA, the transmembrane helix of TolR itself or the third 
transmembrane helix of TolQ (see below). But sometimes the interacting partners are not 
present in the immediate vicinity of each other. In this respect, the case of colicin N reveals 
an interesting feature: its translocation domain is intrinsically disordered, and there are now 
pieces of evidence that upon binding the C-terminus of TolA, the disordered structure 
converts to a folded domain; the TolA receptor can be seen as a folding template allowing 
the colicin to find its final structured state (Anderluh et al., 2004). Finally, one of the most 
compelling suggestions for the participation of unstructured proteins in binding interactions 
was provided by Shoemaker et al. (Shoemaker et al., 2000). The authors envisage that an 
unstructured protein would have a greater “capture radius” for a specific binding site than 
the folded state with restricted conformational flexibility and smaller fluctuations. The image 
that they conjure up is of a “fly-casting” mechanism, whereby the unfolded state binds 
weakly at a large distance and then folds as it “reels in” its target, thereby completing folding 
and binding simultaneously. 
 Handling of proteins with high conformational flexibility and polydispersity prompted 
researchers to study these proteins using hyperthermophilic strains, as exemplified by the 
C-terminus of FliG, a component of the rotor in the bacterial flagellar motor. This portion of 
the E. coli protein failed to crystallize, however, the same domain from the hyperthermophile 
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Thermotoga maritima was successful in giving crystals, and a structure at 2.2 Å resolution 
was determined (Lloyd et al., 1999). Unfortunately, the only thermophilic strain known to 
possess the tol-pal gene cluster is Methanobacterium thermoautotrophicum, but the 
homology of the putative TolR equivalent is very weak. It is believed that the tolQ/R gene 
pair in this strain was the original starting point for the evolution of this system, and that it 
was subsequently embellished during the development of Gram negative bacteria (Sturgis, 
2001). Alternatively, one could think of designing a new construct starting at position 66 
(amino acids “VEVSG….”, see Figure 2-9), as the 10 amino acids located upstream are 
predicted to be disordered, and the downstream sequence shows some globularity. These 
assumptions are based on a software, that allows the user to plot the tendency within a 
query protein for order/globularity and disorder (available at http://globplot.embl.de and 
further discussed in Linding et al. (2003)). 
 Our results support the hypothesis that a dimerization module might be located in 
the N-terminal region of our first construct, more precisely between the residues 41 and 54. 
Indeed, when removing these thirteen amino acids, the protein shows an unambiguous 
monomeric behavior (Figure 2-13b), whereas the first construct tends to form dimers or 
even trimers (Figure 2-11a). Interestingly, crosslinking studies performed in the analogous 
TonB system found that ExbB (TolQ homologue) and ExbD (TolR homologue) were forming 
homodimers and homotrimers in vivo (Higgs et al., 1998); these authors later established 
the precise stoichiometry of the complex, namely one TonB for two ExbD and seven ExbB 
(Higgs et al., 2002). The presence of a dimeric TolR has also been reported by others when 
performing in vivo crosslinking studies with a construct extending from position 44 to 142, a 
so-called “TolRII-III” (Journet et al., 1999). The question of the stoichiometry of TolR in the 
inner membrane of E. coli has recently been adressed in an alternative way, in view of the 
structural and functional homologies of the TolQRA system with MotA and MotB of the 
flagellar motor. Based only on homology modeling with the MotAB system, these authors 
proposed an inner membrane unit consisting of TolQ4TolR2TolA1. Furthermore, despite any 
sequence homology between the C-terminus of TolR and MotB, they see the involvement of 
the C-terminus of TolR as a bilayer-penetrating loop, responsible for forming an ion-
selectivity filter, as seen for MotB (Cascales et al., 2001). MotB disposes of a large amount 
of sequence (about 140 residues) between the C-terminus of the transmembrane α-helix 
and a periplasmic region, called peptidoglycan binding motif. These authors have proposed 
that this sequence might function as a linker between the MotA/MotB complex and the cell 
surface. This linker is divided into two parts, the first (about 90 amino acids) is wholly or 
party dispensable and the second is indispensable (Figure 2-14). They propose that the first 
part is a random coil with little elastic properties and the second part forms an ordered 
domain, whose compact structure allows it to function like a spring and provide suitable 
elastic coupling between the Mot complexes and the cell surface (Muramoto and Macnab, 
1998). If these dynamic properties of the periplasmic segment of MotB has any relevance 
for TolR is still questionable; TolR and MotB show a consensus sequence only in their 
transmembrane domains. There is now a growing body of evidence that MotB forms a 
symmetric dimer via its transmembrane α-helix, and that this association is direct and does 
not require MotA (Braun and Blair, 2001).  
THE STRUCTURAL BASIS OF PHAGE DISPLAY 55     
 
   
 
Figure 2-14. Cartoon of MotA and MotB showing their topology with respect to the cytoplasmic 
membrane (CM) and cytoplasmic and periplasmic regions. The transmembrane regions are 
presumed to be α-helical, but the boundaries of the transmembrane helices (boxes) should be 
regarded as only approximate. In MotB, the first linker region (position 51 to 138) thought to form a 
random coil, is dispensable for proper function. The second linker region lies in the vicinity of the 
peptidoglycan layer (PG). It forms a structurally ordered domain and is thought to be essential for the 
stability of MotB. Proposed roles of regions of sequence in proton conductance (heavily boxed 
transmembrane helices) and torque generation are indicated. The peptidoglycan binding motif 
necessary for anchoring to the cell surface is boxed in red. The circles denote positions of suppressor 
mutations. Picture taken from Muramoto and Macnab (1998). 
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The question of the natural interacting partners of TolR in vivo still remains a critical issue 
and forms a prerequisite for a structural characterization of its flexible C-terminus. The 
extreme C-terminus was suggested to interact either with the third transmembrane helix of 
TolQ and/or the transmembrane segment of TolR (Lazzaroni et al., 1995). Furthermore, 
these authors showed that TolRIII (residues 117 to 142) participates in the TolQ-TolR 
interaction; however, TolR deleted of this domain still crosslinked to TolQ. Therefore, the 
issue of knowing if co-expression of the C-terminal fragment with one or both of these 
transmembrane helices might have a stabilizing effect on the TolR conformation in solution 
remains highly hypothetical.  Only the interactions between the transmembrane domains of 
TolQ, TolR and TolA have been well established and confirmed. 
 The in vivo localization of TolRII-III (residues 44 to 142) has been investigated; this 
portion of TolR appeared to be enriched in fractions with a sucrose density gradient 
intermediate between the fractions corresponding to the inner membrane and the outer 
membrane. This result argued in favor of an interaction of the TolR C-terminal domain with 
the membranes, but the authors went further by suggesting a localization of this domain in 
the contact sites between the inner and outer membranes (Journet et al., 1999). It was 
further demonstrated that the region from amino acid position 117 to 142 (so-called TolRIII) 
is not essential for TolR dimerization, and it plays a role in the TolA-TolR interaction, 
because deletion of this domain abolished the TolA-TolR complex. Journet et al. concluded 
from this finding that TolRIII plays a role in the TolA-TolR interaction, insisting on the fact 
that there exists no proof of a direct interaction between these two members, as no complex 
has ever been isolated or detected in vivo. Their results rather suggested that TolRIII 
interacts with proteins localized in the contact sites and/or the outer membrane, concordant 
with the results of Lazzaroni et al., who found that the C-terminus of TolR was not 
accessible to carboxypeptidase digestion (Lazzaroni et al., 1995). In the case of ExbD, a 
role for its C-terminal domain in the interaction with ExbB and TonB has also been 
suggested (Braun, 1995). It clearly appears then that the C-terminus of TolR is engaged in 
many interactions with neighbouring partners of the periplasm, and a more detailed 
understanding of the biochemistry of the TolQRA system is a prerequisite for structural 
characterizations of its members.      
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The TonB-dependent complex of Gram-negative bac-
teria couples the inner membrane proton motive force
to the active transport of ironsiderophore and vitamin
B12 across the outer membrane. The structural basis of
that process has not been described so far in full detail.
The crystal structure of the C-terminal domain of TonB
from Escherichia coli has now been solved by multi-
wavelength anomalous diffraction and refined at 1.55-Å
resolution, providing the first evidence that this region
of TonB (residues 164–239) dimerizes. Moreover, the
structure shows a novel architecture that has no struc-
tural homologs among any known proteins. The dimer of
the C-terminal domain of TonB is cylinder-shaped with
a length of 65 Å and a diameter of 25 Å. Each monomer
contains three  strands and a single  helix. The two
monomers are intertwined with each other, and all six
-strands of the dimer make a large antiparallel -sheet.
We propose a plausible model of binding of TonB to
FhuA and FepA, two TonB-dependent outer-membrane
receptors.
The outer membrane (OM1) of Gram-negative bacteria con-
stitutes a permeability barrier, protecting the cell against a
variety of toxic agents. The lipopolysaccharides located in the
outer leaflet of the OM confer to the bacteria a polar and
negatively charged surface, restricting the cellular uptake of
toxic organic molecules and detergents such as bile salts, the
detergents in the gut. However, although the OM is an effective
protective barrier against harmful environmental components,
it also represents an additional obstacle for the uptake of nu-
trients, which can be circumvented in three ways. While small
hydrophilic nutrients (600 Da) enter the periplasm by simple
diffusion through porins in a non-selective manner (1), larger
molecules are taken up by pores with an internal binding site
for the ligand (such as LamB) in a stereospecific and selective
manner (2) and can subsequently enter the cytoplasm by a
variety of transporters located in the inner membrane (3). A
few nutrients, notably iron and vitamin B12, need to be taken
up into the periplasm against their concentration gradients.
For this purpose, a complex consisting of TonB, ExbB, and
ExbD couples the inner membrane proton motive force (pmf) to
the active transport of iron siderophores and vitamin B12
across the OM through specialized porins. Recently, crystal
structures were solved for two TonB-dependent receptors,
FepA and FhuA (4–6). Like all other known porins, they are
-barrels, but unlike the other porin structures they have much
larger interiors, which are almost completely obscured by a
protein domain sitting inside the barrel (termed the “cork” or
“hatch region”), which is encoded within the N-terminal seg-
ment of either protein.
Iron uptake into bacteria is initiated by the binding of the
ironsiderophore complex to the high affinity OM receptor. The
dissociation constant is around 100–200 nM (7, 8). An electron
spin resonance study (9), later rationalized by three-dimen-
sional structural models (4–6), has shown that this event trig-
gers conformational changes in the OM receptor. This might
allow TonB to contact specific regions on the receptor. It ap-
pears that “energized” TonB is then able to deliver its energy to
the receptor, resulting in ligand translocation into the
periplasm (10, 11). ExbBExbD are implicated in the recycling
of TonB, from its high affinity OM receptor association to a
high affinity inner membrane association (12, 13). The struc-
tural changes in this whole process have remained almost
completely unclear.
TonB of Escherichia coli is a protein consisting of 239 amino
acids. Homologs of TonB have been found in several Gram-
negative species (14). The N terminus is in the cytoplasm; the
protein is anchored in the inner membrane by its uncleaved
N-terminal signal sequence (15, 16), and most of the protein
extends into the periplasm. The membrane anchor sequence
contains a set of highly conserved residues located on one face
of the -helix (SHLS motif). The sequence SXXXH (where X is
any amino acid) has been defined as the minimal structural
requirement for the coupling of TonB to the electrochemical
gradient of the inner membrane (17). The amino acid sequence
of TonB contains a long central region with a high percentage
of proline residues between residues 70 and 102 (17%), which is
thought to confer to TonB the conformational rigidity and ex-
tended shape necessary to span the periplasm, and thereby to
allow the C-terminal domain to contact the receptor embedded
in the OM (18). Mutational studies have defined the last 48
residues as being essential to make contact with the OM
receptor (19).
TonB forms a complex in the inner membrane with ExbB and
ExbD (13), two membrane proteins that could potentially act as
proton translocators. ExbB is homologous to the protein MotA,
and ExbD has a similar topology as MotB, both of which are
thought to exploit the proton gradient to drive the bacterial
flagellum. ExbB has been proposed to modulate the conforma-
tion of TonB (20), as well as mediate its recycling (12, 13), but
it has remained an enigma as to what these structural changes
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“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
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might be. Cross-linking studies have suggested the regions
through which TonB might interact with its partners in the
inner membrane: The contact with ExbB is mediated by the
signal anchor (20), whereas the residues responsible for the
interaction with ExbD are unknown (21).
TonB and its associated proteins ExbBExbD thus play the
role of an energy-transducing complex, coupling the electro-
chemical proton gradient of the inner membrane to active im-
port processes across the OM (13, 22). The energy is provided
by the proton motive force (10, 23, 24). For the transduction
process to occur, the C-terminal domain of TonB must contact
the OM receptor. Based on genetic (25, 26), cross-linking (19,
27–29), and affinity chromatography (30) studies, a recognition
site has been suggested on the receptor, the TonB box, a hy-
drophobic stretch of seven amino acids, which is highly con-
served in all the TonB-dependent OM receptors (31). A recent
study resulted in the proposal that the conformation rather
than the sequence of the TonB box is important for the recog-
nition process between TonB and the receptor (19). Moreover, it
has been hypothesized that other regions of both interacting
partners are also involved (27). Most strikingly, TonB depend-
ence is maintained if the complete cork domain is deleted (32,
33), including the TonB box. It follows that the recognition site
cannot be limited to the TonB box.
A number of phages and colicins have exploited the
TonBExbBExbD system for gaining entry into bacteria (34). A
similar system, TolQRA, has also been described as allowing
entry for other phages and colicins (34). The cellular function of
the TolQRA system has remained enigmatic, and its deletion
leads to a leaky phenotype (although no such effect is caused by
the deletion of TonBExbBExbD). Nevertheless, both systems
can partially complement each other (35). We have recently
described the crystal structure of the C-terminal domain of
TolA (36), and we became interested in finding out whether any
structural similarity might exist between the C-terminal do-
mains of both TonB and TolA.
In this paper, we present the crystal structure of the C-
terminal domain of TonB at 1.55-Å resolution and show that
this protein exhibits a novel fold that is without homology to
any known structures. Moreover, we provide the first evidence
that the C-terminal domain of TonB forms a tightly inter-
twined dimer.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—The sequence encoding resi-
dues 155–239 of tonB from E. coli strain JM83 was polymerase chain
reaction-amplified and cloned into the plasmid pAT37 (based on pQE30
from Qiagen). pAT37 codes for protein D (gpD) from bacteriophage 
with an N-terminal His-tag, under control of the T5 promoter (37). The
tonB gene was fused to the C terminus of gpD, with an enterokinase
cleavage site engineered by the polymerase chain reaction in between
the two proteins. Recombinant bovine enterokinase (purchased from
Invitrogen) cleaves after the sequence Asp-Asp-Asp-Asp-Lys. The re-
combinant protein was expressed overnight at 30 °C in E. coli XL1-
Blue, after induction with 1 mM isopropyl--D-thio-galactopyranoside.
Cells were lysed with a French press and, after centrifugation, the
gpD-TonB fusion protein remained in the soluble fraction. The undi-
gested fusion was purified at pH 8.0, using the coupled IMAC-IEX
(cation exchange) protocol (38) on a BIOCAD-60 workstation. After
dialysis against 50 mM Tris, pH 8.0, 1 mM CaCl2, 0.1% Tween 20, the
cleavage reaction was performed at room temperature for 4 h, using 1
unit per mg of fusion of the recombinant bovine enterokinase (Invitro-
gen). The solution was then dialyzed against 50 mM Mes/Hepes/acetate
buffer, pH 8.0. Removal of gpD and enterokinase was again achieved
with the coupled IMAC-IEX (cation exchange) protocol, based on the
different pI of TonB, gpD, and enterokinase.
Crystallization and Structure Solution—The C-terminal domain of
TonB was dialyzed against 20 mM Tris buffer at pH 7.5 and was
concentrated to 15 mg/ml. Crystallization was performed by the hang-
ing-drop vapor diffusion method at 22 °C. Crystal screen I (Hampton
Research) was used for the initial screening. Small, rod-shaped crystals
were found under conditions 6, 19, 27, and 36. The final refined crys-
tallization conditions were 28–30% polyethylene glycol 3350, 0.1 M Tris
buffer at pH 7.5, 50–100 mM CaCl2. After refinement of the conditions,
crystals were grown to the size of 0.3–0.5 mm. When a crystal was
picked up from a droplet, the diffraction pattern showed split spots or
high mosaicity. To improve their quality, crystals were moved from the
droplet to a well containing mother liquor and stored for more than 1
day. Such treatment both increased the resolution of diffraction and
lowered the mosaicity. TonB crystals were found to belong to the or-
thorhombic space group P21212 with the unit cell parameters a  63.78
Å, b  86.34 Å, c  26.56 Å. The asymmetric unit contains two mole-
cules, and the VM value is 1.89 Å
3/Da (solvent content 35%).
The structure of TonB was solved by derivatization with Br ions (39,
40). To prepare a crystal for this procedure, it was soaked for 50 s in a
solution containing 1.0 M KBr in addition to the crystallization buffer.
Subsequently, the crystal was picked up with a nylon loop (Hampton
Research) and was flash-frozen in a nitrogen stream. All data sets were
collected at 100 K using the ADSC Quantum 4 charge-coupled device
detector on the synchrotron beamline X9B at the National Synchrotron
Light Source, Brookhaven National Laboratory, Upton, NY. The bro-
mine fluorescence edge was scanned to determine the energy of the
inflection, peak, and remote points. Three data sets were measured at
2.0-Å resolution to provide all information necessary for a multiwave-
length anomalous diffraction (MAD) experiment. In addition, a data set
extending to 1.55 Å was obtained for the purpose of structure refine-
ment. Data were integrated and scaled using the HKL2000 program
suite (41). Data collection statistics are summarized in Table I.
Four Br sites were found by both direct and Patterson methods and
were refined using the program SOLVE (42), utilizing three data sets
corresponding to the peak, inflection, and remote wavelengths, in the
resolution range 10–2.5 Å. These sites were also confirmed with the
program SHELXD (43). The phases from SOLVE were modified and
extended to 1.55 Å using the program DM (44) in the CCP4 program
suite (45), with the solvent content set at 25%. The mean figure of merit
of the phase set was 0.608 for the 10–2.5 Å data after SOLVE, and 0.489
for 20–1.55 Å after DM (0.780 for 20–2.5 Å). The initial model was built
using the automatic model-building option of the program ARP/wARP
(46) with the full-DM phase set as input. The model was rebuilt with the
program O (47) using either electron density maps based on the com-
bination of the MAD and model phases, or straight 2Fo  Fc maps. The
combined phase set was obtained using SIGMAA in the CCP4 program
package. After each cycle of rebuilding, the model was refined using
SHELXL (48) at the resolution range of 20 to 1.55 Å, without applying
any non-crystallographic (NCS) restraints, as the latter prevented
proper convergence. Eight full cycles of remodeling and refinement
were performed, with the refinement of individual anisotropic B-factors
for all atoms initiated in cycle six. In addition to protein atoms, 219
water molecules and four bromide ions have been added to the model.
The R-value for all reflections between 20 and 1.55 Å is 16.0% (Rfree
23.0%). The geometrical properties of the model were assessed by the
TABLE I
Data collection statistics
Remote 2 Remote 1 Peak Inflection
Wavelength (Å) 0.9800 0.9163 0.9196 0.9199
Resolution (Å) 20–1.55 20–2.0 20–2.0 20–2.0
Total reflections 138,987 80,451 81,133 58,622
Unique reflections 21,518 19,195
(F and F separated)
19,199
(F and F separated)
19,128
(F and F separated)
Completeness (%) (last shell) 96.8 (80.2) 99.6 (98.3) 99.6 (97.6) 99.1 (96.5)
Rmerge 2.7 (11.0) 2.3 (4.1) 2.5 (4.3) 1.7 (4.2)
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program PROCHECK (49), and the secondary structure elements were
assigned by the program PROMOTIF (50). The figures were prepared
with Molscript (51) or Bobscript (52) and rendered with Raster3D (53).
RESULTS
The crystal structure of the C-terminal domain of TonB has
been determined by multiwavelength anomalous diffraction,
and has been refined using SHELXL at 20–1.55 Å, yielding a
model with low R-factor and excellent stereochemistry. The
refinement statistics and the indicators of model quality are
listed in Table II. The electron density maps (both the com-
bined map utilizing the phases of the MAD data and of the
model, and the final 2Fo  Fc map) are generally of excellent
quality (Fig. 1). However, both maps are poorly defined in the
neighborhood of residues 194–201. In this region, B-factors of
all atoms are relatively high, indicating extensive flexibility of
the polypeptide chain. Some disorder is also present at both
termini of each molecule. Residues that are not visible in the
maps include the first ten N-terminal amino acids of our con-
struct (residues 155–164), as well as the last one or two resi-
dues on the C terminus (residues 238 and 239 of molecule A,
and 239 of molecule B). The electron density of the remaining
parts of the protein is very well defined. The mean positional
error in atomic coordinates as estimated by the Luzzati plot is
0.16 Å. All non-glycine and non-proline residues of the model
lie either in the most favorable region or in the additionally
allowed region of the Ramachandran plot.
The C-terminal domain of TonB is cylinder-shaped with the
length of 65 Å, and the diameter of 25 Å, with two protein
chains forming a single compact entity. Each chain is rich in
-strands (50% of the secondary structure) with much more
limited extent (15%) of residues found in helical conformation
(either -helix or 310 helix). Each monomer contains three
-strands (strand S1, residues 169–182; S2, 188–194; and S3,
221–236) and one -helix (residues 200–210 in molecule A, and
200–211 of molecule B). In addition, a short 310 helix includes
residues 211–213 of molecule A. All six -strands make a large
antiparallel -sheet. The -strand S3 of each monomer is
FIG. 1. Electron density maps of the
central -sheet region of TonB. a, ste-
reoview of the MAD-phased electron den-
sity map contoured at 1.0 . The map was
calculated with phases from the program
SOLVE (42), modified with DM (44). b,
stereoview of the final 2Fo  Fc map cal-
culated with the program SHELX (48),
contoured at 1.5 .
TABLE II
Refinement statistics for the final coordinates of the C-terminal
domain of TonB
Resolution range 20.0–1.55 Å
Unique reflections used 20,365
Rcryst 16.0%
Rfree 23.0% (5% test set)
r.m.s. deviations from ideality
Bond lengths 0.009 Å
Angles 0.028 Å
Non-zero chiral volumes 0.054 Å3
Zero chiral volumes 0.047 Å3
Number of amino acid residues 73  74
Number of protein atoms 578  586
Number of heteroatoms 4
Number of solvent atoms 219
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swapped between the monomers (Fig. 2). Four -strands, S1
and S3 of both molecules, are located on one side, whereas the
two short -strands S2 and the helices are located on the other
side (Fig. 3).
The two monomers differ slightly from each other. At any
refinement stage, application of non-crystallographic re-
straints between the two molecules resulted in significantly
worse behavior than if such restraints were not utilized. The
r.m.s. deviation between the C atoms of the two monomers is
0.42 Å, whereas the r.m.s. deviation between the side-chain
atoms of the two monomers is 1.15 Å. In the case of the main
chain of the protein, the largest differences are found at the N
terminus. As judged by their high temperature factors, both
termini are located in highly flexible regions of the structure.
The difference between C positions of Ala-165, the first visible
residue on the N terminus, exceeds 2 Å (residues preceding
Ala-165 were not visible in either molecule). In the case of the
side chains, several residues show significantly different values
of the 1 angle. These residues include Leu-170, Arg-171, Glu-
173, Asn-200, Lys-219, and Lys-231. The only hydrophobic
amino acid among them is Leu-170, and different orientation of
its side chain leads to the presence of more hydrophobic con-
tacts in molecule B. The other residues are all polar or charged,
and all are solvent-exposed. The orientations of the C atoms in
the residues belonging to the -sheet (Arg-171, Glu-173, Lys-
231) closely coincide. For positively charged residues (Arg-171
and Lys-231 of both molecules) C atoms point toward the N
terminus of molecule A. The C atoms of the negatively
charged residue Glu-173 point toward the N terminus of mol-
ecule B. Asn-200 is located just after the highly flexible loop
and is itself flexible, judged by its high B-factor. Lys-219 is
located at the end of the molecule and is also flexible.
The interactions between the two protein chains that form a
single compact molecule of the C-terminal domain of TonB are
unusually extensive. The dimeric interface area covers 41% of
the surface of each monomer, thus the individual chains are
unlikely to be able to exist independently and the protein
becomes stable only as a dimer. The region of the -sheet shows
tight dimeric interactions, whereas the interactions on the
opposite side of the molecule are not as close. Although the
single antiparallel -sheet present in the dimer is composed of
strands originating from different molecules, the hydrogen
bonding pattern is close to ideal. The loop between -strand S2
and the -helix is very flexible, as indicated by its high B-
factor. The average B-factors of the main-chain atoms in this
loop are 71 Å2 and 60 Å2 for molecules A and B, respectively, as
compared with the respective averages for other areas of 20.6
Å2 and 21.7 Å2. Crystal packing in the vicinity of these loops is
rather loose, resulting in the formation of clefts or channels on
the molecular surface. The channels are made by residues
195–200 and 172–176 in both molecules, the former belonging
to the loop, and the latter to the -strand S1.
DISCUSSION
The binding of a nutrient, such as vitamin B12 or an
ironsiderophore complex, to the external face of an outer mem-
brane receptor triggers a series of conformational changes: The
N-terminally located TonB box, which is hidden within the
barrel of the unliganded receptor, is made to project in an
extended form into the periplasm and, thus, becomes freely
accessible for interaction with the C-terminal domain of TonB
(28). Additionally, subtle structural changes of the receptor
observed crystallographically, such as the upward translation
of selected loops of the cork domain (also termed “hatch re-
gion”), may disrupt hydrophobic interactions between the so-
FIG. 2. Schematic diagram of the secondary structure topol-
ogy of the C-terminal domain of TonB. Molecule A is colored in red
and molecule B in blue. The arrows represent  strands, and each
cylinder represents a helix. The secondary structure elements are la-
beled, and the residues belonging to each of them are described in the
text.
FIG. 3. Stereo ribbon diagram of the
C-terminal domain of TonB, showing
the intertwined dimer. The color
scheme is the same as in Fig. 2. The
atomic coordinates have been deposited in
the Protein Data Bank (accession code
1IHR).
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called switch helix (residues 24–29 in FhuA) and the internal
wall of the barrel, and the helix unfolds (6). It thus constitutes
a candidate for signaling the occupancy of the outer binding
site by a ligand to the periplasm. However, the actual “tag”
being recognized by TonB could still be the TonB box, the
switch helix mediating its accessibility. Nevertheless, there
must be additional crucial conformational changes occurring in
the barrel itself. Both in FhuA and FepA, the cork domain has
been completely deleted and the TonB dependence of transport
was fully maintained (32, 33). It follows that TonB must inter-
act with the barrel itself, but this result certainly does not
refute an interaction with the TonB box or other regions in the
plug domains in wild-type receptors.
It is not clear whether substrate transport normally involves
the complete dissociation of the plug domain from the barrel.
On the one hand, this does not seem to be necessary, because it
is conceivable that channels of sufficient dimension can be
created by much smaller movements and changes in the cork
domain, even though this is a matter of debate (5, 6). On the
other hand, phages can inject their DNA through this pore (34)
and colicins use it for entry (34), and this is only conceivable
with a completely unplugged pore. Furthermore, the un-
plugged state is apparently functional (32, 33) and thus able to
exist, and therefore a full opening of the pore is likely at least
for the entry of very large molecules.
The ligand-mediated signal could therefore trigger a confor-
mational rearrangement first at the loops of the cork domain
and the barrel of the receptor which is then transmitted along
the barrel. The binding of TonB, which appears to be not
continuous but to occur in cycles (12), may then stabilize an
intrinsically energetically unfavorable conformation of the bar-
rel, which allows the passage of the ligand. Additionally, TonB
may bind to the cork domain in wild-type receptor and help its
dislocation, but this is apparently not the decisive action for
mediating ligand transport. The binding of TonB to the barrel
is needed to effect ligand translocation. The “energizing” of the
receptor might then simply consist of the binding of TonB to an
intrinsically unstable form of the barrel, which stabilizes this
form, allowing the passage of the nutrient, and a subsequent
release of the TonB-receptor interaction is needed. We do not
know which of these steps would require energy, and it might
conceivably be the dissociation of TonB. Although this is ulti-
mately a mechanical act, more sophisticated possibilities exist
for a polypeptide machine than simple rigid movement. The
barrel domain would then return to its ground state, ready to
accept the next ligand molecule. An “energized conformation”
of the TonB C-terminal domain would not be required in our
model. We consider the possibility (see below) that this tran-
sient binding of TonB to the receptor barrel involves a rotary
motion in the cytoplasmic membrane.
Cross-linking studies have indicated that the region around
residue 160 of TonB is crucial for the interaction with the TonB
box (27, 29, 54). In our model, this region is not visible because
of its very high flexibility (see the description of the B-factors in
“Results”). However, it is very likely that other regions of TonB
are involved in the contact with the receptor, and it is clear that
there must be an interaction with the barrel. Based on NMR
studies, it has also been proposed that the C-terminal portion of
the proline-rich segment (Lys-Pro repeats) (amino acids 91–
102) of TonB is involved in a specific interaction with FhuA
(55), but the binding constant is very weak, and this region has
been deleted, with TonB still maintaining activity (56). We
postulate that the region around Asn-200 of TonB (N terminus
of the  helix) constitutes a binding cleft, which could accom-
modate an element of the receptor as the ligand, based on the
relatively high conformational lability of this segment (see
“Results”). Interestingly, the -helix-forming residues (Met-
201 through Arg-214) are conserved among several Gram-neg-
ative species (14). However, it is unlikely that the role assigned
to this otherwise correctly predicted amphipathic helix by
Larsen et al. (56), namely, binding to the outer membrane, is
correct, because the hydrophobic side of this helix faces the core
of the dimer and thus cannot participate in any other
interactions.
Once the substrate reaches the periplasmic side of the recep-
tor (e.g. FepA), it is taken up by the periplasmic-binding pro-
tein FepB. The subsequent steps of import are not well known.
Substrate-containing FepB might then bind to the ABC trans-
porter FepC2DG, resulting in transport across the inner mem-
brane, using energy derived from ATP hydrolysis (3). FhuA
uses an analogous system with FhuD as a periplasmic-binding
protein and FhuBC anchored in the inner membrane (57, 58).
In the present work, we provide the first evidence that the
C-terminal domain of TonB forms a dimer. However, this
dimerization that involves almost half of the surface of this
protein domain does not correlate with the recent model, show-
ing a homotrimeric ExbBExbD complex interacting with a
FIG. 4. Hypothetical models of the interaction of dimeric TonB
with (a) a single complex of trimeric ExbBExbD or (b) two
complexes of ExbBExbD. For details, see text.
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TonB monomer, which in turn contacts the OM receptor (21).
Furthermore, the antiparallel orientation of each monomer as
well as the cylindrical shape do not correspond to any topolog-
ical representation of TonB described so far in the literature.
Recently, a soluble form of TonB was expressed, which lacks
the N-terminal anchor helix but contains the full proline-rich
region (59). The authors interpreted equilibrium sedimentation
and gel filtration data as indicating mostly monomers, even
though the measured molecular weight was somewhat higher
than expected.
The tightly intertwined dimeric structure of TonB seen in the
crystal now leads to two possible, albeit speculative models
(Fig. 4). In one case (Fig. 4a), both TonB proteins interact with
the same ExbBExbD complex. It is attractive to hypothesize
that the proton gradient might cause a torsional motion, as is
found in several molecular machines such as the flagellum or
ATP synthases, because of some homology in ExbB to MotA
and a similar topology of ExbD to MotB. Two proline-rich
regions would provide a stiffer structure than only one, which
could thus directly transduce this force to the TonB C-terminal
domain and mediate its transient interaction with the receptor
barrel and/or the cork domain. Alternatively (Fig. 4b), each
TonB monomer might be linked to a different ExbBExbD com-
plex, yet a torsion of both might still be mechanically trans-
duced to the outer membrane. Postle and co-workers (56) also
deleted most of the proline-rich region, yet TonB was still
functional. Nevertheless, a torsional mechanism could still be
operational in these short-necked constructs. In our model,
TonB only needs to bind, and dissociate again, but in a cyclic
manner—we cannot distinguish which is the energy-requiring
step. Undoubtedly, further work is necessary to test the valid-
ity of either model, and particularly the arrangement in the
inner membrane needs to be clarified.
One of the goals of this project was to determine if any
structural homology exists between the C-terminal domains of
TonB and TolA (36). A direct comparison of these domains
proves that their structure is completely different. Moreover, a
comparison of the structure of TonB with all known protein
folds (60) detected no structural relationship between the C-
terminal domain of TonB and any other structure represented
in the Protein Data Bank. This was true regardless of whether
a monomer or a dimer of TonB was utilized as a search model.
In this respect, the structure described here represents a to-
tally new fold that has never been observed so far.
In conclusion, the most surprising finding of our structure is
that the C-terminal domain of TonB forms a rigid and tightly
intertwined dimer. It is conceivable that this is essential for
transducing a mechanical force from the inner to the outer
membrane, and it would be much harder to imagine this to
occur with a monomeric molecule. Even though polyproline
stretches have extended conformations, they are still flexible
and are typical hinge regions, as exemplified in IgG molecules.
It would thus be difficult to visualize how mechanical energy
can be transduced with a flexible tether of a monomeric mole-
cule. Our dimeric structure provides now a framework for
further probing of the mechanism of the TonB-dependent
import.
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2.3 New results on TonB and the ExbB-ExbD pathway 
2.3.1 Discussion 
 The question of the oligomeric state of TonB in vivo and in vitro has been a subject 
of intense discussions since the publication of our dimeric structure. The scepticism 
displayed in the beginning by certain authors has been rapidly cleared up, and based on 
data reported by several groups it has become increasingly clear that the C-terminal domain 
(residues 155-239) forms a dimer in vitro, and that this is not due to a crystallization artifact. 
This is now widely accepted among researchers of the field, and we can reasonably say that 
our structure is correct and reflects the true in vitro state of TonB in solution. Molecular 
dynamics simulations have even been undertaken to confirm our finding (see 
http://indigo1.biop.ox.ac.uk/josed/thesis/chapter6.pdf, unpublished results). However, many 
authors found that our model did not fit with their data. As first pointed out by Letellier et al., 
a longer fragment (residues 33-239) clearly behaved as a monomer in sedimentation 
analyses (Moeck and Letellier, 2001). By analyzing TonB proteins of several lengths, 
Koedding et al. (2004) came to the same conclusion:  a short C-terminal fragment of TonB 
encompassing residues 164 to 239 (TonB-77) or 155 to 239 (TonB-86) formed homodimers 
in solution, whereas longer fragments (starting at residues 145, 135 or 125) remained 
monomeric (Koedding et al., 2004). Of all the fragments investigated by these authors, it 
was found that TonB-77 was not able to bind to FhuA in vivo, whereas all the others 
constructs did. They conclude that the dimeric structures of TonB-77 and TonB-86 are not 
the in vivo functional state, because the longer fragments were monomeric and inhibited 
TonB-dependent transport far more effectively. Sauter at al. (2003) came to the same 
conclusion: although TonB (164-239) formed a dimer in vivo when fused to ToxR (cholera 
toxin gene), they did not find any evidence of dimer formation with a fusion between a longer 
TonB (residue 33-239) and ToxR, thereby proposing that a region between residues 33 and 
164 prevents dimer formation (Sauter et al., 2003). But they further note that if the full TonB 
(1-239) is fused to ToxR, then the ability to form dimer is restored, thus showing the 
importance of the transmembrane region in dimer formation of full-length TonB. It appears 
then that TonB contains both N-proximal and C-proximal dimerization modules. From all the 
above mentioned studies, one might at first draw the conclusion that our TonB molecule is 
simply not functional. 
 But the reality is perhaps a bit more complex, especially when the interaction with 
the outer membrane receptor (e.g. FhuA) is considered (Figure 2-15). A proposed 
mechanism of FhuA-TonB interaction postulates that when the dimeric C-terminal TonB 
(residue 155-239) contacts FhuA, an “encounter complex” is formed with a certain affinity 
(∼840 nM), which is lowered to form a functional complex upon addition of the ligand 
(ferricrocin). However, in the case of the full periplasmic fragment (residue 32-239), the 
“encounter complex” might involve two TonB monomers bound to FhuA at both the N-
terminal and C-terminal domains of each TonB monomers, thus yielding a bound dimer of 
TonB. Upon addition of ferricrocin, the affinity of the N-terminal domain of TonB for FhuA 
increases; the affinity of the C-terminal domain decreases (Khursigara et al., 2004). Similar 
experiments were performed in Susan Buchanan’s group in order to co-crystallize TonB with 
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the purified outer membrane receptor FecA. A his-tagged FecA (plus or minus ferric citrate) 
was first incubated with “our” TonB, and the mixture was applied onto a Ni-NTA column, the 
idea being to capture TonB and bind the whole complex to the column via the FecA his-tag. 
However, a mixture of FecA and TonB was present in the flowthrough, and only 
uncomplexed FecA bound to the column. Similarly, it was not clear whether the co-crystals 
may contain TonB. The same set of experiments has been repeated with Cir (colicin I 
receptor), again without success (Susan Buchanan, personal communications). All these 
considerations let us to suppose that “our” TonB does not interact with either transporter 
strongly enough to isolate a complex, which led some authors to suggest that as a result of 
crystallization in the absence of the amino-terminus, our structure might represent an 
intermediate unenergized form of TonB (Ghosh and Postle, 2004). In agreement with this 
suggestion, other authors (Sean Peacock et al., 2005) have solved by NMR the structure of 
a longer TonB fragment (residue 103-239) and found it to be monomeric, including several 
structural aspects that are different from the previously published crystal structures. They 
postulate that both the monomer and dimer forms of TonB may contribute to the energy 
transduction process across the periplasm. 
 
Figure 2-15. Proposed mechanism of FhuA-TonB interactions. In panel A, H6.’TonB (CT) is the 
hexahistidine-tagged C-terminal TonB, residues 155-239. Panel B involves a hexa-histidine-tagged 
full length TonB consisting of residues 32-239. The oval shapes represent the C-terminal domain for 
both H6.’TonB (CT) and H6.’TonB, whereas the rectangular shape represents the N-terminal domain 
found in H6.’TonB only. Differences in shading represent the modulations in affinity caused by the 
natural ligand (ferricrocin). Dark gray shading indicates a stronger affinity than light gray. Picture 
taken from Khursigara et al. (2004).   
 Our understanding of the processes governing transduction of the proton motive 
force (pmf) energy from the inner to the outer membrane still remains far from complete. 
Two models have emerged in the last few years, and they are discussed in greater details in 
THE STRUCTURAL BASIS OF PHAGE DISPLAY   69
 
  
in a recent microreview (Postle and Kadner, 2003). The propeller model (Figure 4, our 
publication) states that TonB remains permanently associated with the inner membrane, 
undergoing a rotary motion of the carboxy-terminal propeller, that is initiated at the inner 
membrane by ExbB, ExbD and the pmf. In the shuttle model, uncharged TonB in complex at 
the inner membrane with ExbB/D is converted to charged TonB by the passage of a proton 
through the ExbB/D complex. Charged TonB shuttles to the outer membrane where it docks 
with the outer membrane receptor complexed with its ligand. After C-terminal contact with 
the outer membrane, the TonB N-terminus is released from the ExbB/D complex and would 
associate with the outer membrane transporter. Ligand binding results in a conformational 
change in the transporter, which induces a productive interaction with charged TonB and 
release of conformationally stored potential energy from TonB. Available data suggest that, 
although the inner membrane pmf is required to energize TonB, it does not energize the 
shuttling between membranes. A possible energy source for this “back-and-forth” movement 
between membranes could be ATP hydrolysis. The shuttle model has been tested in vivo 
(Larsen et al., 2003) and the data support the interpretation that, at some point during the 
transduction cycle, TonB is wholly associated with the outer membrane, having relinquished 
its inner membrane anchor. The single objection these authors formulate to their model is 
that the requirement for the hydrophobic transmembrane domain of TonB to leave and 
reinsert into the inner lipid bilayer is a thermodynamically unfavourable process. 
 Since the publication of our paper, the ferric dicitrate transporter FecA (Ferguson et 
al., 2002) and the cobalamin transporter BtuB (Chimento et al., 2003) have been 
crystallized, allowing a broader description of the structural features that are common or 
specific to each transporter. The basic modular architecture of the cobalamin transporter 
BtuB is similar to that of the iron siderophore transporters FepA, FhuA and FecA; 
specifically, an N-terminal hatch domain is embedded within the lumen of a 22-stranded β-
barrel. The strands are tilted by around 45° relative to the membrane bilayer. The barrels are 
generally elliptical in cross-section, but are not superimposable. The FecA structure reveals 
that the ligand, in this case ferric citrate, binds to transporter and closes the central channel 
behind it, preventing access to the external milieu. This finding generated the air-lock model, 
suggesting that the loops occlude the channel to prevent passage of external material that 
might come across the outer membrane into the periplasm along with the transported 
substrate. Comparison of the structures of the three loaded transporters (FhuA, FecA and 
BtuB) shows that the relative locations of the binding sites for three very dissimilar 
substrates are nonetheless very similar in their location. BtuB is between 60-100 residues 
shorter than the iron siderophore transporters solved so far. BtuB has a more squat 
structure, possessing shorter extracellular loops and containing a smaller hatch domain than 
these other transporters. From the structure, it is clear that the loops in BtuB are unable to 
intertwine and block the channel from the outside, as seen for FecA. The structures of the 
hatches are highly conserved among all transporters, and the interface between hatch and 
barrel is mainly through polar interactions, with no large hydrophobic patches. Investigations 
of the physical properties of the hatch domain alone, as it may exist if it is removed from the 
FepA barrel, established that it behaves in vitro as a predominantly unfolded yet soluble 
protein (Usher et al., 2001). The finding that the hatch domain alone retained some 
specificity for FepA ligand (ferric enterobactin), though 100-fold lower than for the wild-type 
FepA receptor (5 µM against 50 nM for intact FepA), is consistent with its retaining biological 
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function outside of the barrel. However, the authors conclude that it remains entirely possible 
that the hatch domain does not come out of the barrel at all, but instead undergoes a major 
conformational rearrangement within the barrel to form a channel large enough to allow the 
ligand to pass by. They further propose that larger objects such as colicins cross the 
membrane by some other mechanism.   
 The crystal structures for FhuA (Ferguson et al., 1998; Locher et al., 1998), FecA 
(Ferguson et al., 2002) and BtuB (Chimento et al., 2003) bound and unbound to their 
cognate ligand have been solved. In all three cases, binding of ligand to the external face of 
the transporter causes a large conformational shift in the region of the protein at the 
periplasmic face. Intriguingly, this conformational change does not alter the location of the 
globular hatch domain or create a passageway through which ligand can exit. It has long 
remained a challenging question whether transport involves the complete or partial 
dissociation of the hatch domain from the barrel. Two models have been proposed (Figure 
2-16), each having its major drawback (Usher et al., 2001).  
 
 
Figure 2-16. Schematic diagram illustrating critical steps in the transport cycle of siderophores by 
FepA (or other TonB-dependent receptors). The FepA transporter resides in the outer membrane of 
E. coli; the plug domain folds up inside the barrel and completely occludes the barrel’s interior (upper 
cartoon). Upon ligand binding (e.g. siderophore), a signal is transmitted to TonB. This model proposes 
that TonB pulls the unfolded plug domain out of the barrel entirely or that TonB causes a major 
conformational rearrangement of the plug domain within the barrel, thereby forming a channel large 
enough to allow the passage of the ligand. Picture taken from Usher et al. (2001).   
THE STRUCTURAL BASIS OF PHAGE DISPLAY   71
 
  
The model presented in Figure 2-16 is consistent for small molecules such as enterobactin 
or siderophores. However, it does not explain how larger objects such as colicins can cross 
the outer membrane. An attractive idea was recently presented in the view of the crystal 
structure of colicin E3 R-domain bound to BtuB. The authors provide evidence that we might 
have been entirely confused; these outer membrane transporters, according to their views, 
do not form pores and are not gated open by their ligands, which suggests that they should 
be called TonB-gated transporters to reflect the way they work. This statement was used to 
propose a new transport mechanism, implying the OmpF porin as a translocator (Figure 2-
17).            
 
Figure 2-17. Model for an interaction between BtuB and OmpF that would be mediated by the colicin 
E3 bound to BtuB. The different colors in the colicin E3 symbolize the translocation (blue), catalytic 
(magenta) and immunity (yellow) domains. OmpF is a trimer in the outer membrane. Picture taken 
from Kurisu et al. (2003). 
 The Ton box is a short, moderately conserved stretch of residues near the amino-
terminus of most TonB-dependant transporters. It is a key factor in signaling and transport, 
and is so far the only site of mutations that confer a TonB-uncoupled phenotype. Several 
lines of evidence point to interaction of the Ton box with TonB, which does not exclude that 
other sites in TonB or in the transporter may be in contact. This region is the site of 
mutations, such as the substitution of Pro for Leu-8 or Val-10 in BtuB, which result in loss of 
cobalamin transport but do not affect cobalamin binding or entry of the TonB-independent 
phage BF23 or E colicins. The Ton box could be modeled in the recent crystal structure of 
BtuB, but only minor changes were observed after cobalamin binding (Chimento et al., 
2003). Using site-directed spin labeling of the N-terminal region of BtuB, the Kadner lab 
presented some direct evidence for the substrate-induced structural transition of the Ton box 
(Cadieux et al., 2003; Fanucci et al., 2003a). Their data support a consistent scenario in 
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which the Ton box conformation exists in equilibrium between a docked and undocked state, 
and that the binding of the translocation domain of colicin E3 shifts this equilibrium toward 
the docked state. In this conformation, the Ton box exhibits low backbone mobility and low 
accessibility to labeling agents. This stabilization ensures that there is no interaction 
between BtuB and TonB, and that there is no opening of the transport pore. This finding 
suggests that the colicin probably does not cross the outer membrane through the BtuB 
barrel, consistent with the model depicted in Figure 2-17. Another BtuB substrate, cyano-
cobalamin, had the opposite effect on accessibility of the Ton box; its binding results in 
undocking, which is characterized by high residue mobility and high labeling. The increasing 
disorder of positions 6 to 8 of the Ton box upon cyano-cobalamin binding has also been 
observed in the crystal structure (relatively high B-factors of the Cα in the structure solved 
with the ligand). It is somewhat striking that both these substrates have opposite effects on 
the energetics of the Ton box segment of BtuB. An interesting structural challenge will be to 
determine how two opposite conformations of the Ton box are propagated through the BtuB 
barrel to the periplasm. Additional data about the structure and mobility of the Ton box were 
reported, indicating that, in its docked state, the Ton box is predominantly in a β–strand or 
extended conformation. Loss on conformational constraint upon cyano-cobalamin binding 
affects residues 1 to 15 of the BtuB core, and residues 16 and 17 appear to be near a hinge 
responsible for opening the Ton box (Fanucci et al., 2003b). 
 In recent years, important advances have furthered our understanding of the 
sophisticated and highly efficient process of siderophore uptake in gram-negative bacteria. 
Among these, it is worth noting the use of spectroscopic techniques (e.g. EPR, SDSL) to 
monitor the uptake process in vivo, the progression in the characterization of the Ton 
complex and, most notably, the determination of the atomic structure of several outer-
membrane receptors. However, it seems that fundamental questions concerning many 
aspects of the transport process remain to be resolved. It is still not clear, what parts of 
TonB are involved in interaction with the transporters: the extreme C-terminus is important 
for function, but the sequences show low homology. The conformational changes that the 
outer-membrane receptors must undergo to allow permeation are also unknown, and how 
the hatch domain reorients to allow passage of substrate is still a matter of controversy. 
Similarly, the mechanism by which these changes are energetically activated from the inner 
membrane is poorly understood, as is the dependance of the Ton complex on the inner-
membrane proton gradient. 
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SECTION 3  
Application of phage display 
Introduction 
 The aim of this third section is to illustrate by a concrete example the usefulness of 
the current knowledge in filamentous phage biology. The growing amount of knowledge 
collected over the last decade has led some researchers to take profit of this wealth of data 
to design a new technology which has become an indispensable tool for protein 
engineering. Fifteen years have elapsed since the first demonstration that antibodies could 
be displayed on the surface of phage (McCafferty et al., 1990). During these years, the 
power of combining the technologies of phage display and protein chemistry has become 
increasingly apparent. In phage display, large combinatorial libraries of encoded proteins (in 
our case, recombinant antibodies) are displayed as fusions to the minor coat protein of the 
phage capsid. Phage displaying a protein with a desired property can be retrieved from the 
library and decoded by sequencing the encapsulated phage DNA. By this way, phenotype 
(the displayed protein) and genotype (DNA) are physically linked. 
 Nearly all of the work on protein engineering using phage display has been done 
using the filamentous phage M13 or the closely related phage fd. This is in part due to the 
ease with which this phage can be manipulated and also to our detailed understanding of 
the viral life cycle and phage structure (see section 1). In our set-up, the display of proteins 
on the phage surface is accomplished by inserting the DNA encoding the displayed protein 
(i.e. the genotype) between the signal sequence of the coat protein and the amino terminus 
of the C-terminal part of gene 3 protein. The signal sequence is proteolytically removed 
upon secretion into the periplasm of E. coli where phage assembly occurs.  
 The principle of selection we have applied is based on searching the antibody 
library for those members with the highest affinity for a particular target. To achieve this 
affinity maturation process, an off-rate selection has been applied. Phage displaying 
antibodies are allowed to bind biotinylated antigen in solution. By setting the concentration 
of the biotinylated antigen lower than the equilibrium dissociation constant (Hawkins et al., 
1992), phage could be selected based on their relative binding strength. This method can be 
adapted to select for prolonged off-rate (koff). After this initial binding event, a large excess of 
free unlabelled antigen is added resulting in dissociation of the phage from the biotinylated 
antigen (Jermutus et al., 2001; Zahnd et al., 2004). The rate of this reaction is proportional 
to koff and the exposed antibody heads are captured by unlabelled antigen. The longer this 
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off-reaction is allowed to proceed before capture, the greater the selection for prolonged off-
rate. The complexes of phage still bound to the biotinylated antigen are then captured on 
streptavidin-coated paramagnetic beads. After washing the beads, the phage are eluted and 
can be used for a next selection round. 
 Off-rate selection has been applied to a recombinant antibody directed against the 
murine MHC-gp33 peptide complex, in order to improve its moderate affinity constant (low 
micromolar range). The contrasting results of this study are presented and discussed in the 
following pages. 
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Biochemical characterization of a single-domain antibody 
selected against a murine MHC-peptide complex 
3.1 Introduction 
 The immune system is a remarkably adaptive defense system that has evolved in 
vertebrates to protect them from invading pathogenic microorganisms. It is able to generate 
an enormous variety of cells and molecules capable of specifically recognizing and 
eliminating an apparently limitless variety of foreign invaders. The immune system is able to 
recognize subtle chemical differences that distinguish one foreign pathogen from another. 
Once a foreign organism is recognized, the immune system enlists the participation of a 
variety of cells and molecules to mount an appropriate response, known as an effector 
function, to eliminate or neutralize the organism. Viruses are such foreign invaders, able to 
divert the host’s cellular machinery to translate their own proteins and replicate the viral 
genome. The strategy for recognition of these intracellular parasites by the cellular immune 
system involves the cell surface presentation of short segments of intracellularly processed 
proteins of the invading organism by major histocompatibility complex (MHC) class I 
molecules on the surface of the infected cell; this conversion of foreign proteins into MHC-
associated peptide fragments is called antigen processing, and the composition of the pool 
on the surface of the infected cell mirrors its intracellular protein content (Yewdell, 2001; 
Yewdell and Bennink, 2001). These peptides usually derive from defective ribosomal 
translation products (Princiotta et al., 2003), but in a virally infected cell, MHC-presented 
peptides derive from viral proteins. More than 10’000 different peptides, of about 8 or 9 
amino acids in length, are displayed on each cell. Infections by pathogens result in the 
appearance of foreign or “abnormal” peptides, which mark the cell for destruction by 
cytotoxic T lymphocytes (CTL). It has been known for some time that most of MHC class I-
presented peptides are generated by proteolytic degradation of endogenous proteins. The 
proteasome, a cytoplasmic multi-unit structure has been identified as a key element in the 
processing pathway, responsible for the generation of the COOH terminus of the peptide 
(Niedermann, 2002). The protease trimming the NH2 terminus of the peptide remained 
largely elusive, until its recent identification (Saric et al., 2002; York et al., 2002). 
 The MHC class I molecule consists of three distinct regions: cytoplasmic, 
transmembrane and extracellular. The latter is a heterodimer of a heavy chain, a 45’000 MW 
type I integral membrane glycoprotein, and β2-microglobulin (β2m), a 12’000 MW soluble 
protein. The extracellular region of the heavy chain folds into three domains (α1,α2, α3) with 
a noncovalently associated molecule of β2-microglobulin (Figure 3-10). X-ray 
crystallographic studies have revealed that the peptide-binding site on the MHC consists of 
a flat undulating groove, located on the upper surface of the molecule, between the two 
antiparallel α helices of the α1/α2 domain (Young et al., 1994). 
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 T-cell receptors (TCRs) are heterodimers, composed of two protein chains (αβ) 
linked by disulfide bridges. Each chain consists of an N-terminal variable (V) region and a C-
terminal constant (C) region. The Vα and Vβ regions are structurally related to the V 
domains of the heavy (H) and light (L) chains of immunoglobulins (Igs) and their mode of 
interaction is identical to that found in antibody VL-VH dimers. T-cell receptors scan the 
composite surfaces produced by the MHC molecules and “sense” the presence of peptides 
residing in their groove; this information is then relayed to the interior of T-cells triggering 
their proliferation (Valitutti et al., 1995). All TCRs analyzed to date bind to the peptide-MHC 
complex (pMHC) with roughly similar diagonal geometry (Hennecke and Wiley, 2001; 
Housset and Malissen, 2003). A major difference in antigen recognition by antibody as 
compared with TCR is that the former commonly functions through high-affinity interactions, 
whereas the strength of the TCR interaction with pMHC is weaker (Willcox et al., 1999). 
  Detailed knowledge of the formation of the pMHC complex and the nature of its 
binding to the TCR are prerequisites for a complete understanding of the cellular and 
molecular processes governing antigen processing and presentation on the surface of the 
infected cell. However, to date very few tools have been developed to directly detect, 
visualize, count and study peptidic antigen present on an infected cell. To fulfill this role, 
there have been attempts to use soluble and specific TCRs engineered from cloned T cells 
of known pMHC specificity (Holler et al., 2003; Plaksin et al., 1997). Although engineered 
TCRs seem to be ideal for this purpose, it has been proven practically difficult to engineer 
these molecules because their inherent low affinity for their target ligands and their instability 
as recombinant-engineered molecules may limit their use as detection reagents (Wülfing 
and Plückthun, 1994). Clearly, there is a growing need for engineering new targeting 
molecules, able to recognize with high affinity and specificity pMHC complexes. Antibodies 
represent the most suitable strategy for such an approach, and they have already been 
used to study antigen presentation (Day et al., 1997; Porgador et al., 1997; Zhong et al., 
1997), to localize and quantify antigen-presenting cell displaying a T cell epitope (Inaba et 
al., 1997), specifically mask an autoimmune T cell epitope (Aharoni et al., 1991; Puri et al., 
1997) or as a targeting tool in a mouse model (Reiter et al., 1997). Such unique antibodies 
with T-cell receptor-like specificity may prove to be a valuable tool not only for obtaining 
precise information about the presence, expression pattern and distribution of the pMHC 
complex, but they may also serve as good candidates for targeting reagents in constructing 
recombinant immunotoxins or for antibody-based therapeutic approaches. Using very large 
nonimmune phage antibody libraries, the direct selection of such antibodies with exquisite 
specificity was only recently demonstrated (Chames et al., 2000; Denkberg et al., 2002). 
Detailed in Figure 3-10, the crystal structure of an affinity-matured Fab bound to an HLA-
A1:MAGE-A1 complex supports the evidence that antibodies and TCR share a 
characteristic diagonal docking mode for most peptide-MHC interactions (Hülsmeyer et al., 
2005). Another group has taken advantage of this technique to select high affinity human 
Fab antibodies against a tumor-associated antigen (Lev et al., 2002). 
 The scFv_A8 was originally isolated from HuCAL, a fully synthetic antibody library 
displayed on filamentous phage (Knappik et al., 2000). It was selected against the 
extracellular part of a murine MHC-gp33 peptide complex. Four panning rounds of phage 
display against the MHC-gp33 complex permitted the rapid identification of a few candidate  
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clones. One of them (scFv_A8) showed promising results with regard to its specificity and 
expression behaviour (Frédéric Pécorari, unpublished results), and was converted to 
another antibody format (Fab fragment, see example structure in Figure 3-10), thus resulting 
in Fab_A8. As shown by surface plasmon resonance studies (BIACORE), Fab_A8 has an 
affinity of 1 µM for the MHC-gp33 complex (Maurice Brozzo, diploma thesis, Zürich 2000). 
Based on previous observations (Ewert et al., 2003a), six amino acid mutations were 
introduced into the variable domain of the heavy chain (VH6 framework), thus markedly 
improving the thermodynamical properties and the expression behaviour of this domain. 
VH6 domains (as well as VH2 and VH4) exhibited low cooperativity during denaturant-
induced unfolding, lower expression yields, and higher tendency to aggregate (Ewert et al., 
2003a). In all subsequent chapters, I will refer to this particular clone Fab_A8 as the 
ConFab, meaning the non-improved Fab fragment containing the wild-type amino acid 
sequence.  
 In the present work, we describe the in vitro affinity maturation of the ConFab, 
conducted using phage display methods. Genetic diversity is introduced into the gene 
encoding ConFab by error-prone PCR; variants showing apparently improved affinity for the 
MHC-gp33 complex were isolated, and we provide evidences that, using a particular 
antibody format, the main features of the ConFab could be maintained. The isolation of a 
single-domain antibody is detailed and its slightly improved binding properties are illustrated 
in comparison with the parental ConFab. 
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3.2 Materials & Methods     
Construction of phage libraries and mutagenesis 
 We made use of the plasmid pMorph18 (Morphosys, Martinsried, Germany), a 
phagemid construct with chloramphenicol resistance containing the gene encoding the 
ConFab, as the parental (“wild-type”) construct for libraries described here. In subsequent 
chapters, we will refer to this clone as the “control Fab” (or ConFab). The libraries are fused 
as an N-terminal fusion to the C-terminus of gene 3 protein (pIII) from bacteriophage M13 
(Figure 3-1a). Randomized libraries were generated by error-prone PCR (epPCR) 
amplification of the ConFab template, allowing control over the number of mutations per 
gene (Zaccolo et al., 1996). The whole variable domain of the light chain (Vκ2 subtype) was 
amplified with the primers Vκ2_for (5’-TGCACTGCAGAAGCAGCCAAA-3’) and Vκ2_rev (5’-
AAGGCCTTCGTACGTTTAATTTCAACTT-3’). The whole variable domain of the heavy 
chain (VH6 subtype) was amplified with the following primers:  
 
5’-TAACGCTACAATTGGTACAGTCTGGT-3’   (VH6_for) 
 
5’-TAATGGCCTTGGCCCCAATAATC-3’          (VH6_rev) 
 
Standard PCR conditions were used for the amplification, except that 6-(2-deoxy-β-D-
ribofuranosyl)-3,4-dihydro-8H-pyrimidino-[4,5-c][1,2]oxazin-7-on-triphosphate (dPTP) and 8-
oxo-2’-deoxyguanosine (8-oxo-dGTP) were added (Jena Biosciences, cat.# NU-1119S and 
NU-1117S, respectively). Two libraries were designed, containing 5 (low error) and 15 (high 
error) mutations per clone on average. Based on 20 PCR cycles the nucleotide analogues 
dPTP and 8-oxo-dGTP were added at 1/10 (40 µM total) and 3/10 (120 µM total) of the total 
concentration of dNTPs (400 µM) for the low and high error library, respectively. The PCR 
products were purified by gel extraction, digested using restriction enzymes PstI/Bsi WI (for 
Vκ2 library) and MfeI/StyI (for VH6 library). The restricted and purified PCR products were 
ligated into the pMorph18 phagemid, digested with the corresponding restriction enzymes, 
electroporated into competent XL1-Blue F+ E. coli cells and amplified by growing 15-16 
hours at 30°C. The library was rescued by overnight growth at 37°C, using the VCSM13 
helper phage (Stratagene, Cat.# 200251) with a titer of 1010. Phage particles were purified 
and concentrated by two PEG/NaCl precipitations (20% polyethyleneglycol 6000, 2.5M 
NaCl, sterile filtered), resuspended in 1ml PBS buffer (50 mM potassium phosphate, 150 
mM NaCl, pH 7.5), and filtered through a 0.45µm sterile filter. The complexity of the libraries 
were estimated based on plating of the initial electroporation onto 2 x TY plates containing 
chloramphenicol (34 µg/ml)+1% glucose, and reached the following values: 105 (Vκ2), 106 
(VH6 “low error”), 3x106 (VH6 “high error”). The efficiency of error-prone PCR mutagenesis 
was checked by sequencing using the following primers (Figure 3-1): “M13 rev” for Vκ2 (5’-
CAGGAAACAGCTATGAC-3’) and “HuCAL for” for  VH6 (5’-TACCGTTGCTCTTCACCCC-
3’). Sequencing results are presented in Figure 3-2. 
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Off-rate selection 
 Each of the three libraries (Vκ2 “low error”, VH6 “low error” and “high error”) was 
treated separately for 2 rounds of phage display selections. All selections and washing steps 
were done at room temperature. Antigen solutions and magnetic beads are equilibrated in 
PBS buffer pH 7.4 before use. For each round, approximately 1011 phages (≈1 nM) 
displaying the library were screened for binding to biotinylated MHC-gp33, whose 
concentration was 100 nM and 50 nM for selection rounds 1 and 2 respectively. The mixture 
of phage and antigen, containing a 100x excess of β2-microglobulin was gently rotated for 
one hour. A large molar excess of non-biotinylated over biotinylated MHC-gp33 (50 times in 
round 1, 100 times in round 2) was then added in order to select for Fab fragments with the 
lowest dissociation constant (koff). Competition was allowed to occur for 1 and 10 minutes (in 
round 1), 10 and 100 minutes (in round 2), before capturing the bound complexes with 200 
µl of milk-blocked streptavidin magnetic beads (Roche, cat.# 1’641’778) in round 1, and 100 
µl of milk-blocked avidin agarose beads (Sigma, cat.# A9207) in round 2. Capture with 
beads was done for 30 minutes, before washing them 9 times for 2 minutes: three times in 
PBS/2% milk, three times in PBS/0.1% Tween-20, three times in PBS. For elution, the 
beads were supplemented with 200 µl of 100 mM triethylamine and agitated for 8 minutes. 
After removal of the beads, the supernatant was neutralized with 200 µl of 1M  Tris, pH7.4, 
and used to infect 10 ml log phage E. coli XLI Blue F+ cells (OD600 = 0.5). Subcloning of 
DNA from the final selection rounds into the plasmid pMorphx9_FH (from Morphosys, see 
Figure 3-1b) allowed soluble periplasmic expression under the control of the lac promoter in 
E. coli strain SB536.  
ELISA with peptide-MHC complex 
 All antigens were coated directly onto Maxisorp plates (NUNC, cat.# 442404) in 
TBS150 (20 mM Tris, 150 mM NaCl, pH 8.0), overnight at 4°C at a concentration of 120 nM. 
Plates were washed three times with TBST150 (TBS150 containing 0.05% Tween-20) and 
blocked with 5% milk-TBST150 for 2 hours at room temperature. After 3 times washing, 
antibodies (as crude extract or purified protein) were added and incubated for 90 minutes at 
room temperature. Following 3 washes, detection was done either with mouse anti-Flag M2 
(Sigma, cat.# F3165, 1:1’000 dilution) or mouse anti Tetra-His (Qiagen, cat.# 34670, at 
1:1’000) in 2% milk-TBST150. As a secondary antibody, a goat anti-mouse IgG conjugated to 
alkaline phosphatase was used (Sigma, cat.# A3562, at 1:5’000 in 2% milk-TBST150). Color 
development was done with 4-NPP (3 mM 4-NPP, 50 mM NaHCO3, 50 mM MgCl2), and 
absorbance was measured at 405 nm with an HTS 7000 PLUS plate reader  (Perkin Elmer). 
Crude extracts of Fab were prepared as follows: His- and Flag-tagged Fab antibody 
fragments inserted into plasmid pMorphx7_FH were expressed overnight in SB536 strain of 
E. coli at 30°C under constant agitation, in a sterile Maxisorp plate (Nunc, cat.# 163320). 
Lysis was done by adding into each well 40 µl of BEL buffer (400 mM boric acid, 320 mM 
NaCl, 4 mM EDTA, pH8.0) containing 2.5 mg/ml lysozyme, and shaking for 1 hour at room 
temperature. Twenty microliters of this crude extract preparation were pipetted into coated 
wells of an ELISA plate. 
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For the phage ELISA, an anti-M13 antibody coupled to horseradish peroxidase was used 
(Amersham Pharmacia Biotech, cat.# 27-9421-01) and detection was done with soluble BM 
blue POD substrate (Roche Diagnostics, cat.# 1484281). Absorbance was measured at 405 
nm with an HTS 7000 PLUS plate reader  (Perkin Elmer). Phage particles were precipitated 
once with an ice cold  PEG/NaCl solution (20% polyethyleneglycol 6000, 2.5 M NaCl, sterile 
filtered), redissolved in 1 ml PBS buffer and titrated before adding them into the ELISA 
wells. 
Western blot of Fab fragments 
 15% SDS-PAGE gels were blotted onto ProtranTM nitrocellulose membranes 
(Schleicher&Schuell, cat.# 10401196) for 1 hour under constant voltage (1 Volt/cm2 
membrane). All the following incubations were done in 5% MTBST150 for 1 hour at room 
temperature: after blocking, the membrane was incubated with either an anti-human kappa 
light chain coupled to alkaline phosphatase (Southern Biotech, cat.# 2060-04, dilution 
1:3’000) or an anti-TetraHis (1:1’000) antibody. A goat anti-mouse IgG coupled to alkaline 
phosphatase (1:5’000) was used as secondary antibody with anti-Tetra His. Detection was 
performed with 100 µl NBT (30 mg/ml in 70% DMF) and 100 µl BCIP (15mg/ml in 100% 
DMF) dissolved in 10 ml AP buffer (100 mM Tris pH 9.5, 0.5 mM MgCl2). Color development 
takes 10 minutes. 
Expression and purification of peptide-MHC complexes 
 Plasmids encoding H-2Db or β2-microglobulin were transformed into E. coli strain  
BL21-CodonPlus-(DE3)-RIL and expression was carried out for 5 hours at 37°C. One liter of 
2xTY medium (containing 100 µg/ml Ampicillin, 30 µg/ml Chloramphenicol, 0.1% glucose) 
was inoculated with 25 ml (for H-2Db) or 12 ml (for β2-m) of a saturated overnight culture. At 
on OD600 of 0.7-0.8, expression was induced by addition of a 1 mM IPTG solution (final 
concentration) and the cultures were incubated for 4 hours at 37°C, whereby they reached a 
typical OD600 of 4.5. The bacteria were pelleted (30 min, 20’000g, 4°C), resuspended in lysis 
buffer (50 mM Tris pH 8.0, 1 mM EDTA, 500 mM NaCl, 10 µg/ml DNAse I) and disrupted by 
French Press (Emulsiflex, Avestin) lysis. Inclusion bodies were pelleted by centrifugation (20  
min, 39’000g, 4°C). The supernatant was discarded, the inclusion bodies were carefully 
resuspended by sonication (3 x 2 minutes) in 15 ml TE buffer (50 mM Tris, 1 mM EDTA, pH 
8.0) containing 1% Triton X-100, and then centrifuged for 20 minutes (39’000g, 4°C). The  
supernatant was discarded and this washing procedure was repeated two times more until 
the supernatant was not yellow anymore. The washing was repeated one time with TE 
buffer alone, and two times with TE buffer containing 1 M guanidinium-HCl. The pellet of 
inclusion bodies was homogenously beige after this extensive washing procedure and 
solubilization could be started by adding the 10 ml solubilization buffer (50 mM Tris pH 8.0, 
6 M guanidinium-HCl, 2 mM DTT (usually 10 ml is enough for a pellet resulting from 1 L 
culture). The inclusion bodies were resuspended by sonication (2 x 3 minutes) and placed at 
room temperature with stirring overnight to complete solubilization. Remaining insoluble 
particles were pelleted by centrifugation (20 minutes, 39’000g). The denatured and reduced 
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H-2Db subunit (≈32 mg) and β2-m subunit (≈ 12mg) were refolded by rapid dilution in 1 liter  
of refolding buffer consisting of 100 mM Tris, 1 M L-arginine, 2 mM EDTA, 1 mM oxidized 
glutathione, 0.2 mM reduced glutathione containing 10 mg of gp33 or ASIA peptide (see 
sequences below). The refolding buffer was cooled at 4°C and the pH adjusted to 8.0. 
Refolding was performed at 4°C for 24 hours under stirring. The protein solution was 
concentrated to 50 ml with an Amicon 8400 concentrator and then dialyzed once against 30 
mM MHA buffer pH 8.0 (10 mM MES, 10 mM HEPES, 10 mM sodium acetate). After 
elimination of insoluble material by centrifugation (20 minutes, 5’000g) and filtration (0.22 
µm pore size), the peptide-MHC complex was purified over a strong anion exchange 
chromatography column (equilibrated with MHA buffer, pH 8.0) on a BioCAD perfusion 
chromatography workstation (Applied Biosystems). The bound protein was eluted using an 
NaCl gradient ranging from 150 mM to 2.4 M NaCl. Purity was checked on a 15% SDS-
PAGE; the protein solution was dialyzed twice against TBS150 (20 mM Tris, 150 mM NaCl, 
pH 8.0), aliquoted and stored at -80°C for further use. 
Peptides 
 Peptides were synthesized by Jerini (Jerini AG, Berlin, Germany) to 95% purity and 
checked for molecular mass by mass spectrometry analysis. The synthetic peptides had the 
following sequences: SALQNAASIA (ASIA peptide) and KAVYNFATC (gp33 peptide). 
Biotinylation of  the MHC-gp33 complex 
 The MHC-gp33 complex in TBS150, pH 8.0 was mixed in a 2 ml volume with 5 mM 
ATP, 10 µM biotin, 2.5 µM BirA, 50 mM Tris pH 7.4, 5 mM MgCl2, and the reaction was 
allowed to proceed overnight at room temperature. End concentration of the MHC complex 
in the reaction was around 3 µM. The solution was then dialyzed twice against 1 L PBS, pH 
7.4, and purified through a monomeric avidin column (Pierce). Free biotin was removed by 
dialysis against PBS buffer. The yield of the reaction after purification was around 20%.   
Biotinylation of the antigen was checked on an immunoblot using an anti-streptavidin 
antibody coupled to alkaline phosphatase (Roche, cat.# 1089161). 
BirA was produced as a C-terminal fusion to protein D as follows: the gene coding for BirA 
was cloned between the restriction sites KpnI/HindIII of the vector pAT194, thus giving rise 
to the construct pAT212 (Forrer and Jaussi, 1998). After transformation into competent 
XLIBlue cells, the culture was grown at 37°C in LB medium (supplemented with 100 µg/ml 
ampicillin, 1% glucose) until an OD600 ≈ 1.0 was reached. Fifteen minutes before induction, 
50 µM D-biotin (Sigma) was added to the medium. Expression was then induced with 0.4 
mM IPTG during 4 hours, at 37°C (typical OD600 ≈ 3.0). Cells were harvested, resuspended 
in TBS500 (20 mM Tris pH 8.5, 500 mM NaCl, 50 µM D-biotin), disrupted by French Press 
and the soluble fraction loaded onto an IMAC column saturated with Ni2+-ions (immobilized 
metal ion affinity chromatography) on a BIOCAD perfusion chromatography workstation 
(Applied Biosystems). Protein could be eluted from the column with 300 mM imidazol (pH 
8.0), and the eluate was reloaded onto an anion exchange column. The flowthrough was 
collected and dialyzed against BirA buffer (50mM Tris pH7.5, 250mM KCl, 0.1 mM DTT), 
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supplemented with 5% glycerol after dialysis. The enzyme was stored at 4°C. The final yield 
was 10 mg per liter culture. 
Cloning and expression of the single-domain VH6 antibody 
 The variable domain of the heavy chain of the ConFab was PCR amplified using 
the following primers:  
5’-GGCCTTCCATGGGACAGGTGCAATTGGTACAGTC-3’ (named sdVH6_for)  
5’-CTATCAAGCTTATCAGTGATGGTGATGGTGATGAGATCCTGAGCTAACCGTCACCAGG-3’ 
(named sdVH6_rev), containing an His-tag (underlined). 
The conditions for the PCR reactions were as follows: 92°C (2 min); then 30 cycles at 92°C 
(30 sec.); 58°C (50 sec.); 72°C (40 sec.); and a final elongation step of 10 min at 72°C. 
Product size: 372 nucleotides.  
The PCR product was purified and digested overnight at 37°C using the restriction enzymes 
NcoI/HindIII. After purification, the restricted PCR product was inserted into the similarly 
restricted pTFT74 vector. The ligated product was transformed into chemically competent E. 
coli XLIBlue cells. The sequence was verified by nucleotide sequencing. 
Expression was done in 2xTY medium in BL21(DE3) cells as follows: from freshly 
transformed colonies on an agar plate, a single clone was picked and used to inoculate a 
culture containing 1% glucose and 100 µg/ml ampicillin. After overnight growth at 37°C, the  
culture was diluted 100x into fresh LB medium (supplemented with 100 µg/ml ampicillin, but 
without glucose) and allowed to grow until an OD600 of 0.8 was reached. Protein expression 
was induced with 1 mM IPTG, at 37°C. After 6h growth, cells usually reached an OD600 of 
4.8. Cells were then harvested, resuspended in TE buffer pH 8.0 (20 mM Tris, 1 mM EDTA) 
containing 10 µg/ml DNAse. Cell lysis was performed with a French Press (Emulsiflex, 
Avestin). After centrifugation (30 minutes at 20’000 rpm), the pellet was kept. The inclusion 
bodies were washed as described for the MHC (see above). Refolding was performed in the 
same way as done for the MHC, except that the refolding buffer contained a five times 
excess of reduced glutathione over oxidized glutathione (5 mM to 1 mM). After 
concentration, the refolding solution was dialyzed against 20 mM NaH2PO4 pH7.5, 500 mM 
NaCl, and purified using a Nickel-NTA affinity column (IMAC) on a BioCAD perfusion 
chromatography workstation (Applied Biosystems). The bound protein was eluted with 200 
mM imidazol (pH 8.0), and the buffer was changed to TBS150 (pH 7.5) for immediate use. 
Three milligrams pure refolded protein could be obtained from 1 L culture. Concentrations 
were measured by UV absorption using an extinction coefficient of 49’560 M-1 cm-1 
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 Three libraries were constructed; the variable domain of the light chain (Vκ2 subtype) 
has only been subjected to a mild randomization, thus yielding a “Vκ2 low error” library, 
whereas both a “VH6 high error” and a “VH6 low error” library of the variable domain of the 
heavy chain (VH6 subtype) were created. For each library, eight clones were randomly 
picked and sequenced. The average number of amino acid mutations per clone was 5 for 
the “Vκ2 low error” library, 7.5 for the “VH6 low error” library and 16 for the “VH6 high error” 
library. Mutations were equally spread between the CDR and framework regions, with the 
notable exception that the framework region before the CDR1 of the Vκ2 domain was left 
untouched by the randomization procedure (Figure 3-2).  
 In the absence of any information regarding the specific amino acids which  
interact between ConFab and the MHC-gp33 complex, we decided to randomize the whole 
variable domain of the light and the heavy chain of ConFab, using error-prone PCR (see 
Materials and Methods). In analogy to previous examples in the literature (Boder et al., 
2000; Zahnd et al., 2004), we reasoned that randomizing regions of an antibody outside its 
CDR loops might significantly increase the probability of finding a better binder. This was 
later exemplified by the three-dimensional crystal structure of the affinity-matured Fab 
“hyb3” directed against a human MHC variant: all of the 22 mutations in the light chain were 
located at the periphery of the variable domain, far from the binding interface (Hülsmeyer et 
al., 2005).     
Figure 3-1. The pMorph18 display vector (“phagemid”) is depicted on the left; the Fab library is fused 
to the amino terminus of the C-terminal domain of the minor coat protein (pIII) of phage M13. The 
restriction sites used for library cloning are indicated: PstI/BsiWI for Vκ2 and MunI/StyI for VH6. “cat” 
denotes the chloramphenicol resistance gene. pMx9_FH expression vector (right); the antibody is 
cloned in the same orientation, and antibiotic resistance is provided by the same antibiotic as in the 
pMorph18 system. M2 Flag- and His-tags are present at the C-terminus of the antibody fragment. 
Both vectors contain the XbaI/EcoRI restriction sites, allowing subcloning of the entire Fab fragment 
from one vector into another.  
3.3 Results 
Figure 3-2. Alignment of unselected library members from the “Vk2 low error” library. Each randomly picked clone is denominated by a number (1 through 8). 
The second column indicates the number of mutation for each clone. The last clone (vk2-6) contains a STOP codon highlighted in green. Additional or lost 
cysteine residues are highlighted in yellow.  
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# mutations CDR-1
ConFab D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L D
vk2-8 3 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L D
vk2-2 3 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L G
vk2-4 7 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L D
vk2-1 6 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L G
vk2-5 8 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y S Y L D
vk2-7 2 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L D
vk2-3 6 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S P L H S N G Y N Y L D
vk2-6 9 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y D Y L D
CDR-2
ConFab W Y L Q K P G Q S P Q L L I Y L G S N R A S G V P D R F S G S G S G T D F T L
vk2-8 W Y L Q K P G Q S P Q L L T Y L G S N R A S G V P D R F S G S G S G T D F T L
vk2-2 W Y L Q K P G Q S P P L L I Y L G S N R A S G V P D R F S G S G S G T D F T L
vk2-4 W Y L Q K P G Q S P Q L S I Y L G S D R A S G V P D R F S G S G F G T G F T L
vk2-1 W Y L R R P G Q S P Q L L I Y L G S N R A S G V P D R F S G S G S G T D F T L
vk2-5 W H L Q K P G Q S P Q L L I Y L G S N R T S G V P G R F S G S G S G T D F T L
vk2-7 W Y L Q K P G Q S P Q L L I Y L G S N R A G G V P D R F S G S G S G T D L T L
vk2-3 W Y L Q K P G Q S P Q L L I H L G S N R A S G V P D R F S G S G S G T D F T L
vk2-6 W Y L R R P G Q Y P * L L V Y L G S N R A G G V P D R F S G S G S G T G F T L
CDR-3
ConFab K I S R V E A E D V G V Y Y C Q H Y N S H P Y T F G Q G T K V E I K R T
vk2-8 K I S R V E A E D V G V Y Y R Q Y Y N S H P Y T F G Q G T K V E I K R T
vk2-2 K I S R V E A E D V G V Y Y C Q R Y N S H P Y T F G Q G T K V E I K R T
vk2-4 K I S C V E A E D V G V Y Y C Q H Y D S H P Y T L G Q G T K V E I K R T
vk2-1 K I S R A E A E D V G V Y Y C Q H C D S H P Y T F G Q G T K V E I K R T
vk2-5 K I S R V E A E D V G V C H C Q H Y N P H P Y T F G Q G P K V E I K R T
vk2-7 K I S R V E A E D V G V Y Y C Q H Y N S H P Y T F G Q G T K V E I K R T
vk2-3 K I S R A E A E D V G V Y Y C Q H Y S S H P Y T F G R G T K I E I K R T
vk2-6 G I S R V E A E D V G V R Y C Q H Y N S H P Y T F G Q G T K V E I K R T  
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All three libraries were independently panned against the biotinylated MHC-gp33 complex 
bound to streptavidin magnetic beads (round 1) and avidin agarose beads (round 2). We 
first performed 2 rounds of selection, using decreasing biotinylated antigen concentration to 
favor selection of improved binders (Figure 3-3). Concomitantly, the concentration of the 
free competitor (non-biotinylated MHC-gp33) and the dissociation time were increased, as 
suggested elsewhere (Hawkins et al., 1992). After none of these first two rounds could any 
significant enrichment be observed: all three libraries showed enrichment factors not higher 
than 2- or 3-fold over a control selection containing only phage particles, magnetic beads 
and non-biotinylated MHC-gp33. However, a dramatic difference was observed in the 
second round of the Vκ2 selection; the number of phages eluted from the sample where off-
rate selection was allowed for 10 minutes was nine times larger than the sample in which 
the off-rate was done for 100 minutes (Figure 3-3). Following these two rounds of initial off-
rate selection, the DNA encoding the pool of selected Fabs with the randomized VH6 
domains (from “high error” and “low error” libraries) was pooled, digested using MunI/StyI 
restriction enzymes and inserted into the phagemid encoding the selected Fabs with the 
randomized Vκ2 domain, digested with the same restriction enzymes. This procedure gave 
rise to a new library, termed “input Round 3” (see below). By this way, the randomized and 
selected variable domains of all three libraries (two from VH, one from VL) were genetically 
combined into the phagemid vector pMorph18. One additional selection round was 
performed with the “input round 3” library, but the clones isolated from this third selection 
round (output R3) could not be sequenced. We assume that some internal deletion 
occurred, thereby removing the annealing sites of the sequencing primers (data not shown).  
 
Figure 3-3. Selection scheme for off-rate selection. On the top, the black bars symbolize the CDRs. The output observed after every selection round 
represents the number of phages recovered for each selection (cfu) compared to a selection control where the biotinylated antigen is absent.
88  SECTION 3
 
 
VH6 input R1 high error (3x106 clones) 
Conditions: 25 nM pMHC⊕biot, 50x 
excess pMHC, 5 min dissociation 
Conditions: 50 nM pMHC⊕biot, 10x 
excess pMHC, 1 min dissociation 
Output R2: 1.8 x 103 cfu, 6 x 102 cfu 
(control) 
VH6 output R1 high error
ROUND 1 
ROUND 2 
 
CH VH6 CL Vk2 CH VH6 Vk2     
 epPCR
CL 
epPCR 
VH6 input R1 low error (106 clones) 
Conditions: 50 nM pMHC⊕biot, 50x 
excess pMHC, 10 min dissociation 
Output R2: 1.2 x 104 cfu (10 min), 
5 x 103 cfu (control) 
Conditions: 25 nM pMHC⊕biot, 
100x excess pMHC, 50 min 
dissociation 
VH6 output R1 low error
ROUND 1 
ROUND 2 
Conditions: 50 nM pMHC⊕biot, 
100x excess pMHC, 10 and 100 min 
dissociation 
Output R2: 7 x 103 cfu (10 min), 8 x 
102 cfu (100 min), 4 x 103 cfu 
(control) 
Conditions: 100 nM 
pMHC⊕biot, 60x excess pMHC, 
1 and 10 min dissociation 
Vk2 input R1 (105 clones) 
Vk2 output R1 
Combine genetically selected domains Æ library „input R3” 
ROUND 1 
ROUND 2
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Single clone analysis of members of the “input R3” library was performed in ELISA format: 
92 clones were expressed as Fab fragments in microtiter plates, and cells were lysed 
chemically by incubating the culture with lysozyme and tested for binding to MHC-gp33, 
MHC-ASIA and β2-microglobulin, all immobilized onto Maxisorp plates. A dozen clones 
showed higher signals (higher absorption at 405 nm), compared to ConFab and were further 
tested for specificity against unrelated peptide-MHC complexes (Figure 3-4). These 
promising clones were sequenced. Curiously, the wild-type parental variable domain of the 
heavy chain has been re-selected for all of them. All the selected Fabs contained the same 
heavy chain sequence as the ConFab, on the amino acid and on the nucleotide level (data 
not shown). All the mutations have been accumulated in the variable domain of the light 
chain. They were evenly distributed between the CDRs and the framework regions with the 
notable exception that the first framework region did not contain any mutated residue. 
Moreover, it was observed that tyrosine residues were quite frequently mutated to cysteine. 
An alignement of a subset of the selected Fabs is shown in Figure 3-5. 
Figure 3-4. Crude extract ELISA performed with single clones of the “input R3” library. After a first 
initial screening, a dozen Fabs were further investigated with regard to their binding specificity against 
MHC-gp33 (blue), MHC-ASIA (yellow) and β2-microglobulin (purple) coated onto a Maxisorp plate. 
Fabs bound to these antigens were detected with an anti-Flag M2 and goat anti-mouse IgG coupled 
to alkaline phosphatase. The background has been subtracted (well containing the coated antigen, 
the detection antibodies, but no Fab fragment). 
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# mutations CDR1
ConFab_A8 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L D
vk2_C4 13 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y S H L D
vk2_D4 6 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L D
vk2_E4 2 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L D
vk2_A8 5 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S S G C N Y L D
vk2_H9 6 D I V M T Q S P L S L P V T P G E P A S I S C R S S Q S L L H S N G Y N Y L D
CDR2
ConFab_A8 W Y L Q K P G Q S P Q L L I Y L G S N R A S G V P D R F S G S G S G T D F T L
vk2_C4 W C L Q K P G Q G P Q L L A Y L G S N R V S G V P G R F S G P G S G T D F T L
vk2_D4 W Y L Q K P D Q S P Q L L I Y P G G S R A S G V P D R F S G S G S G T D F T L
vk2_E4 W Y P Q K P G Q S P Q L L I Y L G S N R A S G V P D R F S G P G S G T D F T L
vk2_A8 W Y L Q K P G Q S P Q L L I Y L G S D R A S G V L D R F S G S G S G T D F T L
vk2_H9 W Y L Q K P G Q S P Q L L I Y L G S N R A S G V P D R L S G P G S G T D P T L
CDR3
ConFab_A8 K I S R V E A E D V G V Y Y C Q H Y N S H P Y T F G Q G T K V E I K R T
vk2_C4 K I S R V E A E D V G V Y Y C Q R Y S S H S Y A L G Q G T K V E I K R T
vk2_D4 K I S R V E A E D V G V Y Y R Q H Y N S H P H T F G Q G T K V E I K R T
vk2_E4 K I S R V E A E D V G V Y Y C Q H Y N S H P Y T F G Q G T K V E I K R T
vk2_A8 K I S R V E A E D V G V Y Y C Q H Y N S H P Y T S G Q G T K V E I K R T
vk2_H9 R I S R V E V E D V G V Y Y C Q H Y N S H P C T F G Q G T K V E I K R T
 
Figure 3-5. Alignment of selected library members from the “Vk2 low error” library. Each clone is denominated by a letter and a number. The second column 
indicates the number of mutations for each clone. Note that no mutations affect the framework region located before the CDR1. Every clone (except E4) 
contains an additional or a removed cysteine residue (highlighted in yellow). 
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Aliquots of an overnight expression culture were loaded on an SDS-PAGE and blotted 
separately for detection via the anti-TetraHis antibody (detecting the heavy chain) or the 
human anti-kappa light chain (binding the Vκ2 domain). Surprisingly, the light chain of every 
selected Fab was found in the insoluble fraction (Figure 3-6). Presence of an additional 
cysteine residue or removal of an existing one could not be the sole reason for this 
observation as Fab_E4, for instance, also showed a precipitated light chain, whereas none 
of its mutations affected cysteine residues (see Figure 3-5). In the Western blot detecting 
the heavy chain, a very faint band is present in the soluble fraction of Fab_A8, Fab_H9 and 
of even stronger intensity for Fab_E4. These three clones were expressed on a bigger scale 
and the Fabs were purified through a Nickel-NTA affinity column (IMAC). By subjecting the 
purified proteins to a mass spectrometry analysis, it turned out that we purified the complete 
heavy chain of the Fab (variable and constant domains) in complex with the cytoplasmic 
chaperone GroEL. This association might likely have arisen during bacterial lysis previous to 
the purification procedure. As expected, addition of adenosine triphosphate in order to 
dissociate the chaperone resulted in the precipitation of the heavy chain of the antibody 
(data not shown).         
(a) (b) 
 
   H9  D4  E4 ConFab A8  C4  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-6. (a) The Fab fragments have been periplasmically expressed at 22°C. After overnight 
growth, cells have been centrifuged, resuspended, lysed by French Press and centrifuged again to 
separate the soluble (s) and the insoluble fraction (p). (b) On a Western blot, the light chains are 
mostly present in the insoluble fraction, whereas a tiny fraction of the heavy chain of Fab_A8, Fab_H9 
and Fab_E4 remains in the soluble fraction. The numbers on the left indicate molecular weight 
standards (in kilodaltons). ConFab stands for the original wild-type Fab fragment used for 
randomization. 
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In view of this quite unexpected result, we decided to analyze the phage pools of each 
library, collected after each selection round. The binding of the phage to MHC-gp33 was 
investigated, as well as the binding to an anti-human kappa light chain antibody. The 
rationale behind this experiment was to investigate whether the selected phage were still 
able to recognize the peptide-MHC complex and display the light chain at their tip, which is 
only associated when the heavy chain is fused to pIII. The two phage ELISAs shown in 
Figure 3-7 brought some informative insights into the mechanism found by the system to 
escape the selection pressure. One can immediately notice the total absence of binding to 
MHC-gp33 for all of the pools, with the notable exception of the “VH6 output R1” (output of 
the first selection round of the VH6 library). The binding signal unequivocally lies below the 
background threshold for most of the analyzed pools (Figure 3-7, upper panel). This was not 
unexpected since the randomization procedure performed by error-prone PCR will have an 
impact on the integrity of the library members, and consequently lead to non-functionality for 
a fraction of them. This is most clearly seen for the light chain, whose presence was 
investigated with an anti-kappa antibody: after one single selection round on the Vκ2 library, 
the signal for binding to the coated anti-kappa antibody was dramatically reduced (Figure 3-
7, upper panel; see “Vκ2 output R1”). However, surprisingly, none of the phage in the pool 
of the “input R3” library displayed a Fab with a functional light chain able to bind the anti-
kappa light chain antibody coated onto the ELISA plate (Figure 3-7b). One has to stress that 
these ELISAs were performed with pools of phage, and by no way did it tell us anything 
about the presence or absence of the light chain for single clones. As shown below, at least 
one clone still displayed its light chain at the phage tip but its signal was quenched in this 
phage ELISA by the overwhelming majority of the clones which had lost it.  
Considering the outcome of this experiment, we investigated the pool of the VH6 
library after one selection round in greater detail (“VH6 output R1”, in Figure 3-7). This pool 
seemed to be slightly enriched in potential binders to MHC-gp33 and the light chain still 
retained its ability to bind the coated anti-kappa light chain antibody. However, it turned out 
that the original ConFab had been re-selected, attesting to the fact that the selection had 
converged to a single and unique sequence. Thus, after two selection rounds, the original 
nucleotide sequence of the parental ConFab had been recovered for all members of the 
VH6 library, no matter if the clones were originating from the “high error” or the “low error “  
sublibrary (data not shown). Considering these disappointing results, the clone Fab_A8 from 
the “input R3 library” was further investigated, as this clone seemed to be the most 
promising one in ELISA performed with crude extracts of proteins (Figure 3-4). The DNA 
encoding the nucleotide sequence of the selected Fab_A8 was subcloned into the vector 
pMorph18 in order to be displayed at the tip of the phage particle. Binding and inhibition to 
various coated antigens were tested. 
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Figure 3-7. Phage ELISAs: analysis of selected pools for binding either to anti-kappa light chain 
antibody (a) or MHC-gp33 (b). Phage pools after the first and before the third selection round were 
incubated with immobilized antigen, either with anti-kappa light chain antibody (a) or MHC-gp33 (b) at 
indicated dilutions (1x1010 or 2x109 phage/ml). The ConFab (parental clone) is included as a control 
on the far right side of each plot. For inhibition experiments, phage pools were pre-incubated with 
excess antigen for 1 hour at RT under constant agitation. Note the different scale on the y-axis in (a) 
and (b). The horizontal line symbolizes the background level, measured from a well containing the 
same reagents, except the phage. The measurements were carried out in triplicates.  
The abbreviations used for the pools are described in Figure 3-3 
phage / ml 
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Very surprisingly, the selected Fab_A8 gave a strong signal for binding to the coated anti-
kappa light chain which could be inhibited with soluble anti-kappa antibody, thus 
demonstrating the presence of a functional light chain displayed at the tip of the phage 
(Figure 3-8, right). A binding signal to MHC-gp33 could be detected as well. Although the 
signal was very weak after background subtraction, the binding to MHC-gp33 could be 
inhibited with an excess of MHC-gp33 in solution, giving credit to the idea that this clone 
might be specific (Figure 3-8, left). Moreover, it could still discriminate between the gp33 and 
ASIA peptide, in full accord with the conclusions drawn from the ELISA performed with the 
periplasmically-expressed protein (Figure 3-4): the signal intensity between the two MHCs 
differed by around 50% in both ELISA formats. This type of assay has been conducted in 
the same way with the ConFab displayed on phage; however the signal was too weak to 
obtain any reliable results (data not shown). 
Taking into account the fact that the selected Fab_A8 lost its light chain upon 
expression in the periplasm of E. coli (Figure 3-6) but was still retaining binding to the MHC-
gp33 (Figure 3-4), we investigated whether the single heavy chain might still display some 
residual binding and specificity. The entire variable domain of the heavy chain (VH6 
subtype) was PCR amplified and inserted into the vector pTFT74, thus allowing expression 
in inclusion bodies. As suggested elsewhere, such domains are heavily prone to 
aggregation when expressed in E. coli (Ewert et al., 2003a; Ewert et al., 2003b). This single-
domain VH6 antibody (“sdVH6”) was expressed in BL21(DE3) strain and refolded at 4°C 
(see “Materials & Methods” for details). The protein had to be prepared freshly for each 
experiment, as it tended to precipitate after 2 days storage at 4°C. 
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Figure 3-8. Phage ELISAs of the selected Fab_A8, isolated from the input R3 library. The antigens 
indicated MHC-gp33, MHC-ASIA, BSA (left plot) and anti-kappa light chain antibody (right plot) were 
coated on a Maxisorp plate. An equal phage concentration (1010 phage/ml) was pipetted into each 
well. For inhibition experiments, phage were pre-incubated with excess antigen (indicated by color 
codes) or buffer (for the “no inhibition” sample) during 1 hour at RT under constant agitation, before 
incubation with the coated antigen. Detection was performed with an anti-M13 antibody coupled to 
horseradish peroxidase (see Materials & Methods”). Note the different scale on the y-axis in the left 
and right plot. Background was subtracted similarly as done in Figure 3-7. 
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 The day after purification, this protein preparation was used in an ELISA assay in 
order to test for binding to MHC-gp33. The results depicted in Figure 3-9 confirmed our 
hypothesis: the single-domain VH6 antibody was able to bind to MHC-gp33, and this 
reaction could be inhibited if ten times excess of free soluble MHC-gp33 was present in the 
well. This reaction showed a reasonable degree of specificity, as a much smaller signal was 
detected if BSA was coated onto the plate. However, the sdVH6 was not able to 
discriminate between the gp33 and the ASIA peptide in the context of an MHC molecule. 
Furthermore, its binding to MHC-gp33 could also be inhibited by excess of BSA. For 
comparison, the same experiment has been performed with the parental ConFab, and the 
binding pattern looked much the same (Figure 3-9). It could not distinguish between the 
gp33 and the ASIA peptide as well, and it sticked to the same extent to coated β2-
microglobulin. The amount of protein (5 µM) used in this assay in order to detect a reliable 
signal hinted at a fairly poor binding constant, thus precluding any visualization of a complex 
formation on a gel filtration column. The same experiment performed with 1 µM protein gave 
a signal at the background level for both the single-domain VH6 and the ConFab (data not 
shown). One could immediately notice, however, that the binding signal to MHC-gp33 was 
clearly higher (around 5-fold) for the single-domain VH6 antibody, which let us suppose that 
the affinity may have been slightly improved.   
 (a) 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
MHC-gp33 MHC-ASIA beta-2micro BSA
coated antigen
O
D
 4
05
 n
m
no inhibition
10x MHC-gp33
10x MHC-ASIA
10x beta-2micro
10x BSA
0
0.05
0.1
0.15
0.2
0.25
MHC-gp33 MHC-ASIA beta-2micro
coated antigen
O
D
 4
05
 n
m
no inhibition
10x MHC-gp33
10x MHC-ASIA
10x beta-2micro
 
 (b) 
 
CDR1
Q V Q L V Q S G P G L V K P G Q T L S L T C A I S G D S V S S N S A A W N W I R
CDR2
Q S P G R G L E W L G R I Y Y R S K W Y N D Y A D S V K G R I T I N P D T S K N
CDR3
Q F Y L Q L N S V T P E D T A V Y Y C A R N Y T N W K Y K D P P Y T P Y G F D Y
linker
W G Q G P L V T V S S G S H H H H H H
Figure 3-9. ELISAs with the purified single-domain VH6 antibody (left plot) and ConFab (right plot). 
(a) In both cases, 5 µM purified protein was used. The signal for binding to the MHC-gp33 is 
significantly higher for the single-domain VH6 (OD405nm = 0.9) than for the parental ConFab (OD405nm = 
0.18). Overall both antibodies behave pretty much the same with regard to their binding to other 
antigens. Background has been subtracted. (b) Amino acid sequence of the single-domain VH6 
antibody, corresponding to the variable domain of the heavy chain alone (VH6 subtype). The three 
CDRs are boxed. A two-amino acid linker was inserted between the protein and the C-terminal hexa-
histidine tag. This sequence is identical to the sequence of the variable domain of the heavy chain of 
the parental ConFab. 
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3.4 Discussion 
 We isolated from our phage display libraries an antibody performing as well as (or 
“as poorly as”!) the parental ConFab. The parental ConFab cannot discriminate between the 
ASIA and gp33 peptide, nor can the single-domain VH6 antibody. Obviously, the off-rate 
selection did not restore the peptide specificity. Furthermore, both antibodies stick to coated 
β2-microglobulin for unknown reasons (Figure 3-9), although a large molar excess of this 
antigen was added as a competitor during all panning steps. In ELISA performed with 
purified proteins, both antibodies could be inhibited with an excess of MHC-gp33 in solution. 
As for the affinity, we cannot affirm to have significantly improved the binding constant, if 
one takes into consideration the ELISA signals in Figure 3-9. The high concentration (5 µM) 
of proteins needed to detect a reliable signal hints at a fairly low affinity, which precludes 
any more precise measurement (e.g. BIACORE). Ideally, the off-rate selection should have 
resulted in a clone showing a ten times improved binding constant compared to the ConFab 
Therefore, it is a fair statement to say that we did not greatly improve the binding 
characteristics of the ConFab, but we also did not make them worse. We eventually fished 
out of the libraries a shortened version of the parental clone, trimmed down to its minimal 
component, sufficient for binding the targeted antigen. 
 It is remarkable that none of the selected Fabs contained a randomized VH 
domain. The sequences perfectly matched those of the parental ConFab, on the amino acid 
as well as on the nucleotide level. The reason for this phenomenon is unknown, but one 
notices that a clone containing a VH domain with a nucleotide sequence exactly identical to 
the ConFab already existed in the input library, VH6 input R1 high error (data not shown). 
This clone might have profited from a selective advantage and predominated over the other 
library members during the selections. 
  Another issue which is worthwile being considered is the case of the light chain 
domain, and especially, why the selected Fabs lost their association with the light chain. It is 
widely accepted that the overall stability of recombinant antibody molecules depends on the 
intrinsic structural stability of the heavy- and light chain as well as on the extrinsic 
stabilization provided by their interaction (reviewed in Worn and Plückthun, 2001). We can 
therefore assume that the intrinsic stability of all the selected light chain domains has been 
severely affected through the randomization procedure, thereby leading to their aggregation 
in the periplasm (Figure 3-6b, lower blot). It was expected that a fraction of them would lose 
their solubility and/or functionality upon library construction, but that all of them were 
rendered inactive was very surprising. The addition or removal of cysteine residues cannot 
by itself account for the aggregation tendency of the selected light chains: one selected 
clone (Fab_E4) has no mutations involving a cysteine residue (Figure 3-5), yet its 
periplasmic expression does not yield a soluble light chain either. Precipitation of the light 
chain domains resulted in heavy chain domains having no partner to pair with in the 
periplasm. This had the major consequence that most of the heavy chains also precipitated, 
due to hydrophobic patches exposure of the former heavy- and light chain interface. 
However, when lysing the bacteria, a proportion of heavy chain fragment remained tightly 
bound to the cytoplasmic chaperone GroEL, thereby ensuring a tiny fraction of correctly 
folded and functional heavy chain domains. This was especially the case for Fab_A8,    
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Fab_H9 and to a greater extent for Fab_E4 (Figure 3-6b, upper blot). Furthermore, if one 
postulates, as suggested elsewhere (Hülsmeyer et al., 2005), that most of the direct 
contacts between the selected Fabs and the MHC-gp33 peptide complex are mediated by 
the heavy chain, an antibody consisting on a single heavy chain could still fulfil its function. 
The absence of the light chain certainly had a severe impact on the overall stability of the 
heavy chain: the hydrophobic interface became thereby much more exposed to the solvent. 
But the GroEL chaperone could enhance the folding of the single heavy chain fragment and 
protects its exposed hydrophobic interface. This complex formation obviously did not affect 
binding, as the gp33 and ASIA peptides could even be discriminated in the MHC context 
(Figure 3-4). The experiments described later on with the engineered single domain VH6 
antibody became possible, maybe due to the unusually 21 amino acid long CDR3 of VH. It 
has been suggested that a long CDR-H3 may partially cover the hydrophobic interface 
region to VL (Ewert et al., 2003b).  
 Finally, one fundamental question remains to be asked: did the system do what we 
wanted it to do? In other words, does the selected Fab_A8 displayed at the phage tip show 
improved binding properties compared to the ConFab? Having a closer look at the Figure 3-
8, one can answer yes. In the phage ELISA format, the selected Fab_A8 does show a 
slightly preferential binding to MHC-gp33 (as opposed to the MHC-ASIA) and is still 
composed of a heavy chain non-covalently associated with a light chain. The weakness of 
the ELISA signal (especially for the ConFab, data not shown) precludes any suppositions 
regarding the magnitude of the affinity improvement. If it did really occur, it certainly does 
not lie in the desired range. In the Fab ELISA format, the 5-fold higher signal of the sdVH6 
bound to MHC-gp33 (Figure 3-9) is appreciable, but the high concentrations of purified 
proteins used in this assay prevent us from drawing reliable conclusions about the affinity 
increase. It is, however, remarkable that the selected Fab_A8 retained its full integrity when 
displayed at the phage tip, meaning that the light chain was still non-covalently associated 
with the heavy chain when fused to pIII and expressed in the phagemid format. The loss of 
the light chain must then be due to a problem occurring during the periplasmic over-
expression of the Fab in the expression vector. The reason for this different behavior of the 
selected Fab_A8 in the two vector systems is unknown.   
 The isolation of a single-domain antibody after panning against an antibody library 
is not uncommon. It has been recently reported that a single light-chain antibody (derived 
from an affinity-matured scFv) was able to prevent aggregation of huntingtin. The authors 
claimed that this is the first reported case where an scFv paratope was mapped entirely to 
the light chain domain (Colby et al., 2004). On the contrary, a recent publication shows the 
preponderant role played by the heavy chain for the recognition of a peptide-MHC complex 
(Figure 3-10). 
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Figure 3-10. Overall topography of the “Hyb3” antibody in complex with the HLA-A1:MAGE-A1 
complex. The MAGE-A1 peptide is colored in pink; its C-terminus is in front (left), or rotated by 90° 
(right). The color code for the Fab, pMHC and CDR loops is given in the legend (Hülsmeyer et al., 
2005). 
 The affinity-matured Fab fragment “Hyb3” contacts the HLA-A1:MAGE-A1 peptide-
MHC complex mainly with its CDR-H3, whereas the CDR-L1 and L2 contribute only 
marginally. In the light chain, only the CDR-L3 makes a direct contribution to the interaction 
by contacting the α-helix of the MHC (Hülsmeyer et al., 2005). This finding clearly illustrates 
that the heavy chain mediates most of the direct contacts with the antigen, adding credence 
to the proposal that an antibody consisting of a single heavy chain might still fulfil its 
function. The affinity of the starting clone (250 µM) could be markedly improved; the best 
improved variant showed an affinity of 14 nM as directly measured by BIACORE. This order 
of magnitude in the binding improvement has already been achieved for many different 
targets, and since the first paper about affinity maturation published in 1992 (Hawkins et al., 
1992), much higher affinity improvements could be realised (Boder et al., 2000; Holler et al., 
2000; Jermutus et al., 2001; Low et al., 1996; Schier et al., 1996; Zahnd et al., 2004). 
 There exist alternative hypotheses to rationalize why the light chain gets so easily 
eliminated during directed evolution. An attractive idea can be found in recent protein 
evolution studies dealing with the plasticity of proteins and their resistance to amino acid 
mutations. Arnold and coworkers postulate that the fractions of folded and thus functional 
mutants gained from a directed evolution experiment can be significantly increased if 
thermodynamically stable parents are used. They provide an algorithm for predicting
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which structures are better amenable to a high mutational load (Bloom et al., 2005). In our 
particular case, it could be interesting to check if the low tolerance for mutations of the 
ConFab is due to a poor thermodynamic stability. This opinion is counterbalanced by other 
authors who notice that sequence plasticity may be an intrinsic feature of naturally occurring 
proteins, giving credence to the widespread belief that many experimental mutations have a 
significant probability in resulting in unchanged or increased stability, but sometimes at the 
expense of functionality (Taverna and Goldstein, 2002). This dilemma between stability and 
functionality is probably what the system had to cope with in our selection, and at a certain 
time it had to choose between the two options in order to circumvent the selection pressure. 
Obviously, it decided to preserve functionality. And since we selected for binding, it did what 
we wanted it to do. 
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Abbreviations 
 
BCIP 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt 
BSA bovine serum albumin 
CDR (e.g. CDR-H1) complementary determining region (e.g. first CDR of the heavy 
chain) 
DMF dimethylformamide 
dNTP desoxy-nucleotide triphosphate 
DTT dithiothreitol 
EDTA ethylene diamine tetra-acetate 
ELISA enzyme linked immunosorbent assay 
epPCR error-prone PCR 
Fab fragment antigen binding (antigen-binding fragment obtained 
by papain digestion of an immunoglobulin) 
HSQC heteronuclear single quantum correlation 
IMAC immobilized metal ion affinity chromatography 
IPTG isopropyl-β-D-thiogalactopyranoside 
MALDI matrix assisted laser ion desorption 
MHC major histocompatibility complex 
MW molecular weight 
NMR nuclear magnetic resonance 
NBT nitro blue tetrazolium 
PBS phosphate buffer saline 
PCR polymerase chain reaction 
PVDF polyvinylidene fluoride 
RT room temperature 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
VH/VL variable domain of the heavy chain / light chain 
4-nPP 4-nitrophenyl phosphate 
HLA Human Leukocyte Antigen (human MHC) 
MAGE melanoma-associated antigen 
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pIII minor coat protein (P03662) 
                 18       25  
M K K L L F A I P L V V P F Y S H S A E T V E S C L 
                          
A K S H T E N S F T N V W K D D K T L D R Y A N Y E 
                          
 54          64       71        
G C L W N A T G V V V C T G D E T Q C Y G T W V P I 
                          
G L A I L E N E G G G S E G G G S E G G G S E G G G 
                          
T K P P E Y G D T P I P G Y T Y I N P L D G T Y P P 
                          
G T E Q N P A N P N P S L E E S Q P L N T F M F Q N 
                          
N R F R N R Q G A L T V Y T G T V T Q G T D P V K T 
                          
                       206   
Y Y Q Y T P V S S K A M Y D A Y W N G K F R D C A F 
                          
          219                
H S G F N E D L F V C E Y Q G Q S S D L P Q P P V N 
                          
A G G G S G G G S G G G S E G G G S E G G G S E G G 
                          
G S E G G G S G G G S G S G D F D Y E K M A N A N K 
                          
G A M T E N A D E N A L Q S D A K G K L D S V A T D 
                          
Y G A A I D G F I G D V S G L A N G N G A T G D F A 
                          
G S N S Q M A Q V G D G D N S P L M N N F R Q Y L P 
                          
             378             
S L P Q S V E C R P F V F S A G K P Y E F S I D C D 
                          
K I N L F R G V F A F L L Y V A T F M Y V F S T F A 
                          
N I L R N K E S                    
 
Amino acid sequence of the pIII minor coat protein from bacteriophage M13  (SwissProt 
entry P03662). The first 18 residues contain the signal sequence. The protein therefore 
starts at position 19 (N1 domain) . Six cysteine residues form three pairs of disulfide bridges 
in the native protein: Cys 25 with Cys 54, Cys 64 with Cys 71 and Cys 206 with Cys 219. 
The glycine-rich linkers are boxed. Ser 378 is replaced by a Glycine in our variant. For more 
details about constructs used for expression and characterization, see section 2-1, page 27.
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TOLR_ECOLI (P05829) 
                   20       
M A R A R G R G R R D L K S E I N I V P L L D V L L
                          
             40             
V L L L I F M A T A P I I T Q S V E V D L P D A T E
                          
                          
S Q A V S S N D N P P V I V E V S G I G Q Y T V V V
                          
                          
E K D R L E R L P P E Q V V A E V S S R F K A N P K
                          
                          
T V F L I G G A K D V P Y D E I I K A L N L L H S A
                          
           142               
G V K S V G L M T Q P I                
 
Amino acid sequence of the TolR protein (SwissProt entry P05829). The first twenty 
positions are the probable cytoplasmic part. Residues 20 to 40 contain a putative signal 
anchor for type II membrane protein. The periplasmic portion starts at position 41. See 
section 2.2 for further details about constructs used for expression and characterization 
(page 45). 
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TONB_ECOLI (P02929) 
M T L D L P R R F P W P T L L S V C I H G A V V A G
     32                     
L L Y T S V H Q V I E L P A P A Q P I S V T M V T P
                          
A D L E P P Q A V Q P P P E P V V E P E P E P E P I 
                         103  
P E P P K E A P V V I E K P K P K P K P K P K P V K
                          
K V Q E Q P K R D V K P V E S R P A S P F E N T A P
                        155  
A R L T S S T A T A A T S K P V T S V A S G P R A L
        164                   
S R N Q P Q Y P A R A Q A L R I E G Q V K V K F D V
                          
T P D G R V D N V Q I L S A K P A N M F E R E V K N
                          
A M R R W R Y E P G K P G S G I V V N I L F K I N G
                          
T T E I Q                       
 
Amino acid sequence of the TonB protein (SwissProt entry P02929). The region anchored in 
the bacterial inner membrane covers the first 32 amino acids. The segment including a 
proline-rich region is boxed, this part is thought to exist in an extended conformation in the 
native protein. The visible part of our crystal structure presented in section 2-3a (page 59) 
starts at position 164, whereas we cloned the fragment starting at position 155. Another 
structure, done with a fragment covering residue 164 to 239 also crystallized as a dimer 
(Koedding et al., 2004). A third structure was solved with a construct including residues 103-
239; this domain was found to be monomeric with several unexpected structural elements 
distinct from the previously determined crystal structures (Sean Peacock et al., 2005). 
Literature 
Koedding, J., Howard, P., Kaufmann, L., Polzer, P., Lustig, A., and Welte, W. (2004). 
Dimerization of TonB Is Not Essential for Its Binding to the Outer Membrane Siderophore 
Receptor FhuA of Escherichia coli. J Biol Chem 279, 9978-9986. 
Sean Peacock, R., Weljie, A. M., Peter Howard, S., Price, F. D., and Vogel, H. J. (2005). 
The Solution Structure of the C-terminal Domain of TonB and Interaction Studies with TonB 
Box Peptides. J Mol Biol 345, 1185-1197. 
 
APPENDIX – CURRICULUM VITAE  113  
 
 
   
   
Curriculum Vitae 
Name Mooser 
First names Alexandre Pierre 
Date and place of birth August 29th 1973 in Fribourg, Switzerland 
Nationality Swiss 
 
Education 
1998-2005 Dissertation in the group of Prof. Dr. Andreas Plückthun, 
Department of Biochemistry, University of Zürich, Switzerland. 
Thesis title: ” Filamentous phage infection of E. coli: mechanistic 
aspects and applications to in vitro protein evolution” 
1994-1998 Diplom in Biology, University of Fribourg, Switzerland. Title of 
the diploma thesis: “Functional analysis of a PI 3-Kinase 
Homologue in C.elegans” conducted at the Department of 
Zoology (Prof. Tobler) 
Summer 1996 Practical training at the Department of Biochemistry, University 
of Zürich, Switzerland (Prof. Hübscher) 
1989 - 1993 Gymnasium, Maturatypus B, Collège St-Michel, Fribourg 
 
